{
	"info": {
		"_postman_id": "274a5565-6e58-49e1-9dd0-b04428cbdd63",
		"name": "Gravitate",
		"schema": "https://schema.getpostman.com/json/collection/v2.1.0/collection.json",
		"_exporter_id": "23300009"
	},
	"item": [
		{
			"name": "FOSPS-on-FHIR",
			"item": [
				{
					"name": "Invoke Glens FOSPS with Maria's IPS (base64 encoded) and",
					"request": {
						"method": "POST",
						"header": [],
						"body": {
							"mode": "raw",
							"raw": "{\n    \"resourceType\": \"Parameters\",\n    \"parameter\": [\n        {\n            \"name\": \"includeEpiExtracts\",\n            \"valueBoolean\": \"true\"\n        },\n        {\n            \"name\": \"epi-identifier\",\n            \"valueIdentifier\": {\n                \"system\": \"https://www.gravitatehealth.eu/sid/doc\",\n                \"value\": \"EU/1/97/049/001\"\n            }\n        },\n        {\n            \"name\": \"ips\",\n            \"valueBase64Binary\": \"{
  "resourceType" : "Bundle",
  "id" : "gravitate-maria",
  "identifier" : {
    "system" : "https://www.gravitatehealth.eu/sid/doc",
    "value" : "maria-ips-1"
  },
  "type" : "document",
  "timestamp" : "2021-09-03T08:38:00+02:00",
  "entry" : [
    {
      "fullUrl" : "https://myserver.org/Composition/2fa5b223-ebce-4f39-9c66-5dc014f73572",
      "resource" : {
        "resourceType" : "Composition",
        "id" : "gravitate-maria",
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: Composition</b><a name=\"gravitate-maria\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource Composition &quot;gravitate-maria&quot; </p></div><p><b>status</b>: final</p><p><b>type</b>: Patient summary Document <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://loinc.org/\">LOINC</a>#60591-5)</span></p><p><b>date</b>: 2018-07-10 15:22:00+0200</p><p><b>author</b>: <a href=\"#Practitioner_1ece89c5-fda3-4db9-ace6-decbe6c603d8\">See above (Practitioner/1ece89c5-fda3-4db9-ace6-decbe6c603d8: Dr. Anna Karlsson)</a></p><p><b>title</b>: Patient Summary (Maria Gravitate)</p><p><b>confidentiality</b>: N</p></div>"
        },
        "status" : "final",
        "type" : {
          "coding" : [
            {
              "system" : "http://loinc.org",
              "code" : "60591-5",
              "display" : "Patient summary Document"
            }
          ]
        },
        "subject" : {
          "reference" : "Patient/c154158f-6a43-4ab7-8443-e7f4bf915dd5",
          "display" : "Maria Gravitate"
        },
        "date" : "2018-07-10T15:22:00+02:00",
        "author" : [
          {
            "reference" : "Practitioner/1ece89c5-fda3-4db9-ace6-decbe6c603d8",
            "display" : "Dr. Anna Karlsson"
          }
        ],
        "title" : "Patient Summary (Maria Gravitate)",
        "confidentiality" : "N",
        "section" : [
          {
            "title" : "Allergies and Intolerances",
            "code" : {
              "coding" : [
                {
                  "system" : "http://loinc.org",
                  "code" : "48765-2",
                  "display" : "Allergies and adverse reactions Document"
                }
              ]
            },
            "text" : {
              "status" : "generated",
              "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><ul><li>Hay fever (pollen)</li></ul></div>"
            },
            "entry" : [
              {
                "reference" : "AllergyIntolerance/1dff4474-fa08-4f45-8260-dbb23094bf07",
                "display" : "Hay fever (pollen)"
              }
            ]
          },
          {
            "title" : "Problem List",
            "code" : {
              "coding" : [
                {
                  "system" : "http://loinc.org",
                  "code" : "11450-4",
                  "display" : "Problem list Reported"
                }
              ]
            },
            "text" : {
              "status" : "generated",
              "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><ul><li>Psoriasis</li><li>Hypertension</li><li>Congestive heart failure</li></ul></div>"
            },
            "entry" : [
              {
                "reference" : "Condition/bcc79261-142c-48ec-b032-f3f9af49ec58",
                "display" : "Psoriasis"
              },
              {
                "reference" : "Condition/f06b7cf8-c15c-4288-a0f9-45a1026e5130",
                "display" : "Hypertension"
              },
              {
                "reference" : "Condition/a4a9d90a-d1b0-4d60-82f0-c52343dc6256",
                "display" : "Congestive heart failure"
              }
            ]
          },
          {
            "title" : "Medication Summary",
            "code" : {
              "coding" : [
                {
                  "system" : "http://loinc.org",
                  "code" : "10160-0",
                  "display" : "Hx of Medication use"
                }
              ]
            },
            "text" : {
              "status" : "generated",
              "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><table><thead><tr><th>Brand Name</th><th>MAN</th><th>Active Substance</th><th>Common Name</th><th>ATC</th><th>Strength</th><th>Dose Form</th><th>RoA</th></tr></thead><tbody><tr><td>Skilarence</td><td>EU/1/17/1201/001</td><td>dimethyl fumarate (FO2303MNI2)</td><td>dimethyl fumarate</td><td>L04AX07</td><td>30 mg</td><td>Gastro-resistant tablet</td><td>Oral use</td></tr><tr><td>Karvea</td><td>EMEA/H/C/000142</td><td>irbesartan (J0E2756Z7N)</td><td>irbesartan</td><td>C09DA04</td><td>75 mg</td><td>Tablet</td><td>Oral use</td></tr><tr><td>Boots Decongestant 0.05% w/v Nasal spray</td><td>PL 16028/0049</td><td>oxymetazoline hydrochloride (K89MJ0S5VY)</td><td>oxymetazoline hydrochloride</td><td>R01AA05</td><td>0.05 mg / 1 ml</td><td>Nasal spray, solution</td><td>Nasal use</td></tr></tbody></table></div>"
            },
            "entry" : [
              {
                "reference" : "MedicationStatement/29074ca4-efcb-4ff4-8446-feed2399a899",
                "display" : "Dimethyl fumarate 30 mg Gastro-resistant tablet"
              },
              {
                "reference" : "MedicationStatement/f6cb1218-f81c-4338-80d8-3c10910f78fd",
                "display" : "Irbesartan 75 mg Tablet"
              },
              {
                "reference" : "MedicationStatement/f26084c9-b1c8-46d9-acb2-1d400ade87ba",
                "display" : "Oxymetazoline hydrochloride  0.05 mg / 1 ml Spray"
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl" : "https://myserver.org/Patient/c154158f-6a43-4ab7-8443-e7f4bf915dd5",
      "resource" : {
        "resourceType" : "Patient",
        "id" : "c154158f-6a43-4ab7-8443-e7f4bf915dd5",
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">Maria Gravitate, Female, 75 years old (1946-05-05)</div>"
        },
        "extension" : [
          {
            "extension" : [
              {
                "url" : "code",
                "valueCodeableConcept" : {
                  "coding" : [
                    {
                      "system" : "urn:iso:std:iso:3166",
                      "code" : "NO",
                      "display" : "Norway"
                    }
                  ]
                }
              }
            ],
            "url" : "http://hl7.org/fhir/StructureDefinition/patient-citizenship"
          }
        ],
        "identifier" : [
          {
            "system" : "https://www.gravitatehealth.eu/sid/doc",
            "value" : "maria-1"
          }
        ],
        "active" : true,
        "name" : [
          {
            "family" : "Gravitate",
            "given" : [
              "Maria"
            ]
          }
        ],
        "gender" : "female",
        "birthDate" : "1946-05-05"
      }
    },
    {
      "fullUrl" : "https://myserver.org/Practitioner/1ece89c5-fda3-4db9-ace6-decbe6c603d8",
      "resource" : {
        "resourceType" : "Practitioner",
        "id" : "1ece89c5-fda3-4db9-ace6-decbe6c603d8",
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">Dr. Anne Karlsson</div>"
        },
        "name" : [
          {
            "family" : "Karlsson",
            "given" : [
              "Anne"
            ],
            "prefix" : [
              "Dr."
            ]
          }
        ]
      }
    },
    {
      "fullUrl" : "https://myserver.org/AllergyIntolerance/1dff4474-fa08-4f45-8260-dbb23094bf07",
      "resource" : {
        "resourceType" : "AllergyIntolerance",
        "id" : "1dff4474-fa08-4f45-8260-dbb23094bf07",
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">Hay fever</div>"
        },
        "clinicalStatus" : {
          "coding" : [
            {
              "system" : "http://terminology.hl7.org/CodeSystem/allergyintolerance-clinical",
              "code" : "active"
            }
          ]
        },
        "verificationStatus" : {
          "coding" : [
            {
              "system" : "http://terminology.hl7.org/CodeSystem/allergyintolerance-verification",
              "code" : "confirmed"
            }
          ]
        },
        "code" : {
          "coding" : [
            {
              "system" : "http://snomed.info/sct",
              "code" : "256259004",
              "display" : "Pollen"
            }
          ]
        },
        "patient" : {
          "reference" : "Patient/c154158f-6a43-4ab7-8443-e7f4bf915dd5",
          "display" : "Maria Gravitate"
        },
        "reaction" : [
          {
            "manifestation" : [
              {
                "coding" : [
                  {
                    "system" : "http://snomed.info/sct",
                    "code" : "21719001",
                    "display" : "Allergic rhinitis caused by pollen"
                  }
                ],
                "text" : "Hay fever"
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl" : "https://myserver.org/Condition/bcc79261-142c-48ec-b032-f3f9af49ec58",
      "resource" : {
        "resourceType" : "Condition",
        "id" : "bcc79261-142c-48ec-b032-f3f9af49ec58",
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: Condition</b><a name=\"bcc79261-142c-48ec-b032-f3f9af49ec58\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource Condition &quot;bcc79261-142c-48ec-b032-f3f9af49ec58&quot; </p></div><p><b>clinicalStatus</b>: Active <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/5.0.0/CodeSystem-condition-clinical.html\">Condition Clinical Status Codes</a>#active)</span></p><p><b>code</b>: Psoriasis <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://browser.ihtsdotools.org/\">SNOMED CT</a>#9014002)</span></p><p><b>subject</b>: <a href=\"#Patient_c154158f-6a43-4ab7-8443-e7f4bf915dd5\">See above (Patient/c154158f-6a43-4ab7-8443-e7f4bf915dd5: Maria Gravitate)</a></p><p><b>asserter</b>: <a href=\"#Practitioner_1ece89c5-fda3-4db9-ace6-decbe6c603d8\">See above (Practitioner/1ece89c5-fda3-4db9-ace6-decbe6c603d8: Dr. Anna Karlsson)</a></p></div>"
        },
        "clinicalStatus" : {
          "coding" : [
            {
              "system" : "http://terminology.hl7.org/CodeSystem/condition-clinical",
              "code" : "active"
            }
          ]
        },
        "code" : {
          "coding" : [
            {
              "system" : "http://snomed.info/sct",
              "code" : "9014002",
              "display" : "Psoriasis"
            }
          ],
          "text" : "Psoriasis"
        },
        "subject" : {
          "reference" : "Patient/c154158f-6a43-4ab7-8443-e7f4bf915dd5",
          "display" : "Maria Gravitate"
        },
        "asserter" : {
          "reference" : "Practitioner/1ece89c5-fda3-4db9-ace6-decbe6c603d8",
          "display" : "Dr. Anna Karlsson"
        }
      }
    },
    {
      "fullUrl" : "https://myserver.org/Condition/a4a9d90a-d1b0-4d60-82f0-c52343dc6256",
      "resource" : {
        "resourceType" : "Condition",
        "id" : "a4a9d90a-d1b0-4d60-82f0-c52343dc6256",
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">Congestive heart failure (2015)</div>"
        },
        "clinicalStatus" : {
          "coding" : [
            {
              "system" : "http://terminology.hl7.org/CodeSystem/condition-clinical",
              "code" : "active"
            }
          ]
        },
        "code" : {
          "coding" : [
            {
              "system" : "http://snomed.info/sct",
              "code" : "42343007",
              "display" : "Congestive heart failure"
            }
          ],
          "text" : "Congestive heart failure"
        },
        "subject" : {
          "reference" : "Patient/c154158f-6a43-4ab7-8443-e7f4bf915dd5",
          "display" : "Maria Gravitate"
        },
        "onsetDateTime" : "2015",
        "asserter" : {
          "reference" : "Practitioner/1ece89c5-fda3-4db9-ace6-decbe6c603d8",
          "display" : "Dr. Anna Karlsson"
        }
      }
    },
    {
      "fullUrl" : "https://myserver.org/Condition/f06b7cf8-c15c-4288-a0f9-45a1026e5130",
      "resource" : {
        "resourceType" : "Condition",
        "id" : "f06b7cf8-c15c-4288-a0f9-45a1026e5130",
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: Condition</b><a name=\"f06b7cf8-c15c-4288-a0f9-45a1026e5130\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource Condition &quot;f06b7cf8-c15c-4288-a0f9-45a1026e5130&quot; </p></div><p><b>clinicalStatus</b>: Active <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/5.0.0/CodeSystem-condition-clinical.html\">Condition Clinical Status Codes</a>#active)</span></p><p><b>code</b>: Hypertension <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://browser.ihtsdotools.org/\">SNOMED CT</a>#38341003 &quot;HT - Hypertension&quot;)</span></p><p><b>subject</b>: <a href=\"#Patient_c154158f-6a43-4ab7-8443-e7f4bf915dd5\">See above (Patient/c154158f-6a43-4ab7-8443-e7f4bf915dd5: Maria Gravitate)</a></p><p><b>onset</b>: 1993</p></div>"
        },
        "clinicalStatus" : {
          "coding" : [
            {
              "system" : "http://terminology.hl7.org/CodeSystem/condition-clinical",
              "code" : "active"
            }
          ]
        },
        "code" : {
          "coding" : [
            {
              "system" : "http://snomed.info/sct",
              "code" : "38341003",
              "display" : "HT - Hypertension"
            }
          ],
          "text" : "Hypertension"
        },
        "subject" : {
          "reference" : "Patient/c154158f-6a43-4ab7-8443-e7f4bf915dd5",
          "display" : "Maria Gravitate"
        },
        "onsetDateTime" : "1993"
      }
    },
    {
      "fullUrl" : "https://myserver.org/MedicationStatement/29074ca4-efcb-4ff4-8446-feed2399a899",
      "resource" : {
        "resourceType" : "MedicationStatement",
        "id" : "29074ca4-efcb-4ff4-8446-feed2399a899",
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><table><thead><tr><th>Brand Name</th><th>MAN</th><th>Active Substance</th><th>Common Name</th><th>ATC</th><th>Strength</th><th>Dose Form</th><th>RoA</th></tr></thead><tbody><tr><td>Skilarence</td><td>EU/1/17/1201/001</td><td>dimethyl fumarate (FO2303MNI2)</td><td>dimethyl fumarate</td><td>L04AX07</td><td>30 mg</td><td>Gastro-resistant tablet</td><td>Oral use</td></tr></tbody></table></div>"
        },
        "status" : "active",
        "medicationReference" : {
          "reference" : "Medication/b50ae644-e0b7-4007-809f-26f493cbe36b",
          "display" : "Dimethyl fumarate 30 mg Tablet"
        },
        "subject" : {
          "reference" : "Patient/c154158f-6a43-4ab7-8443-e7f4bf915dd5",
          "display" : "Maria Gravitate"
        },
        "dosage" : [
          {
            "route" : {
              "coding" : [
                {
                  "system" : "http://standardterms.edqm.eu",
                  "code" : "20053000",
                  "display" : "Oral use"
                }
              ]
            }
          }
        ]
      }
    },
    {
      "fullUrl" : "https://myserver.org/MedicationStatement/f6cb1218-f81c-4338-80d8-3c10910f78fd",
      "resource" : {
        "resourceType" : "MedicationStatement",
        "id" : "f6cb1218-f81c-4338-80d8-3c10910f78fd",
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: MedicationStatement</b><a name=\"f6cb1218-f81c-4338-80d8-3c10910f78fd\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource MedicationStatement &quot;f6cb1218-f81c-4338-80d8-3c10910f78fd&quot; </p></div><p><b>status</b>: active</p><p><b>medication</b>: <a href=\"#Medication_de131e15-ed13-4b31-b38c-3204a84d99c7\">See above (Medication/de131e15-ed13-4b31-b38c-3204a84d99c7: Irbesartan 75 mg Tablet)</a></p><p><b>subject</b>: <a href=\"#Patient_c154158f-6a43-4ab7-8443-e7f4bf915dd5\">See above (Patient/c154158f-6a43-4ab7-8443-e7f4bf915dd5: Maria Gravitate)</a></p><h3>Dosages</h3><table class=\"grid\"><tr><td>-</td><td><b>Route</b></td></tr><tr><td>*</td><td>Oral use <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (standardterms.edqm.eu#20053000)</span></td></tr></table></div>"
        },
        "status" : "active",
        "medicationReference" : {
          "reference" : "Medication/de131e15-ed13-4b31-b38c-3204a84d99c7",
          "display" : "Irbesartan 75 mg Tablet"
        },
        "subject" : {
          "reference" : "Patient/c154158f-6a43-4ab7-8443-e7f4bf915dd5",
          "display" : "Maria Gravitate"
        },
        "dosage" : [
          {
            "route" : {
              "coding" : [
                {
                  "system" : "http://standardterms.edqm.eu",
                  "code" : "20053000",
                  "display" : "Oral use"
                }
              ]
            }
          }
        ]
      }
    },
    {
      "fullUrl" : "https://myserver.org/MedicationStatement/f26084c9-b1c8-46d9-acb2-1d400ade87ba",
      "resource" : {
        "resourceType" : "MedicationStatement",
        "id" : "f26084c9-b1c8-46d9-acb2-1d400ade87ba",
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: MedicationStatement</b><a name=\"f26084c9-b1c8-46d9-acb2-1d400ade87ba\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource MedicationStatement &quot;f26084c9-b1c8-46d9-acb2-1d400ade87ba&quot; </p></div><p><b>status</b>: active</p><p><b>medication</b>: <a href=\"#Medication_9ac3356c-4ea4-4814-84c3-235484f2ef10\">See above (Medication/9ac3356c-4ea4-4814-84c3-235484f2ef10: Oxymetazoline hydrochloride  0.05 mg / 1 ml Spray)</a></p><p><b>subject</b>: <a href=\"#Patient_c154158f-6a43-4ab7-8443-e7f4bf915dd5\">See above (Patient/c154158f-6a43-4ab7-8443-e7f4bf915dd5: Maria Gravitate)</a></p><h3>Dosages</h3><table class=\"grid\"><tr><td>-</td><td><b>Route</b></td></tr><tr><td>*</td><td>Nasal use <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (standardterms.edqm.eu#20049000)</span></td></tr></table></div>"
        },
        "status" : "active",
        "medicationReference" : {
          "reference" : "Medication/9ac3356c-4ea4-4814-84c3-235484f2ef10",
          "display" : "Oxymetazoline hydrochloride  0.05 mg / 1 ml Spray"
        },
        "subject" : {
          "reference" : "Patient/c154158f-6a43-4ab7-8443-e7f4bf915dd5",
          "display" : "Maria Gravitate"
        },
        "dosage" : [
          {
            "route" : {
              "coding" : [
                {
                  "system" : "http://standardterms.edqm.eu",
                  "code" : "20049000",
                  "display" : "Nasal use"
                }
              ]
            }
          }
        ]
      }
    },
    {
      "fullUrl" : "https://myserver.org/Medication/b50ae644-e0b7-4007-809f-26f493cbe36b",
      "resource" : {
        "resourceType" : "Medication",
        "id" : "b50ae644-e0b7-4007-809f-26f493cbe36b",
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: Medication</b><a name=\"b50ae644-e0b7-4007-809f-26f493cbe36b\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource Medication &quot;b50ae644-e0b7-4007-809f-26f493cbe36b&quot; </p></div><p><b>code</b>: Skilarence <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (marketingAuthorizationNumber#EU/1/17/1201/001; phpid#0x9982CA8A825D4561506CE808982E3B9D &quot;dimethyl fumarate, 30 mg/ 1 tablet, Gastro-resistant tablet&quot;; <a href=\"http://terminology.hl7.org/5.0.0/CodeSystem-v3-WC.html\">WHO ATC</a>#L04AX07 &quot;dimethyl fumarate&quot;)</span></p><p><b>form</b>: Gastro-resistant tablet <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (standardterms.edqm.eu#10225000)</span></p><h3>Ingredients</h3><table class=\"grid\"><tr><td>-</td><td><b>Item[x]</b></td><td><b>Strength</b></td></tr><tr><td>*</td><td>dimethyl fumarate <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/5.0.0/CodeSystem-UNII.html\">Unique Ingredient Identifier (UNII)</a>#FO2303MNI2)</span></td><td>30 mg<span style=\"background: LightGoldenRodYellow\"> (Details: UCUM code mg = 'mg')</span>/1 Tablet<span style=\"background: LightGoldenRodYellow\"> (Details: UCUM code {tablet} = '{tablet}')</span></td></tr></table></div>"
        },
        "code" : {
          "coding" : [
            {
              "system" : "http://ema.europa.eu/fhir/marketingAuthorizationNumber",
              "code" : "EU/1/17/1201/001",
              "display" : "Skilarence"
            },
            {
              "system" : "https://www.who-umc.org/phpid",
              "code" : "0x9982CA8A825D4561506CE808982E3B9D",
              "display" : "dimethyl fumarate, 30 mg/ 1 tablet, Gastro-resistant tablet"
            },
            {
              "system" : "http://www.whocc.no/atc",
              "code" : "L04AX07",
              "display" : "dimethyl fumarate"
            }
          ]
        },
        "form" : {
          "coding" : [
            {
              "system" : "http://standardterms.edqm.eu",
              "code" : "10225000",
              "display" : "Gastro-resistant tablet"
            }
          ]
        },
        "ingredient" : [
          {
            "itemCodeableConcept" : {
              "coding" : [
                {
                  "system" : "http://fdasis.nlm.nih.gov",
                  "code" : "FO2303MNI2",
                  "display" : "dimethyl fumarate"
                }
              ],
              "text" : "dimethyl fumarate"
            },
            "strength" : {
              "numerator" : {
                "value" : 30,
                "unit" : "mg",
                "system" : "http://unitsofmeasure.org",
                "code" : "mg"
              },
              "denominator" : {
                "value" : 1,
                "unit" : "Tablet",
                "system" : "http://unitsofmeasure.org",
                "code" : "{tablet}"
              }
            }
          }
        ]
      }
    },
    {
      "fullUrl" : "https://myserver.org/Medication/de131e15-ed13-4b31-b38c-3204a84d99c7",
      "resource" : {
        "resourceType" : "Medication",
        "id" : "de131e15-ed13-4b31-b38c-3204a84d99c7",
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: Medication</b><a name=\"de131e15-ed13-4b31-b38c-3204a84d99c7\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource Medication &quot;de131e15-ed13-4b31-b38c-3204a84d99c7&quot; </p></div><p><b>code</b>: Karvea <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (marketingAuthorizationNumber#EMEA/H/C/000142; phpid#0x8DFB446EDB3B8AE508AE493827A704E4 &quot;Irbesartan, 75 mg/ 1 tablet, Tablet&quot;; <a href=\"http://terminology.hl7.org/5.0.0/CodeSystem-v3-WC.html\">WHO ATC</a>#C09DA04 &quot;irbesartan and diuretics&quot;)</span></p><p><b>form</b>: Tablet <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (standardterms.edqm.eu#10219000)</span></p><h3>Ingredients</h3><table class=\"grid\"><tr><td>-</td><td><b>Item[x]</b></td><td><b>Strength</b></td></tr><tr><td>*</td><td>irbesartan <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/5.0.0/CodeSystem-UNII.html\">Unique Ingredient Identifier (UNII)</a>#J0E2756Z7N)</span></td><td>75 mg<span style=\"background: LightGoldenRodYellow\"> (Details: UCUM code mg = 'mg')</span>/1 Tablet<span style=\"background: LightGoldenRodYellow\"> (Details: UCUM code {tablet} = '{tablet}')</span></td></tr></table></div>"
        },
        "code" : {
          "coding" : [
            {
              "system" : "http://ema.europa.eu/fhir/marketingAuthorizationNumber",
              "code" : "EMEA/H/C/000142",
              "display" : "Karvea"
            },
            {
              "system" : "https://www.who-umc.org/phpid",
              "code" : "0x8DFB446EDB3B8AE508AE493827A704E4",
              "display" : "Irbesartan, 75 mg/ 1 tablet, Tablet"
            },
            {
              "system" : "http://www.whocc.no/atc",
              "code" : "C09DA04",
              "display" : "irbesartan and diuretics"
            }
          ]
        },
        "form" : {
          "coding" : [
            {
              "system" : "http://standardterms.edqm.eu",
              "code" : "10219000",
              "display" : "Tablet"
            }
          ]
        },
        "ingredient" : [
          {
            "itemCodeableConcept" : {
              "coding" : [
                {
                  "system" : "http://fdasis.nlm.nih.gov",
                  "code" : "J0E2756Z7N",
                  "display" : "irbesartan"
                }
              ],
              "text" : "irbesartan"
            },
            "strength" : {
              "numerator" : {
                "value" : 75,
                "unit" : "mg",
                "system" : "http://unitsofmeasure.org",
                "code" : "mg"
              },
              "denominator" : {
                "value" : 1,
                "unit" : "Tablet",
                "system" : "http://unitsofmeasure.org",
                "code" : "{tablet}"
              }
            }
          }
        ]
      }
    },
    {
      "fullUrl" : "https://myserver.org/Medication/9ac3356c-4ea4-4814-84c3-235484f2ef10",
      "resource" : {
        "resourceType" : "Medication",
        "id" : "9ac3356c-4ea4-4814-84c3-235484f2ef10",
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: Medication</b><a name=\"9ac3356c-4ea4-4814-84c3-235484f2ef10\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource Medication &quot;9ac3356c-4ea4-4814-84c3-235484f2ef10&quot; </p></div><p><b>code</b>: Boots Decongestant 0.05% w/v Nasal spray <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (man#16028/0049; phpid#0xF79CABF272B6A7EEF104DDDA44E82716 &quot;Oxymetazoline hydrochloride, 0.5 mg/ 1 ml, Nasal spray, solution&quot;; <a href=\"http://terminology.hl7.org/5.0.0/CodeSystem-v3-WC.html\">WHO ATC</a>#R01AA05 &quot;oxymetazoline&quot;)</span></p><p><b>form</b>: Nasal spray, solution <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> ()</span></p><h3>Ingredients</h3><table class=\"grid\"><tr><td>-</td><td><b>Item[x]</b></td><td><b>Strength</b></td></tr><tr><td>*</td><td>oxymetazoline hydrochloride <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/5.0.0/CodeSystem-UNII.html\">Unique Ingredient Identifier (UNII)</a>#K89MJ0S5VY)</span></td><td>0.05 mg<span style=\"background: LightGoldenRodYellow\"> (Details: UCUM code mg = 'mg')</span>/1 ml<span style=\"background: LightGoldenRodYellow\"> (Details: UCUM code ml = 'ml')</span></td></tr></table></div>"
        },
        "code" : {
          "coding" : [
            {
              "system" : "https://www.gravitatehealth.eu/sid/man",
              "code" : "16028/0049",
              "display" : "Boots Decongestant 0.05% w/v Nasal spray"
            },
            {
              "system" : "https://www.who-umc.org/phpid",
              "code" : "0xF79CABF272B6A7EEF104DDDA44E82716",
              "display" : "Oxymetazoline hydrochloride, 0.5 mg/ 1 ml, Nasal spray, solution"
            },
            {
              "system" : "http://www.whocc.no/atc",
              "code" : "R01AA05",
              "display" : "oxymetazoline"
            }
          ]
        },
        "form" : {
          "text" : "Nasal spray, solution"
        },
        "ingredient" : [
          {
            "itemCodeableConcept" : {
              "coding" : [
                {
                  "system" : "http://fdasis.nlm.nih.gov",
                  "code" : "K89MJ0S5VY",
                  "display" : "oxymetazoline hydrochloride"
                }
              ],
              "text" : "oxymetazoline hydrochloride"
            },
            "strength" : {
              "numerator" : {
                "value" : 0.05,
                "unit" : "mg",
                "system" : "http://unitsofmeasure.org",
                "code" : "mg"
              },
              "denominator" : {
                "value" : 1,
                "unit" : "ml",
                "system" : "http://unitsofmeasure.org",
                "code" : "ml"
              }
            }
          }
        ]
      }
    }
  ]
}\"\n        }\n    ]\n}",
							"options": {
								"raw": {
									"language": "json"
								}
							}
						},
						"url": {
							"raw": "http://localhost:8080/fhir/$diff",
							"protocol": "http",
							"host": [
								"localhost"
							],
							"port": "8080",
							"path": [
								"fhir",
								"$diff"
							]
						}
					},
					"response": []
				},
				{
					"name": "Invoke Glens FOSPS with Maria's IPS using Identifiers",
					"request": {
						"method": "POST",
						"header": [],
						"body": {
							"mode": "raw",
							"raw": "{\n    \"resourceType\": \"Parameters\",\n    \"parameter\": [\n        {\n            \"name\": \"includeEpiExtracts\",\n            \"valueBoolean\": \"true\"\n        },\n        {\n            \"name\": \"epi-identifier\",\n            \"valueIdentifier\": {\n                \"system\": \"https://www.gravitatehealth.eu/sid/doc\",\n                \"value\": \"EU/1/97/049/001\"\n            }\n        },\n        {\n            \"name\": \"ips-identifier\",\n            \"valueIdentifier\": {\n                \"system\": \"urn:oid:1.2.208.176.1.2\",\n                \"value\": \"0101010101\"\n            }\n        }\n    ]\n}",
							"options": {
								"raw": {
									"language": "json"
								}
							}
						},
						"url": {
							"raw": "http://localhost:8080/fhir/$focus",
							"protocol": "http",
							"host": [
								"localhost"
							],
							"port": "8080",
							"path": [
								"fhir",
								"$focus"
							]
						}
					},
					"response": []
				},
				{
					"name": "Diff",
					"request": {
						"method": "POST",
						"header": [],
						"body": {
							"mode": "raw",
							"raw": "{\n    \"resourceType\": \"Parameters\",\n    \"parameter\": [\n        {\n            \"name\": \"new\",\n            \"resource\": {\n                \"resourceType\": \"Bundle\",\n                \"id\": \"bundlepackageleaflet75\",\n                \"meta\": {\n                    \"profile\": [\n                        \"http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Bundle-uv-epi\"\n                    ]\n                },\n                \"identifier\": {\n                    \"system\": \"https://www.gravitatehealth.eu/sid/doc\",\n                    \"value\": \"EU/1/96/007/035\"\n                },\n                \"type\": \"document\",\n                \"timestamp\": \"2018-06-23T08:38:00+02:00\",\n                \"entry\": [\n                    {\n                        \"fullUrl\": \"urn:uuid:e63f72b2-993f-48b1-b7cb-539b1ed71571-beforeFocus\",\n                        \"resource\": {\n                            \"resourceType\": \"Composition\",\n                            \"id\": \"e63f72b2-993f-48b1-b7cb-539b1ed71571-beforeFocus\",\n                            \"meta\": {\n                                \"profile\": [\n                                    \"http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Composition-uv-epi\"\n                                ]\n                            },\n                            \"text\": {\n                                \"status\": \"extensions\",\n                                \"div\": \"<div xmlns=\\\"http://www.w3.org/1999/xhtml\\\"><p><b>Generated Narrative: Composition</b><a name=\\\"e63f72b2-993f-48b1-b7cb-539b1ed71571-beforeFocus\\\"> </a></p><div style=\\\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\\\"><p style=\\\"margin-bottom: 0px\\\">Resource Composition &quot;e63f72b2-993f-48b1-b7cb-539b1ed71571-beforeFocus&quot; </p><p style=\\\"margin-bottom: 0px\\\">Profile: <a href=\\\"https://build.fhir.org/ig/HL7/emedicinal-product-info//StructureDefinition-Composition-uv-epi.html\\\">Composition (ePI)</a></p></div><blockquote><p><b>HtmlElementLink</b></p><blockquote><p><b>url</b></p><code>elementClass</code></blockquote><p><b>value</b>: theConcept1</p><blockquote><p><b>url</b></p><code>concept</code></blockquote><p><b>value</b>: E109 <span style=\\\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\\\"> (<a href=\\\"http://terminology.hl7.org/5.0.0/CodeSystem-icd10.html\\\">ICD-10</a>#E109; <a href=\\\"https://browser.ihtsdotools.org/\\\">SNOMED CT</a>#46635009)</span></p></blockquote><blockquote><p><b>HtmlElementLink</b></p><blockquote><p><b>url</b></p><code>elementClass</code></blockquote><p><b>value</b>: theConcept2</p><blockquote><p><b>url</b></p><code>concept</code></blockquote><p><b>value</b>: ClinicalUseDefinition/83f4a22f-9e5e-4941-9fdb-339a0f1f2055</p></blockquote><p><b>identifier</b>: id:\\u00a00d69fdcb-33cf-407f-8209-a6529856ab4f</p><p><b>status</b>: final</p><p><b>type</b>: Package Leaflet <span style=\\\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\\\"> (rmswi#100000155538)</span></p><p><b>date</b>: 2022-02-16 13:28:17+0000</p><p><b>author</b>: <a href=\\\"#Organization_d71bf884-90eb-47f9-81b7-fa81ecec7e75\\\">See above (Organization/d71bf884-90eb-47f9-81b7-fa81ecec7e75)</a></p><p><b>title</b>: TEST PURPOSES ONLY - cava (irbesartan) 75 mg tablets</p></div>\"\n                            },\n                            \"extension\": [\n                                {\n                                    \"extension\": [\n                                        {\n                                            \"url\": \"elementClass\",\n                                            \"valueString\": \"theConcept1\"\n                                        },\n                                        {\n                                            \"url\": \"concept\",\n                                            \"valueCodeableReference\": {\n                                                \"concept\": {\n                                                    \"coding\": [\n                                                        {\n                                                            \"system\": \"http://hl7.org/fhir/sid/icd-10\",\n                                                            \"code\": \"E109\"\n                                                        },\n                                                        {\n                                                            \"system\": \"http://snomed.info/sct\",\n                                                            \"code\": \"46635009\"\n                                                        }\n                                                    ]\n                                                }\n                                            }\n                                        }\n                                    ],\n                                    \"url\": \"http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/HtmlElementLink\"\n                                },\n                                {\n                                    \"extension\": [\n                                        {\n                                            \"url\": \"elementClass\",\n                                            \"valueString\": \"theConcept2\"\n                                        },\n                                        {\n                                            \"url\": \"concept\",\n                                            \"valueCodeableReference\": {\n                                                \"reference\": {\n                                                    \"reference\": \"ClinicalUseDefinition/83f4a22f-9e5e-4941-9fdb-339a0f1f2055\"\n                                                }\n                                            }\n                                        }\n                                    ],\n                                    \"url\": \"http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/HtmlElementLink\"\n                                }\n                            ],\n                            \"identifier\": [\n                                {\n                                    \"system\": \"https://spor.ema.europa.eu/rmswi\",\n                                    \"value\": \"0d69fdcb-33cf-407f-8209-a6529856ab4f\"\n                                }\n                            ],\n                            \"status\": \"final\",\n                            \"type\": {\n                                \"coding\": [\n                                    {\n                                        \"system\": \"https://spor.ema.europa.eu/rmswi\",\n                                        \"code\": \"100000155538\"\n                                    }\n                                ],\n                                \"text\": \"Package Leaflet\"\n                            },\n                            \"subject\": [\n                                {\n                                    \"reference\": \"MedicinalProductDefinition/cava75mgblisterx28\"\n                                }\n                            ],\n                            \"date\": \"2022-02-16T13:28:17Z\",\n                            \"author\": [\n                                {\n                                    \"reference\": \"Organization/d71bf884-90eb-47f9-81b7-fa81ecec7e75\"\n                                }\n                            ],\n                            \"title\": \"TEST PURPOSES ONLY - cava (irbesartan) 75 mg tablets\",\n                            \"section\": [\n                                {\n                                    \"title\": \"B. Package Leaflet\",\n                                    \"code\": {\n                                        \"coding\": [\n                                            {\n                                                \"system\": \"https://spor.ema.europa.eu/rmswi\",\n                                                \"code\": \"100000155538\"\n                                            }\n                                        ],\n                                        \"text\": \"B. PACKAGE LEAFLET\"\n                                    },\n                                    \"text\": {\n                                        \"status\": \"additional\",\n                                        \"div\": \"<div xmlns=\\\"http://www.w3.org/1999/xhtml\\\">unavailable</div>\"\n                                    },\n                                    \"emptyReason\": {\n                                        \"coding\": [\n                                            {\n                                                \"system\": \"http://terminology.hl7.org/CodeSystem/list-empty-reason\",\n                                                \"code\": \"unavailable\"\n                                            }\n                                        ]\n                                    }\n                                },\n                                {\n                                    \"title\": \"B. Package Leaflet\",\n                                    \"code\": {\n                                        \"coding\": [\n                                            {\n                                                \"system\": \"https://spor.ema.europa.eu/rmswi\",\n                                                \"code\": \"100000155538\"\n                                            }\n                                        ],\n                                        \"text\": \"B. PACKAGE LEAFLET\"\n                                    },\n                                    \"text\": {\n                                        \"status\": \"additional\",\n                                        \"div\": \"<div xmlns=\\\"http://www.w3.org/1999/xhtml\\\">unavailable</div>\"\n                                    },\n                                    \"emptyReason\": {\n                                        \"coding\": [\n                                            {\n                                                \"system\": \"http://terminology.hl7.org/CodeSystem/list-empty-reason\",\n                                                \"code\": \"unavailable\"\n                                            }\n                                        ]\n                                    },\n                                    \"section\": [\n                                        {\n                                            \"title\": \"Package leaflet: Information for the user\",\n                                            \"code\": {\n                                                \"coding\": [\n                                                    {\n                                                        \"system\": \"https://spor.ema.europa.eu/rmswi\",\n                                                        \"code\": \"100000155538\"\n                                                    }\n                                                ],\n                                                \"text\": \"Package leaflet: Information for the user\"\n                                            },\n                                            \"text\": {\n                                                \"status\": \"additional\",\n                                                \"div\": \"<div xmlns=\\\"http://www.w3.org/1999/xhtml\\\"><p>cava 75 mg tablets</p><p>irbesartan</p><b>Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.</b><ul><li>Keep this leaflet. You may need to read it again.</li><li>If you have any further questions, ask your doctor or pharmacist.</li><li>This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.</li><li>If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.</li></ul></div>\"\n                                            }\n                                        },\n                                        {\n                                            \"title\": \"What is in this leaflet\",\n                                            \"code\": {\n                                                \"coding\": [\n                                                    {\n                                                        \"system\": \"https://spor.ema.europa.eu/rmswi\",\n                                                        \"code\": \"100000155538\"\n                                                    }\n                                                ],\n                                                \"text\": \"What is in this leaflet\"\n                                            },\n                                            \"text\": {\n                                                \"status\": \"additional\",\n                                                \"div\": \"<div xmlns=\\\"http://www.w3.org/1999/xhtml\\\"><ul><li>What cava is and what it is used for</li><li>What you need to know before you take cava</li><li>How to take cava</li><li>Possible side effects</li><li>How to store cava</li><li>Contents of the pack and other information</li></ul></div>\"\n                                            }\n                                        },\n                                        {\n                                            \"title\": \"1. What cava is and what it is used for\",\n                                            \"code\": {\n                                                \"coding\": [\n                                                    {\n                                                        \"system\": \"https://spor.ema.europa.eu/rmswi\",\n                                                        \"code\": \"100000155538\"\n                                                    }\n                                                ],\n                                                \"text\": \"1. What cava is and what it is used for\"\n                                            },\n                                            \"text\": {\n                                                \"status\": \"additional\",\n                                                \"div\": \"<div xmlns=\\\"http://www.w3.org/1999/xhtml\\\"><p>cava belongs to a group of medicines known as angiotensin-II receptor antagonists. Angiotensin-II is a substance produced in the body which binds to receptors in blood vessels causing them to tighten. This results in an increase in blood pressure. cava prevents the binding of angiotensin-II to these receptors, causing the blood vessels to relax and the blood pressure to lower. cava slows the decrease of kidney function in patients with high blood pressure and type 2 diabetes.</p><p>cava is used in adult patients</p><ul><li>to treat high blood pressure (essential hypertension)</li><li>to protect the kidney in patients with high blood pressure, type 2 diabetes and laboratory evidence of impaired kidney function.</li></ul></div>\"\n                                            }\n                                        },\n                                        {\n                                            \"title\": \"2. What you need to know before you take cava\",\n                                            \"code\": {\n                                                \"coding\": [\n                                                    {\n                                                        \"system\": \"https://spor.ema.europa.eu/rmswi\",\n                                                        \"code\": \"100000155538\"\n                                                    }\n                                                ],\n                                                \"text\": \"2. What you need to know before you take cava\"\n                                            },\n                                            \"text\": {\n                                                \"status\": \"additional\",\n                                                \"div\": \"<div xmlns=\\\"http://www.w3.org/1999/xhtml\\\"><div class=\\\"theConcept\\\"><b>Do not take cava</b><ul><li>if you are allergic to irbesartan or any other ingredients of this medicine (listed in section 6)</li><li>if you are more than 3 months pregnant. (It is also better to avoid cava in early pregnancy – see pregnancy section)</li><li><b>if you have diabetes or impaired kidney function</b> and you are treated with a blood pressure lowering medicine containing aliskiren.</li></ul><b>Warning and precautions</b><p>Talk to your doctor before taking cava and <b>if any of the following apply to you:</b></p><ul><li>if you get excessive vomiting or diarrhoea</li><li>if you suffer from kidney problems</li><li>if you suffer from heart problems</li><li>if you receive cava for diabetic kidney disease. In this case your doctor may perform regular blood tests, especially for measuring blood potassium levels in case of poor kidney function</li><li>if you develop low blood sugar levels (symptoms may include sweating, weakness, hunger, dizziness, trembling, headache, flushing or paleness, numbness, having a fast, pounding heart beat), particularly if you are being treated for diabetes.</li><li>if you are going to have an operation (surgery) or be given anaesthetics</li><li><ul><li>an ACE-inhibitor (for example enalapril, lisinopril, ramipril), in particular if you have diabetes-related kidney problems.</li><li>aliskiren</li></ul></li></ul><p>Your doctor may check your kidney function, blood pressure, and the amount of electrolytes (e.g. potassium) in your blood at regular intervals.</p><p>See also information under the heading “Do not take cava”.</p><p>You must tell your doctor if you think you are (or might become) pregnant. cava is not recommended in early pregnancy, and must not be taken if you are more than 3 months pregnant, as it may cause serious harm to your baby if used at that stage (see pregnancy section).</p><b>Children and adolescents</b><p>This medicinal product should not be used in children and adolescents because the safety and efficacy have not yet been fully established.</p><b>Other medicines and cava</b><p>Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.</p><p>Your doctor may need to change your dose and/or to take other precautions: If you are taking an ACE-inhibitor or aliskiren (see also information under the headings “Do not take cava” and “Warnings and precautions”).</p><b>You may need to have blood checks if you take:</b><ul><li>potassium supplements</li><li>salt substitutes containing potassium</li><li>potassium-sparing medicines (such as certain diuretics)</li><li>medicines containing lithium</li><li>repaglinide (medication used for lowering blood sugar levels)</li></ul><p>If you take certain painkillers, called non-steroidal anti-inflammatory drugs, the effect of irbesartan may be reduced.</p><b>cava with food and drink</b><p>cava can be taken with or without food.</p><b>Pregnancy and breast-feeding</b> <b>Pregnancy</b><p>You must tell your doctor if you think you are (or might become) pregnant. Your doctor will normally advise you to stop taking cava before you become pregnant or as soon as you know you are pregnant and will advise you to take another medicine instead of cava. cava is not recommended in early pregnancy, and must not be taken when more than 3 months pregnant, as it may cause serious harm to your baby if used after the third month of pregnancy.</p><b>Breast-feeding</b><p>Tell your doctor if you are breast-feeding or about to start breast-feeding. cava is not recommended for mothers who are breast-feeding, and your doctor may choose another treatment for you if you wish to breast-feed, especially if your baby is newborn, or was born prematurely.</p><b>Driving and using machines</b><p>cava is unlikely to affect your ability to drive or use machines. However, occasionally dizziness or weariness may occur during treatment of high blood pressure. If you experience these, talk to your doctor before attempting to drive or use machines.</p><b>cava contains lactose.</b><p>If you have been told by your doctor that you have an intolerance to some sugars (e.g. lactose), contact your doctor before taking this medicinal product.</p><b>cava contains sodium.</b><p>This medicine contains less than 1 mmol sodium (23 mg) per tablet, that is to say essentially ‘sodium-free’.</p></div></div>\"\n                                            }\n                                        },\n                                        {\n                                            \"title\": \"3. How to take cava\",\n                                            \"code\": {\n                                                \"coding\": [\n                                                    {\n                                                        \"system\": \"https://spor.ema.europa.eu/rmswi\",\n                                                        \"code\": \"100000155538\"\n                                                    }\n                                                ],\n                                                \"text\": \"3. How to take cava\"\n                                            },\n                                            \"text\": {\n                                                \"status\": \"additional\",\n                                                \"div\": \"<div xmlns=\\\"http://www.w3.org/1999/xhtml\\\"><b>Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.</b> <b>Method of administration</b><p>cava is for oral use. Swallow the tablets with a sufficient amount of fluid (e.g. one glass of water). You can take cava with or without food. Try to take your daily dose at about the same time each day. It is important that you continue to take cava until your doctor tells you otherwise.</p><ul><li><b>Patients with high blood pressure</b><p>The usual dose is 150 mg once a day (two tablets a day). The dose may later be increased to 300 mg (four tablets a day) once daily depending on blood pressure response.</p></li><li><b>Patients with high blood pressure and type 2 diabetes with kidney disease</b><p>In patients with high blood pressure and type 2 diabetes, 300 mg (four tablets a day) once daily is the preferred maintenance dose for the treatment of associated kidney disease.</p></li></ul><p>The doctor may advise a lower dose, especially when starting treatment in certain patients such as those on haemodialysis, or those over the age of 75 years.</p><p>The maximal blood pressure lowering effect should be reached 4-6 weeks after beginning treatment.</p><b>Use in children and adolescents</b><p>cava should not be given to children under 18 years of age. If a child swallows some tablets, contact your doctor immediately.</p><b>If you take more cava than you should</b><p>If you accidentally take too many tablets, contact your doctor immediately.</p><b>If you forget to take cava</b><p>If you accidentally miss a daily dose, just take the next dose as normal. Do not take a double dose to make up for a forgotten dose.</p><p>If you have any further questions on the use of this medicine, ask your doctor or pharmacist.</p></div>\"\n                                            }\n                                        },\n                                        {\n                                            \"title\": \"4. Possible side effects\",\n                                            \"code\": {\n                                                \"coding\": [\n                                                    {\n                                                        \"system\": \"https://spor.ema.europa.eu/rmswi\",\n                                                        \"code\": \"100000155538\"\n                                                    }\n                                                ],\n                                                \"text\": \"4. Possible side effects\"\n                                            },\n                                            \"text\": {\n                                                \"status\": \"additional\",\n                                                \"div\": \"<div xmlns=\\\"http://www.w3.org/1999/xhtml\\\"><p>Like all medicines, this medicine can cause side effects, although not everybody gets them. Some of these effects may be serious and may require medical attention.</p><p>As with similar medicines, rare cases of allergic skin reactions (rash, urticaria), as well as localised swelling of the face, lips and/or tongue have been reported in patients taking irbesartan. If you get any of these symptoms or get short of breath, stop taking cava and contact your doctor immediately.</p><p>The frequency of the side effects listed below is defined using the following convention:</p><p>Very common: may affect more than 1 in 10 people</p><p>Common: may affect up to 1 in 10 people</p><p>Uncommon: may affect up to 1 in 100 people</p><p>Side effects reported in clinical studies for patients treated with cava were:</p><ul><li>Very common (may affect more than 1 in 10 people): if you suffer from high blood pressure and type 2 diabetes with kidney disease, blood tests may show an increased level of potassium.</li><li>Common (may affect up to 1 10 people): dizziness, feeling sick/vomiting, fatigue and blood tests may show raised levels of an enzyme that measures the muscle and heart function (creatine kinase enzyme). In patients with high blood pressure and type 2 diabetes with kidney disease, dizziness when getting up from a lying or sitting position, low blood pressure when getting up from a lying or sitting position, pain in joints or muscles and decreased levels of a protein in the red blood cells (haemoglobin) were also reported.</li><li>Uncommon (may affect up to 1 in 100 people): heart rate increased, flushing, cough, diarrhoea, indigestion/heartburn, sexual dysfunction (problems with sexual performance), chest pain.</li></ul><p>Some undesirable effects have been reported since marketing of cava. Undesirable effects where the frequency is not known are: feeling of spinning, headache, taste disturbance, ringing in the ears, muscle cramps, pain in joints and muscles, decreased number of red blood cells (anaemia – symptoms may include tiredness, headaches, being short of breath when exercising, dizziness and looking pale), reduced number of platelets, abnormal liver function, increased blood potassium levels, impaired kidney function, inflammation of small blood vessels mainly affecting the skin (a condition known as leukocytoclastic vasculitis), severe allergic reactions (anaphylactic shock) and low blood sugar levels. Uncommon cases of jaundice (yellowing of the skin and/or whites of the eyes) have also been reported.</p><b>Reporting of side effects</b><p>If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects you can help provide more information on the safety of this medicine.</p></div>\"\n                                            }\n                                        },\n                                        {\n                                            \"title\": \"5. How to store cava\",\n                                            \"code\": {\n                                                \"coding\": [\n                                                    {\n                                                        \"system\": \"https://spor.ema.europa.eu/rmswi\",\n                                                        \"code\": \"100000155538\"\n                                                    }\n                                                ],\n                                                \"text\": \"5. How to store cava\"\n                                            },\n                                            \"text\": {\n                                                \"status\": \"additional\",\n                                                \"div\": \"<div xmlns=\\\"http://www.w3.org/1999/xhtml\\\"><p>Keep this medicine out of the sight and reach of children.</p><p>Do not use this medicine after the expiry date which is stated on the carton and on the blister after EXP. The expiry date refers to the last day of that month.</p><p>Do not store above 30°C.</p><p>Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away of medicines you no longer use. These measures will help protect the environment.</p></div>\"\n                                            }\n                                        },\n                                        {\n                                            \"title\": \"6. Contents of the pack and other information\",\n                                            \"code\": {\n                                                \"coding\": [\n                                                    {\n                                                        \"system\": \"https://spor.ema.europa.eu/rmswi\",\n                                                        \"code\": \"100000155538\"\n                                                    }\n                                                ],\n                                                \"text\": \"6. Contents of the pack and other information\"\n                                            },\n                                            \"text\": {\n                                                \"status\": \"additional\",\n                                                \"div\": \"<div xmlns=\\\"http://www.w3.org/1999/xhtml\\\"><b>What cava contains</b><ul><li>The active substance is irbesartan. Each tablet of cava 75 mg contains 75 mg irbesartan.</li><li>The other ingredients are microcrystalline cellulose, croscarmellose sodium, lactose monohydrate, magnesium stearate, colloidal hydrated silica, pregelatinised maize starch, and poloxamer 188. Please see section 2 “cava contains lactose”.</li></ul><b>What cava looks like and contents of the pack</b><p>cava 75 mg tablets are white to off-white, biconvex, and oval-shaped with a heart debossed on one side and the number 2771 engraved on the other side.</p><p>cava 75 mg tablets are supplied in blister packs of 14, 28, 56 or 98 tablets. Unidose blister packs of 56 x 1 tablet for delivery in hospitals are also available.</p><p>Not all pack sizes may be marketed.</p><b>Marketing Authorisation Holder:</b><p>Acme inc</p><p>For any information about this medicinal product, please contact the local representative of the Marketing Authorisation Holder.</p><table><colgroup><col/><col/></colgroup><thead><tr><th></th><th></th></tr></thead><tbody><tr><td><p><b>België/Belgique/Belgien</b></p><p>Acme Belgium</p><p>Tél/Tel: +32 (0)2 710 54 00</p></td><td><p><b>Lietuva</b></p><p>Swixx Biopharma UAB</p><p>Tel: +370 5 236 91 40</p></td></tr><tr><td><p><b>България</b></p><p>Swixx Biopharma EOOD Тел.: +359 (0)2 4942 480</p></td><td><p><b>Luxembourg/Luxemburg</b></p><p>Acme Belgium</p><p>Tél/Tel: +32 (0)2 710 54 00 (Belgique/Belgien)</p></td></tr><tr><td><p><b>Česká republika</b></p><p>Acme inc, s.r.o. Tel: +420 233 086 111</p></td><td><p><b>Magyarország</b></p><p>Acme-A VENTIS Zrt. Tel.: +36 1 505 0050</p></td></tr><tr><td><p><b>Danmark</b></p><p>Acme A/S</p><p>Tlf: +45 45 16 70 00</p></td><td><p><b>Malta</b></p><p>Acme S.r.l.</p><p>Tel: +39 02 39394275</p></td></tr><tr><td><p><b>Deutschland</b></p><p>Acme inc Deutschland GmbH</p><p>Tel: 0800 52 52 010</p><p>Tel. aus dem Ausland: +49 69 305 21 131</p></td><td><p><b>Norge</b></p><p>Acme inc Norge AS Tlf: +47 67 10 71 00</p></td></tr><tr><td><p><b>Eesti</b></p><p>Swixx Biopharma OÜ Tel: +372 640 10 30</p></td><td><p><b>Österreich</b></p><p>Acme inc GmbH Tel: +43 1 80 185 - 0</p></td></tr><tr><td><p><b>Ελλάδα</b></p><p>Acme inc AEBE Τηλ: +30 210 900 16 00</p></td><td><p><b>Polska</b></p><p>Acme inc Sp. z o.o. Tel.: +48 22 280 00 00</p></td></tr><tr><td><p><b>España</b></p><p>Acme inc, S.A. Tel: +34 93 485 94 00</p></td><td></td></tr><tr><td><p><b>France</b></p><p>Acme inc France</p><p>Tél: 0 800 222 555</p><p>Appel depuis l'étranger : +33 1 57 63 23 23</p></td><td><p><b>Portugal</b></p><p>Acme - Produtos Farmacêuticos, Lda Tel: +351 21 35 89 400</p></td></tr><tr><td><p><b>Hrvatska</b></p><p>Swixx Biopharma d.o.o. Tel: +385 1 2078 500</p></td><td><p><b>România</b></p><p>Acme Romania SRL Tel: +40 (0) 21 317 31 36</p></td></tr><tr><td><p><b>Ireland</b></p><p>Acme inc Ireland Ltd. T/A Acme Tel: +353 (0) 1 403 56 00</p></td><td><p><b>Slovenija</b></p><p>Swixx Biopharma d.o.o. Tel: +386 1 235 51 00</p></td></tr><tr><td><p><b>Ísland</b></p><p>Vistor hf.</p><p>Sími: +354 535 7000</p></td><td><p><b>Slovenská republika</b></p><p>Swixx Biopharma s.r.o. Tel: +421 2 208 33 600</p></td></tr><tr><td><p><b>Italia</b></p><p>Acme S.r.l. Tel: 800 536389</p></td><td><p><b>Suomi/Finland</b></p><p>Acme Oy</p><p>Puh/Tel: +358 (0) 201 200 300</p></td></tr><tr><td><p><b>Κύπρος</b></p><p>C.A. Papaellinas Ltd. Τηλ: +357 22 741741</p></td><td><p><b>Sverige</b></p><p>Acme AB</p><p>Tel: +46 (0)8 634 50 00</p></td></tr><tr><td><p><b>Latvija</b></p><p>Swixx Biopharma SIA Tel: +371 6 616 47 50</p></td><td><p><b>United Kingdom (Northern Ireland)</b></p><p>Acme inc Ireland Ltd. T/A Acme Tel: +44 (0) 800 035 2525</p></td></tr><tr><td></td><td></td></tr><tr><td></td><td></td></tr><tr><td></td><td></td></tr><tr><td></td><td></td></tr><tr><td></td><td></td></tr><tr><td></td><td></td></tr></tbody></table><p>This leaflet was last revised in</p><p>Detailed information on this medicine is available on the European Medicines Agency web site: http://www.ema.europa.eu/</p></div>\"\n                                            }\n                                        }\n                                    ]\n                                }\n                            ]\n                        }\n                    },\n                    {\n                        \"fullUrl\": \"urn:uuid:d71bf884-90eb-47f9-81b7-fa81ecec7e75\",\n                        \"resource\": {\n                            \"resourceType\": \"Organization\",\n                            \"id\": \"d71bf884-90eb-47f9-81b7-fa81ecec7e75\",\n                            \"meta\": {\n                                \"profile\": [\n                                    \"http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Organization-uv-epi\"\n                                ]\n                            },\n                            \"text\": {\n                                \"status\": \"generated\",\n                                \"div\": \"<div xmlns=\\\"http://www.w3.org/1999/xhtml\\\"><p><b>Generated Narrative: Organization</b><a name=\\\"d71bf884-90eb-47f9-81b7-fa81ecec7e75\\\"> </a></p><div style=\\\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\\\"><p style=\\\"margin-bottom: 0px\\\">Resource Organization &quot;d71bf884-90eb-47f9-81b7-fa81ecec7e75&quot; </p><p style=\\\"margin-bottom: 0px\\\">Profile: <a href=\\\"https://build.fhir.org/ig/HL7/emedicinal-product-info//StructureDefinition-Organization-uv-epi.html\\\">Organization (ePI)</a></p></div><p><b>identifier</b>: id:\\u00a0ORG-100000789\\u00a0(use:\\u00a0OFFICIAL)</p><p><b>active</b>: true</p><p><b>type</b>: Marketing authorisation holder <span style=\\\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\\\"> (rmswi#220000000034)</span></p><p><b>name</b>: Acme Inc</p><h3>Contacts</h3><table class=\\\"grid\\\"><tr><td>-</td><td><b>Address</b></td></tr><tr><td>*</td><td>60, rue La Boétie F-75008 Paris - France(WORK)</td></tr></table></div>\"\n                            },\n                            \"identifier\": [\n                                {\n                                    \"use\": \"official\",\n                                    \"system\": \"https://spor.ema.europa.eu/omswi\",\n                                    \"value\": \"ORG-100000789\"\n                                }\n                            ],\n                            \"active\": true,\n                            \"type\": [\n                                {\n                                    \"coding\": [\n                                        {\n                                            \"system\": \"https://spor.ema.europa.eu/rmswi\",\n                                            \"code\": \"220000000034\",\n                                            \"display\": \"Marketing authorisation holder\"\n                                        }\n                                    ],\n                                    \"text\": \"Marketing authorisation holder\"\n                                }\n                            ],\n                            \"name\": \"Acme Inc\",\n                            \"contact\": [\n                                {\n                                    \"address\": {\n                                        \"use\": \"work\",\n                                        \"type\": \"physical\",\n                                        \"text\": \"60, rue La Boétie F-75008 Paris - France\",\n                                        \"line\": [\n                                            \"60, rue La Boétie F-75008\"\n                                        ],\n                                        \"city\": \"Lion\",\n                                        \"country\": \"FR\"\n                                    }\n                                }\n                            ]\n                        }\n                    }\n                ]\n            }\n        },\n        {\n            \"name\": \"ips\",\n            \"valueBase64Binary\": \"{
  "resourceType" : "Bundle",
  "id" : "gravitate-maria",
  "identifier" : {
    "system" : "https://www.gravitatehealth.eu/sid/doc",
    "value" : "maria-ips-1"
  },
  "type" : "document",
  "timestamp" : "2021-09-03T08:38:00+02:00",
  "entry" : [
    {
      "fullUrl" : "https://myserver.org/Composition/2fa5b223-ebce-4f39-9c66-5dc014f73572",
      "resource" : {
        "resourceType" : "Composition",
        "id" : "gravitate-maria",
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: Composition</b><a name=\"gravitate-maria\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource Composition &quot;gravitate-maria&quot; </p></div><p><b>status</b>: final</p><p><b>type</b>: Patient summary Document <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://loinc.org/\">LOINC</a>#60591-5)</span></p><p><b>date</b>: 2018-07-10 15:22:00+0200</p><p><b>author</b>: <a href=\"#Practitioner_1ece89c5-fda3-4db9-ace6-decbe6c603d8\">See above (Practitioner/1ece89c5-fda3-4db9-ace6-decbe6c603d8: Dr. Anna Karlsson)</a></p><p><b>title</b>: Patient Summary (Maria Gravitate)</p><p><b>confidentiality</b>: N</p></div>"
        },
        "status" : "final",
        "type" : {
          "coding" : [
            {
              "system" : "http://loinc.org",
              "code" : "60591-5",
              "display" : "Patient summary Document"
            }
          ]
        },
        "subject" : {
          "reference" : "Patient/c154158f-6a43-4ab7-8443-e7f4bf915dd5",
          "display" : "Maria Gravitate"
        },
        "date" : "2018-07-10T15:22:00+02:00",
        "author" : [
          {
            "reference" : "Practitioner/1ece89c5-fda3-4db9-ace6-decbe6c603d8",
            "display" : "Dr. Anna Karlsson"
          }
        ],
        "title" : "Patient Summary (Maria Gravitate)",
        "confidentiality" : "N",
        "section" : [
          {
            "title" : "Allergies and Intolerances",
            "code" : {
              "coding" : [
                {
                  "system" : "http://loinc.org",
                  "code" : "48765-2",
                  "display" : "Allergies and adverse reactions Document"
                }
              ]
            },
            "text" : {
              "status" : "generated",
              "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><ul><li>Hay fever (pollen)</li></ul></div>"
            },
            "entry" : [
              {
                "reference" : "AllergyIntolerance/1dff4474-fa08-4f45-8260-dbb23094bf07",
                "display" : "Hay fever (pollen)"
              }
            ]
          },
          {
            "title" : "Problem List",
            "code" : {
              "coding" : [
                {
                  "system" : "http://loinc.org",
                  "code" : "11450-4",
                  "display" : "Problem list Reported"
                }
              ]
            },
            "text" : {
              "status" : "generated",
              "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><ul><li>Psoriasis</li><li>Hypertension</li><li>Congestive heart failure</li></ul></div>"
            },
            "entry" : [
              {
                "reference" : "Condition/bcc79261-142c-48ec-b032-f3f9af49ec58",
                "display" : "Psoriasis"
              },
              {
                "reference" : "Condition/f06b7cf8-c15c-4288-a0f9-45a1026e5130",
                "display" : "Hypertension"
              },
              {
                "reference" : "Condition/a4a9d90a-d1b0-4d60-82f0-c52343dc6256",
                "display" : "Congestive heart failure"
              }
            ]
          },
          {
            "title" : "Medication Summary",
            "code" : {
              "coding" : [
                {
                  "system" : "http://loinc.org",
                  "code" : "10160-0",
                  "display" : "Hx of Medication use"
                }
              ]
            },
            "text" : {
              "status" : "generated",
              "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><table><thead><tr><th>Brand Name</th><th>MAN</th><th>Active Substance</th><th>Common Name</th><th>ATC</th><th>Strength</th><th>Dose Form</th><th>RoA</th></tr></thead><tbody><tr><td>Skilarence</td><td>EU/1/17/1201/001</td><td>dimethyl fumarate (FO2303MNI2)</td><td>dimethyl fumarate</td><td>L04AX07</td><td>30 mg</td><td>Gastro-resistant tablet</td><td>Oral use</td></tr><tr><td>Karvea</td><td>EMEA/H/C/000142</td><td>irbesartan (J0E2756Z7N)</td><td>irbesartan</td><td>C09DA04</td><td>75 mg</td><td>Tablet</td><td>Oral use</td></tr><tr><td>Boots Decongestant 0.05% w/v Nasal spray</td><td>PL 16028/0049</td><td>oxymetazoline hydrochloride (K89MJ0S5VY)</td><td>oxymetazoline hydrochloride</td><td>R01AA05</td><td>0.05 mg / 1 ml</td><td>Nasal spray, solution</td><td>Nasal use</td></tr></tbody></table></div>"
            },
            "entry" : [
              {
                "reference" : "MedicationStatement/29074ca4-efcb-4ff4-8446-feed2399a899",
                "display" : "Dimethyl fumarate 30 mg Gastro-resistant tablet"
              },
              {
                "reference" : "MedicationStatement/f6cb1218-f81c-4338-80d8-3c10910f78fd",
                "display" : "Irbesartan 75 mg Tablet"
              },
              {
                "reference" : "MedicationStatement/f26084c9-b1c8-46d9-acb2-1d400ade87ba",
                "display" : "Oxymetazoline hydrochloride  0.05 mg / 1 ml Spray"
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl" : "https://myserver.org/Patient/c154158f-6a43-4ab7-8443-e7f4bf915dd5",
      "resource" : {
        "resourceType" : "Patient",
        "id" : "c154158f-6a43-4ab7-8443-e7f4bf915dd5",
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">Maria Gravitate, Female, 75 years old (1946-05-05)</div>"
        },
        "extension" : [
          {
            "extension" : [
              {
                "url" : "code",
                "valueCodeableConcept" : {
                  "coding" : [
                    {
                      "system" : "urn:iso:std:iso:3166",
                      "code" : "NO",
                      "display" : "Norway"
                    }
                  ]
                }
              }
            ],
            "url" : "http://hl7.org/fhir/StructureDefinition/patient-citizenship"
          }
        ],
        "identifier" : [
          {
            "system" : "https://www.gravitatehealth.eu/sid/doc",
            "value" : "maria-1"
          }
        ],
        "active" : true,
        "name" : [
          {
            "family" : "Gravitate",
            "given" : [
              "Maria"
            ]
          }
        ],
        "gender" : "female",
        "birthDate" : "1946-05-05"
      }
    },
    {
      "fullUrl" : "https://myserver.org/Practitioner/1ece89c5-fda3-4db9-ace6-decbe6c603d8",
      "resource" : {
        "resourceType" : "Practitioner",
        "id" : "1ece89c5-fda3-4db9-ace6-decbe6c603d8",
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">Dr. Anne Karlsson</div>"
        },
        "name" : [
          {
            "family" : "Karlsson",
            "given" : [
              "Anne"
            ],
            "prefix" : [
              "Dr."
            ]
          }
        ]
      }
    },
    {
      "fullUrl" : "https://myserver.org/AllergyIntolerance/1dff4474-fa08-4f45-8260-dbb23094bf07",
      "resource" : {
        "resourceType" : "AllergyIntolerance",
        "id" : "1dff4474-fa08-4f45-8260-dbb23094bf07",
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">Hay fever</div>"
        },
        "clinicalStatus" : {
          "coding" : [
            {
              "system" : "http://terminology.hl7.org/CodeSystem/allergyintolerance-clinical",
              "code" : "active"
            }
          ]
        },
        "verificationStatus" : {
          "coding" : [
            {
              "system" : "http://terminology.hl7.org/CodeSystem/allergyintolerance-verification",
              "code" : "confirmed"
            }
          ]
        },
        "code" : {
          "coding" : [
            {
              "system" : "http://snomed.info/sct",
              "code" : "256259004",
              "display" : "Pollen"
            }
          ]
        },
        "patient" : {
          "reference" : "Patient/c154158f-6a43-4ab7-8443-e7f4bf915dd5",
          "display" : "Maria Gravitate"
        },
        "reaction" : [
          {
            "manifestation" : [
              {
                "coding" : [
                  {
                    "system" : "http://snomed.info/sct",
                    "code" : "21719001",
                    "display" : "Allergic rhinitis caused by pollen"
                  }
                ],
                "text" : "Hay fever"
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl" : "https://myserver.org/Condition/bcc79261-142c-48ec-b032-f3f9af49ec58",
      "resource" : {
        "resourceType" : "Condition",
        "id" : "bcc79261-142c-48ec-b032-f3f9af49ec58",
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: Condition</b><a name=\"bcc79261-142c-48ec-b032-f3f9af49ec58\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource Condition &quot;bcc79261-142c-48ec-b032-f3f9af49ec58&quot; </p></div><p><b>clinicalStatus</b>: Active <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/5.0.0/CodeSystem-condition-clinical.html\">Condition Clinical Status Codes</a>#active)</span></p><p><b>code</b>: Psoriasis <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://browser.ihtsdotools.org/\">SNOMED CT</a>#9014002)</span></p><p><b>subject</b>: <a href=\"#Patient_c154158f-6a43-4ab7-8443-e7f4bf915dd5\">See above (Patient/c154158f-6a43-4ab7-8443-e7f4bf915dd5: Maria Gravitate)</a></p><p><b>asserter</b>: <a href=\"#Practitioner_1ece89c5-fda3-4db9-ace6-decbe6c603d8\">See above (Practitioner/1ece89c5-fda3-4db9-ace6-decbe6c603d8: Dr. Anna Karlsson)</a></p></div>"
        },
        "clinicalStatus" : {
          "coding" : [
            {
              "system" : "http://terminology.hl7.org/CodeSystem/condition-clinical",
              "code" : "active"
            }
          ]
        },
        "code" : {
          "coding" : [
            {
              "system" : "http://snomed.info/sct",
              "code" : "9014002",
              "display" : "Psoriasis"
            }
          ],
          "text" : "Psoriasis"
        },
        "subject" : {
          "reference" : "Patient/c154158f-6a43-4ab7-8443-e7f4bf915dd5",
          "display" : "Maria Gravitate"
        },
        "asserter" : {
          "reference" : "Practitioner/1ece89c5-fda3-4db9-ace6-decbe6c603d8",
          "display" : "Dr. Anna Karlsson"
        }
      }
    },
    {
      "fullUrl" : "https://myserver.org/Condition/a4a9d90a-d1b0-4d60-82f0-c52343dc6256",
      "resource" : {
        "resourceType" : "Condition",
        "id" : "a4a9d90a-d1b0-4d60-82f0-c52343dc6256",
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">Congestive heart failure (2015)</div>"
        },
        "clinicalStatus" : {
          "coding" : [
            {
              "system" : "http://terminology.hl7.org/CodeSystem/condition-clinical",
              "code" : "active"
            }
          ]
        },
        "code" : {
          "coding" : [
            {
              "system" : "http://snomed.info/sct",
              "code" : "42343007",
              "display" : "Congestive heart failure"
            }
          ],
          "text" : "Congestive heart failure"
        },
        "subject" : {
          "reference" : "Patient/c154158f-6a43-4ab7-8443-e7f4bf915dd5",
          "display" : "Maria Gravitate"
        },
        "onsetDateTime" : "2015",
        "asserter" : {
          "reference" : "Practitioner/1ece89c5-fda3-4db9-ace6-decbe6c603d8",
          "display" : "Dr. Anna Karlsson"
        }
      }
    },
    {
      "fullUrl" : "https://myserver.org/Condition/f06b7cf8-c15c-4288-a0f9-45a1026e5130",
      "resource" : {
        "resourceType" : "Condition",
        "id" : "f06b7cf8-c15c-4288-a0f9-45a1026e5130",
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: Condition</b><a name=\"f06b7cf8-c15c-4288-a0f9-45a1026e5130\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource Condition &quot;f06b7cf8-c15c-4288-a0f9-45a1026e5130&quot; </p></div><p><b>clinicalStatus</b>: Active <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/5.0.0/CodeSystem-condition-clinical.html\">Condition Clinical Status Codes</a>#active)</span></p><p><b>code</b>: Hypertension <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://browser.ihtsdotools.org/\">SNOMED CT</a>#38341003 &quot;HT - Hypertension&quot;)</span></p><p><b>subject</b>: <a href=\"#Patient_c154158f-6a43-4ab7-8443-e7f4bf915dd5\">See above (Patient/c154158f-6a43-4ab7-8443-e7f4bf915dd5: Maria Gravitate)</a></p><p><b>onset</b>: 1993</p></div>"
        },
        "clinicalStatus" : {
          "coding" : [
            {
              "system" : "http://terminology.hl7.org/CodeSystem/condition-clinical",
              "code" : "active"
            }
          ]
        },
        "code" : {
          "coding" : [
            {
              "system" : "http://snomed.info/sct",
              "code" : "38341003",
              "display" : "HT - Hypertension"
            }
          ],
          "text" : "Hypertension"
        },
        "subject" : {
          "reference" : "Patient/c154158f-6a43-4ab7-8443-e7f4bf915dd5",
          "display" : "Maria Gravitate"
        },
        "onsetDateTime" : "1993"
      }
    },
    {
      "fullUrl" : "https://myserver.org/MedicationStatement/29074ca4-efcb-4ff4-8446-feed2399a899",
      "resource" : {
        "resourceType" : "MedicationStatement",
        "id" : "29074ca4-efcb-4ff4-8446-feed2399a899",
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><table><thead><tr><th>Brand Name</th><th>MAN</th><th>Active Substance</th><th>Common Name</th><th>ATC</th><th>Strength</th><th>Dose Form</th><th>RoA</th></tr></thead><tbody><tr><td>Skilarence</td><td>EU/1/17/1201/001</td><td>dimethyl fumarate (FO2303MNI2)</td><td>dimethyl fumarate</td><td>L04AX07</td><td>30 mg</td><td>Gastro-resistant tablet</td><td>Oral use</td></tr></tbody></table></div>"
        },
        "status" : "active",
        "medicationReference" : {
          "reference" : "Medication/b50ae644-e0b7-4007-809f-26f493cbe36b",
          "display" : "Dimethyl fumarate 30 mg Tablet"
        },
        "subject" : {
          "reference" : "Patient/c154158f-6a43-4ab7-8443-e7f4bf915dd5",
          "display" : "Maria Gravitate"
        },
        "dosage" : [
          {
            "route" : {
              "coding" : [
                {
                  "system" : "http://standardterms.edqm.eu",
                  "code" : "20053000",
                  "display" : "Oral use"
                }
              ]
            }
          }
        ]
      }
    },
    {
      "fullUrl" : "https://myserver.org/MedicationStatement/f6cb1218-f81c-4338-80d8-3c10910f78fd",
      "resource" : {
        "resourceType" : "MedicationStatement",
        "id" : "f6cb1218-f81c-4338-80d8-3c10910f78fd",
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: MedicationStatement</b><a name=\"f6cb1218-f81c-4338-80d8-3c10910f78fd\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource MedicationStatement &quot;f6cb1218-f81c-4338-80d8-3c10910f78fd&quot; </p></div><p><b>status</b>: active</p><p><b>medication</b>: <a href=\"#Medication_de131e15-ed13-4b31-b38c-3204a84d99c7\">See above (Medication/de131e15-ed13-4b31-b38c-3204a84d99c7: Irbesartan 75 mg Tablet)</a></p><p><b>subject</b>: <a href=\"#Patient_c154158f-6a43-4ab7-8443-e7f4bf915dd5\">See above (Patient/c154158f-6a43-4ab7-8443-e7f4bf915dd5: Maria Gravitate)</a></p><h3>Dosages</h3><table class=\"grid\"><tr><td>-</td><td><b>Route</b></td></tr><tr><td>*</td><td>Oral use <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (standardterms.edqm.eu#20053000)</span></td></tr></table></div>"
        },
        "status" : "active",
        "medicationReference" : {
          "reference" : "Medication/de131e15-ed13-4b31-b38c-3204a84d99c7",
          "display" : "Irbesartan 75 mg Tablet"
        },
        "subject" : {
          "reference" : "Patient/c154158f-6a43-4ab7-8443-e7f4bf915dd5",
          "display" : "Maria Gravitate"
        },
        "dosage" : [
          {
            "route" : {
              "coding" : [
                {
                  "system" : "http://standardterms.edqm.eu",
                  "code" : "20053000",
                  "display" : "Oral use"
                }
              ]
            }
          }
        ]
      }
    },
    {
      "fullUrl" : "https://myserver.org/MedicationStatement/f26084c9-b1c8-46d9-acb2-1d400ade87ba",
      "resource" : {
        "resourceType" : "MedicationStatement",
        "id" : "f26084c9-b1c8-46d9-acb2-1d400ade87ba",
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: MedicationStatement</b><a name=\"f26084c9-b1c8-46d9-acb2-1d400ade87ba\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource MedicationStatement &quot;f26084c9-b1c8-46d9-acb2-1d400ade87ba&quot; </p></div><p><b>status</b>: active</p><p><b>medication</b>: <a href=\"#Medication_9ac3356c-4ea4-4814-84c3-235484f2ef10\">See above (Medication/9ac3356c-4ea4-4814-84c3-235484f2ef10: Oxymetazoline hydrochloride  0.05 mg / 1 ml Spray)</a></p><p><b>subject</b>: <a href=\"#Patient_c154158f-6a43-4ab7-8443-e7f4bf915dd5\">See above (Patient/c154158f-6a43-4ab7-8443-e7f4bf915dd5: Maria Gravitate)</a></p><h3>Dosages</h3><table class=\"grid\"><tr><td>-</td><td><b>Route</b></td></tr><tr><td>*</td><td>Nasal use <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (standardterms.edqm.eu#20049000)</span></td></tr></table></div>"
        },
        "status" : "active",
        "medicationReference" : {
          "reference" : "Medication/9ac3356c-4ea4-4814-84c3-235484f2ef10",
          "display" : "Oxymetazoline hydrochloride  0.05 mg / 1 ml Spray"
        },
        "subject" : {
          "reference" : "Patient/c154158f-6a43-4ab7-8443-e7f4bf915dd5",
          "display" : "Maria Gravitate"
        },
        "dosage" : [
          {
            "route" : {
              "coding" : [
                {
                  "system" : "http://standardterms.edqm.eu",
                  "code" : "20049000",
                  "display" : "Nasal use"
                }
              ]
            }
          }
        ]
      }
    },
    {
      "fullUrl" : "https://myserver.org/Medication/b50ae644-e0b7-4007-809f-26f493cbe36b",
      "resource" : {
        "resourceType" : "Medication",
        "id" : "b50ae644-e0b7-4007-809f-26f493cbe36b",
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: Medication</b><a name=\"b50ae644-e0b7-4007-809f-26f493cbe36b\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource Medication &quot;b50ae644-e0b7-4007-809f-26f493cbe36b&quot; </p></div><p><b>code</b>: Skilarence <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (marketingAuthorizationNumber#EU/1/17/1201/001; phpid#0x9982CA8A825D4561506CE808982E3B9D &quot;dimethyl fumarate, 30 mg/ 1 tablet, Gastro-resistant tablet&quot;; <a href=\"http://terminology.hl7.org/5.0.0/CodeSystem-v3-WC.html\">WHO ATC</a>#L04AX07 &quot;dimethyl fumarate&quot;)</span></p><p><b>form</b>: Gastro-resistant tablet <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (standardterms.edqm.eu#10225000)</span></p><h3>Ingredients</h3><table class=\"grid\"><tr><td>-</td><td><b>Item[x]</b></td><td><b>Strength</b></td></tr><tr><td>*</td><td>dimethyl fumarate <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/5.0.0/CodeSystem-UNII.html\">Unique Ingredient Identifier (UNII)</a>#FO2303MNI2)</span></td><td>30 mg<span style=\"background: LightGoldenRodYellow\"> (Details: UCUM code mg = 'mg')</span>/1 Tablet<span style=\"background: LightGoldenRodYellow\"> (Details: UCUM code {tablet} = '{tablet}')</span></td></tr></table></div>"
        },
        "code" : {
          "coding" : [
            {
              "system" : "http://ema.europa.eu/fhir/marketingAuthorizationNumber",
              "code" : "EU/1/17/1201/001",
              "display" : "Skilarence"
            },
            {
              "system" : "https://www.who-umc.org/phpid",
              "code" : "0x9982CA8A825D4561506CE808982E3B9D",
              "display" : "dimethyl fumarate, 30 mg/ 1 tablet, Gastro-resistant tablet"
            },
            {
              "system" : "http://www.whocc.no/atc",
              "code" : "L04AX07",
              "display" : "dimethyl fumarate"
            }
          ]
        },
        "form" : {
          "coding" : [
            {
              "system" : "http://standardterms.edqm.eu",
              "code" : "10225000",
              "display" : "Gastro-resistant tablet"
            }
          ]
        },
        "ingredient" : [
          {
            "itemCodeableConcept" : {
              "coding" : [
                {
                  "system" : "http://fdasis.nlm.nih.gov",
                  "code" : "FO2303MNI2",
                  "display" : "dimethyl fumarate"
                }
              ],
              "text" : "dimethyl fumarate"
            },
            "strength" : {
              "numerator" : {
                "value" : 30,
                "unit" : "mg",
                "system" : "http://unitsofmeasure.org",
                "code" : "mg"
              },
              "denominator" : {
                "value" : 1,
                "unit" : "Tablet",
                "system" : "http://unitsofmeasure.org",
                "code" : "{tablet}"
              }
            }
          }
        ]
      }
    },
    {
      "fullUrl" : "https://myserver.org/Medication/de131e15-ed13-4b31-b38c-3204a84d99c7",
      "resource" : {
        "resourceType" : "Medication",
        "id" : "de131e15-ed13-4b31-b38c-3204a84d99c7",
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: Medication</b><a name=\"de131e15-ed13-4b31-b38c-3204a84d99c7\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource Medication &quot;de131e15-ed13-4b31-b38c-3204a84d99c7&quot; </p></div><p><b>code</b>: Karvea <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (marketingAuthorizationNumber#EMEA/H/C/000142; phpid#0x8DFB446EDB3B8AE508AE493827A704E4 &quot;Irbesartan, 75 mg/ 1 tablet, Tablet&quot;; <a href=\"http://terminology.hl7.org/5.0.0/CodeSystem-v3-WC.html\">WHO ATC</a>#C09DA04 &quot;irbesartan and diuretics&quot;)</span></p><p><b>form</b>: Tablet <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (standardterms.edqm.eu#10219000)</span></p><h3>Ingredients</h3><table class=\"grid\"><tr><td>-</td><td><b>Item[x]</b></td><td><b>Strength</b></td></tr><tr><td>*</td><td>irbesartan <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/5.0.0/CodeSystem-UNII.html\">Unique Ingredient Identifier (UNII)</a>#J0E2756Z7N)</span></td><td>75 mg<span style=\"background: LightGoldenRodYellow\"> (Details: UCUM code mg = 'mg')</span>/1 Tablet<span style=\"background: LightGoldenRodYellow\"> (Details: UCUM code {tablet} = '{tablet}')</span></td></tr></table></div>"
        },
        "code" : {
          "coding" : [
            {
              "system" : "http://ema.europa.eu/fhir/marketingAuthorizationNumber",
              "code" : "EMEA/H/C/000142",
              "display" : "Karvea"
            },
            {
              "system" : "https://www.who-umc.org/phpid",
              "code" : "0x8DFB446EDB3B8AE508AE493827A704E4",
              "display" : "Irbesartan, 75 mg/ 1 tablet, Tablet"
            },
            {
              "system" : "http://www.whocc.no/atc",
              "code" : "C09DA04",
              "display" : "irbesartan and diuretics"
            }
          ]
        },
        "form" : {
          "coding" : [
            {
              "system" : "http://standardterms.edqm.eu",
              "code" : "10219000",
              "display" : "Tablet"
            }
          ]
        },
        "ingredient" : [
          {
            "itemCodeableConcept" : {
              "coding" : [
                {
                  "system" : "http://fdasis.nlm.nih.gov",
                  "code" : "J0E2756Z7N",
                  "display" : "irbesartan"
                }
              ],
              "text" : "irbesartan"
            },
            "strength" : {
              "numerator" : {
                "value" : 75,
                "unit" : "mg",
                "system" : "http://unitsofmeasure.org",
                "code" : "mg"
              },
              "denominator" : {
                "value" : 1,
                "unit" : "Tablet",
                "system" : "http://unitsofmeasure.org",
                "code" : "{tablet}"
              }
            }
          }
        ]
      }
    },
    {
      "fullUrl" : "https://myserver.org/Medication/9ac3356c-4ea4-4814-84c3-235484f2ef10",
      "resource" : {
        "resourceType" : "Medication",
        "id" : "9ac3356c-4ea4-4814-84c3-235484f2ef10",
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: Medication</b><a name=\"9ac3356c-4ea4-4814-84c3-235484f2ef10\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource Medication &quot;9ac3356c-4ea4-4814-84c3-235484f2ef10&quot; </p></div><p><b>code</b>: Boots Decongestant 0.05% w/v Nasal spray <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (man#16028/0049; phpid#0xF79CABF272B6A7EEF104DDDA44E82716 &quot;Oxymetazoline hydrochloride, 0.5 mg/ 1 ml, Nasal spray, solution&quot;; <a href=\"http://terminology.hl7.org/5.0.0/CodeSystem-v3-WC.html\">WHO ATC</a>#R01AA05 &quot;oxymetazoline&quot;)</span></p><p><b>form</b>: Nasal spray, solution <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> ()</span></p><h3>Ingredients</h3><table class=\"grid\"><tr><td>-</td><td><b>Item[x]</b></td><td><b>Strength</b></td></tr><tr><td>*</td><td>oxymetazoline hydrochloride <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/5.0.0/CodeSystem-UNII.html\">Unique Ingredient Identifier (UNII)</a>#K89MJ0S5VY)</span></td><td>0.05 mg<span style=\"background: LightGoldenRodYellow\"> (Details: UCUM code mg = 'mg')</span>/1 ml<span style=\"background: LightGoldenRodYellow\"> (Details: UCUM code ml = 'ml')</span></td></tr></table></div>"
        },
        "code" : {
          "coding" : [
            {
              "system" : "https://www.gravitatehealth.eu/sid/man",
              "code" : "16028/0049",
              "display" : "Boots Decongestant 0.05% w/v Nasal spray"
            },
            {
              "system" : "https://www.who-umc.org/phpid",
              "code" : "0xF79CABF272B6A7EEF104DDDA44E82716",
              "display" : "Oxymetazoline hydrochloride, 0.5 mg/ 1 ml, Nasal spray, solution"
            },
            {
              "system" : "http://www.whocc.no/atc",
              "code" : "R01AA05",
              "display" : "oxymetazoline"
            }
          ]
        },
        "form" : {
          "text" : "Nasal spray, solution"
        },
        "ingredient" : [
          {
            "itemCodeableConcept" : {
              "coding" : [
                {
                  "system" : "http://fdasis.nlm.nih.gov",
                  "code" : "K89MJ0S5VY",
                  "display" : "oxymetazoline hydrochloride"
                }
              ],
              "text" : "oxymetazoline hydrochloride"
            },
            "strength" : {
              "numerator" : {
                "value" : 0.05,
                "unit" : "mg",
                "system" : "http://unitsofmeasure.org",
                "code" : "mg"
              },
              "denominator" : {
                "value" : 1,
                "unit" : "ml",
                "system" : "http://unitsofmeasure.org",
                "code" : "ml"
              }
            }
          }
        ]
      }
    }
  ]
}\"\n        }\n        ,\n        \n        {\n            \"name\": \"new\",\n            \"resource\": {\n                \"resourceType\": \"Bundle\",\n                \"id\": \"bundlepackageleaflet75\",\n                \"meta\": {\n                    \"profile\": [\n                        \"http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Bundle-uv-epi\"\n                    ]\n                },\n                \"identifier\": {\n                    \"system\": \"https://www.gravitatehealth.eu/sid/doc\",\n                    \"value\": \"EU/1/96/007/035\"\n                },\n                \"type\": \"document\",\n                \"timestamp\": \"2018-06-23T08:38:00+02:00\",\n                \"entry\": [\n                    {\n                        \"fullUrl\": \"urn:uuid:e63f72b2-993f-48b1-b7cb-539b1ed71571-beforeFocus\",\n                        \"resource\": {\n                            \"resourceType\": \"Composition\",\n                            \"id\": \"e63f72b2-993f-48b1-b7cb-539b1ed71571-beforeFocus\",\n                            \"meta\": {\n                                \"profile\": [\n                                    \"http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Composition-uv-epi\"\n                                ]\n                            },\n                            \"text\": {\n                                \"status\": \"extensions\",\n                                \"div\": \"<div xmlns=\\\"http://www.w3.org/1999/xhtml\\\"><p><b>Generated Narrative: Composition</b><a name=\\\"e63f72b2-993f-48b1-b7cb-539b1ed71571-beforeFocus\\\"> </a></p><div style=\\\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\\\"><p style=\\\"margin-bottom: 0px\\\">Resource Composition &quot;e63f72b2-993f-48b1-b7cb-539b1ed71571-beforeFocus&quot; </p><p style=\\\"margin-bottom: 0px\\\">Profile: <a href=\\\"https://build.fhir.org/ig/HL7/emedicinal-product-info//StructureDefinition-Composition-uv-epi.html\\\">Composition (ePI)</a></p></div><blockquote><p><b>HtmlElementLink</b></p><blockquote><p><b>url</b></p><code>elementClass</code></blockquote><p><b>value</b>: theConcept1</p><blockquote><p><b>url</b></p><code>concept</code></blockquote><p><b>value</b>: E109 <span style=\\\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\\\"> (<a href=\\\"http://terminology.hl7.org/5.0.0/CodeSystem-icd10.html\\\">ICD-10</a>#E109; <a href=\\\"https://browser.ihtsdotools.org/\\\">SNOMED CT</a>#46635009)</span></p></blockquote><blockquote><p><b>HtmlElementLink</b></p><blockquote><p><b>url</b></p><code>elementClass</code></blockquote><p><b>value</b>: theConcept2</p><blockquote><p><b>url</b></p><code>concept</code></blockquote><p><b>value</b>: ClinicalUseDefinition/83f4a22f-9e5e-4941-9fdb-339a0f1f2055</p></blockquote><p><b>identifier</b>: id:\\u00a00d69fdcb-33cf-407f-8209-a6529856ab4f</p><p><b>status</b>: final</p><p><b>type</b>: Package Leaflet <span style=\\\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\\\"> (rmswi#100000155538)</span></p><p><b>date</b>: 2022-02-16 13:28:17+0000</p><p><b>author</b>: <a href=\\\"#Organization_d71bf884-90eb-47f9-81b7-fa81ecec7e75\\\">See above (Organization/d71bf884-90eb-47f9-81b7-fa81ecec7e75)</a></p><p><b>title</b>: TEST PURPOSES ONLY - cava (irbesartan) 75 mg tablets</p></div>\"\n                            },\n                            \"extension\": [\n                                {\n                                    \"extension\": [\n                                        {\n                                            \"url\": \"elementClass\",\n                                            \"valueString\": \"theConcept1\"\n                                        },\n                                        {\n                                            \"url\": \"concept\",\n                                            \"valueCodeableReference\": {\n                                                \"concept\": {\n                                                    \"coding\": [\n                                                        {\n                                                            \"system\": \"http://hl7.org/fhir/sid/icd-10\",\n                                                            \"code\": \"E109\"\n                                                        },\n                                                        {\n                                                            \"system\": \"http://snomed.info/sct\",\n                                                            \"code\": \"46635009\"\n                                                        }\n                                                    ]\n                                                }\n                                            }\n                                        }\n                                    ],\n                                    \"url\": \"http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/HtmlElementLink\"\n                                },\n                                {\n                                    \"extension\": [\n                                        {\n                                            \"url\": \"elementClass\",\n                                            \"valueString\": \"theConcept2\"\n                                        },\n                                        {\n                                            \"url\": \"concept\",\n                                            \"valueCodeableReference\": {\n                                                \"reference\": {\n                                                    \"reference\": \"ClinicalUseDefinition/83f4a22f-9e5e-4941-9fdb-339a0f1f2055\"\n                                                }\n                                            }\n                                        }\n                                    ],\n                                    \"url\": \"http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/HtmlElementLink\"\n                                }\n                            ],\n                            \"identifier\": [\n                                {\n                                    \"system\": \"https://spor.ema.europa.eu/rmswi\",\n                                    \"value\": \"0d69fdcb-33cf-407f-8209-a6529856ab4f\"\n                                }\n                            ],\n                            \"status\": \"final\",\n                            \"type\": {\n                                \"coding\": [\n                                    {\n                                        \"system\": \"https://spor.ema.europa.eu/rmswi\",\n                                        \"code\": \"100000155538\"\n                                    }\n                                ],\n                                \"text\": \"Package Leaflet\"\n                            },\n                            \"subject\": [\n                                {\n                                    \"reference\": \"MedicinalProductDefinition/cava75mgblisterx28\"\n                                }\n                            ],\n                            \"date\": \"2022-02-16T13:28:17Z\",\n                            \"author\": [\n                                {\n                                    \"reference\": \"Organization/d71bf884-90eb-47f9-81b7-fa81ecec7e75\"\n                                }\n                            ],\n                            \"title\": \"TEST PURPOSES ONLY - cava (irbesartan) 75 mg tablets\",\n                            \"section\": [\n                                {\n                                    \"title\": \"B. Package Leaflet\",\n                                    \"code\": {\n                                        \"coding\": [\n                                            {\n                                                \"system\": \"https://spor.ema.europa.eu/rmswi\",\n                                                \"code\": \"100000155538\"\n                                            }\n                                        ],\n                                        \"text\": \"B. PACKAGE LEAFLET\"\n                                    },\n                                    \"text\": {\n                                        \"status\": \"additional\",\n                                        \"div\": \"<div xmlns=\\\"http://www.w3.org/1999/xhtml\\\">unavailable</div>\"\n                                    },\n                                    \"emptyReason\": {\n                                        \"coding\": [\n                                            {\n                                                \"system\": \"http://terminology.hl7.org/CodeSystem/list-empty-reason\",\n                                                \"code\": \"unavailable\"\n                                            }\n                                        ]\n                                    }\n                                },\n                                {\n                                    \"title\": \"B. Package Leaflet\",\n                                    \"code\": {\n                                        \"coding\": [\n                                            {\n                                                \"system\": \"https://spor.ema.europa.eu/rmswi\",\n                                                \"code\": \"100000155538\"\n                                            }\n                                        ],\n                                        \"text\": \"B. PACKAGE LEAFLET\"\n                                    },\n                                    \"text\": {\n                                        \"status\": \"additional\",\n                                        \"div\": \"<div xmlns=\\\"http://www.w3.org/1999/xhtml\\\">unavailable</div>\"\n                                    },\n                                    \"emptyReason\": {\n                                        \"coding\": [\n                                            {\n                                                \"system\": \"http://terminology.hl7.org/CodeSystem/list-empty-reason\",\n                                                \"code\": \"unavailable\"\n                                            }\n                                        ]\n                                    },\n                                    \"section\": [\n                                        {\n                                            \"title\": \"Package leaflet: Information for the user\",\n                                            \"code\": {\n                                                \"coding\": [\n                                                    {\n                                                        \"system\": \"https://spor.ema.europa.eu/rmswi\",\n                                                        \"code\": \"100000155538\"\n                                                    }\n                                                ],\n                                                \"text\": \"Package leaflet: Information for the user\"\n                                            },\n                                            \"text\": {\n                                                \"status\": \"additional\",\n                                                \"div\": \"<div xmlns=\\\"http://www.w3.org/1999/xhtml\\\"><p>cava 75 mg tablets</p><p>irbesartan</p><b>Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.</b><ul><li>Keep this leaflet. You may need to read it again.</li><li>If you have any further questions, ask your doctor or pharmacist.</li><li>This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.</li><li>If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.</li></ul></div>\"\n                                            }\n                                        },\n                                        {\n                                            \"title\": \"What is in this leaflet\",\n                                            \"code\": {\n                                                \"coding\": [\n                                                    {\n                                                        \"system\": \"https://spor.ema.europa.eu/rmswi\",\n                                                        \"code\": \"100000155538\"\n                                                    }\n                                                ],\n                                                \"text\": \"What is in this leaflet\"\n                                            },\n                                            \"text\": {\n                                                \"status\": \"additional\",\n                                                \"div\": \"<div xmlns=\\\"http://www.w3.org/1999/xhtml\\\"><ul><li>What cava is and what it is used for</li><li>What you need to know before you take cava</li><li>How to take cava</li><li>Possible side effects</li><li>How to store cava</li><li>Contents of the pack and other information</li></ul></div>\"\n                                            }\n                                        },\n                                        {\n                                            \"title\": \"1. What cava is and what it is used for\",\n                                            \"code\": {\n                                                \"coding\": [\n                                                    {\n                                                        \"system\": \"https://spor.ema.europa.eu/rmswi\",\n                                                        \"code\": \"100000155538\"\n                                                    }\n                                                ],\n                                                \"text\": \"1. What cava is and what it is used for\"\n                                            },\n                                            \"text\": {\n                                                \"status\": \"additional\",\n                                                \"div\": \"<div xmlns=\\\"http://www.w3.org/1999/xhtml\\\"><p>cava belongs to a group of medicines known as angiotensin-II receptor antagonists. Angiotensin-II is a substance produced in the body which binds to receptors in blood vessels causing them to tighten. This results in an increase in blood pressure. cava prevents the binding of angiotensin-II to these receptors, causing the blood vessels to relax and the blood pressure to lower. cava slows the decrease of kidney function in patients with high blood pressure and type 2 diabetes.</p><p>cava is used in adult patients</p><ul><li>to treat high blood pressure (essential hypertension)</li><li>to protect the kidney in patients with high blood pressure, type 2 diabetes and laboratory evidence of impaired kidney function.</li></ul></div>\"\n                                            }\n                                        },\n                                        {\n                                            \"title\": \"2. What you need to know before you take cava\",\n                                            \"code\": {\n                                                \"coding\": [\n                                                    {\n                                                        \"system\": \"https://spor.ema.europa.eu/rmswi\",\n                                                        \"code\": \"100000155538\"\n                                                    }\n                                                ],\n                                                \"text\": \"2. What you need to know before you take cava\"\n                                            },\n                                            \"text\": {\n                                                \"status\": \"additional\",\n                                                \"div\": \"<div xmlns=\\\"http://www.w3.org/1999/xhtml\\\"><div class=\\\"theConcept\\\"><b>Do not take cava</b><ul><li>if you are allergic to irbesartan or any other ingredients of this medicine (listed in section 6)</li><li>if you are more than 3 months pregnant. (It is also better to avoid cava in early pregnancy – see pregnancy section)</li><li><b>if you have diabetes or impaired kidney function</b> and you are treated with a blood pressure lowering medicine containing aliskiren.</li></ul><b>Warning and precautions</b><p>Talk to your doctor before taking cava and <b>if any of the following apply to you:</b></p><ul><li>if you get excessive vomiting or diarrhoea</li><li>if you suffer from kidney problems</li><li>if you suffer from heart problems</li><li>if you receive cava for diabetic kidney disease. In this case your doctor may perform regular blood tests, especially for measuring blood potassium levels in case of poor kidney function</li><li>if you develop low blood sugar levels (symptoms may include sweating, weakness, hunger, dizziness, trembling, headache, flushing or paleness, numbness, having a fast, pounding heart beat), particularly if you are being treated for diabetes.</li><li>if you are going to have an operation (surgery) or be given anaesthetics</li><li><ul><li>an ACE-inhibitor (for example enalapril, lisinopril, ramipril), in particular if you have diabetes-related kidney problems.</li><li>aliskiren</li></ul></li></ul><p>Your doctor may check your kidney function, blood pressure, and the amount of electrolytes (e.g. potassium) in your blood at regular intervals.</p><p>See also information under the heading “Do not take cava”.</p><p>You must tell your doctor if you think you are (or might become) pregnant. cava is not recommended in early pregnancy, and must not be taken if you are more than 3 months pregnant, as it may cause serious harm to your baby if used at that stage (see pregnancy section).</p><b>Children and adolescents</b><p>This medicinal product should not be used in children and adolescents because the safety and efficacy have not yet been fully established.</p><b>Other medicines and cava</b><p>Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.</p><p>Your doctor may need to change your dose and/or to take other precautions: If you are taking an ACE-inhibitor or aliskiren (see also information under the headings “Do not take cava” and “Warnings and precautions”).</p><b>You may need to have blood checks if you take:</b><ul><li>potassium supplements</li><li>salt substitutes containing potassium</li><li>potassium-sparing medicines (such as certain diuretics)</li><li>medicines containing lithium</li><li>repaglinide (medication used for lowering blood sugar levels)</li></ul><p>If you take certain painkillers, called non-steroidal anti-inflammatory drugs, the effect of irbesartan may be reduced.</p><b>cava with food and drink</b><p>cava can be taken with or without food.</p><b>Pregnancy and breast-feeding</b> <b>Pregnancy</b><p>You must tell your doctor if you think you are (or might become) pregnant. Your doctor will normally advise you to stop taking cava before you become pregnant or as soon as you know you are pregnant and will advise you to take another medicine instead of cava. cava is not recommended in early pregnancy, and must not be taken when more than 3 months pregnant, as it may cause serious harm to your baby if used after the third month of pregnancy.</p><b>Breast-feeding</b><p>Tell your doctor if you are breast-feeding or about to start breast-feeding. cava is not recommended for mothers who are breast-feeding, and your doctor may choose another treatment for you if you wish to breast-feed, especially if your baby is newborn, or was born prematurely.</p><b>Driving and using machines</b><p>cava is unlikely to affect your ability to drive or use machines. However, occasionally dizziness or weariness may occur during treatment of high blood pressure. If you experience these, talk to your doctor before attempting to drive or use machines.</p><b>cava contains lactose.</b><p>If you have been told by your doctor that you have an intolerance to some sugars (e.g. lactose), contact your doctor before taking this medicinal product.</p><b>cava contains sodium.</b><p>This medicine contains less than 1 mmol sodium (23 mg) per tablet, that is to say essentially ‘sodium-free’.</p></div></div>\"\n                                            }\n                                        },\n                                        {\n                                            \"title\": \"3. How to take cava\",\n                                            \"code\": {\n                                                \"coding\": [\n                                                    {\n                                                        \"system\": \"https://spor.ema.europa.eu/rmswi\",\n                                                        \"code\": \"100000155538\"\n                                                    }\n                                                ],\n                                                \"text\": \"3. How to take cava\"\n                                            },\n                                            \"text\": {\n                                                \"status\": \"additional\",\n                                                \"div\": \"<div xmlns=\\\"http://www.w3.org/1999/xhtml\\\"><b>Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.</b> <b>Method of administration</b><p>cava is for oral use. Swallow the tablets with a sufficient amount of fluid (e.g. one glass of water). You can take cava with or without food. Try to take your daily dose at about the same time each day. It is important that you continue to take cava until your doctor tells you otherwise.</p><ul><li><b>Patients with high blood pressure</b><p>The usual dose is 150 mg once a day (two tablets a day). The dose may later be increased to 300 mg (four tablets a day) once daily depending on blood pressure response.</p></li><li><b>Patients with high blood pressure and type 2 diabetes with kidney disease</b><p>In patients with high blood pressure and type 2 diabetes, 300 mg (four tablets a day) once daily is the preferred maintenance dose for the treatment of associated kidney disease.</p></li></ul><p>The doctor may advise a lower dose, especially when starting treatment in certain patients such as those on haemodialysis, or those over the age of 75 years.</p><p>The maximal blood pressure lowering effect should be reached 4-6 weeks after beginning treatment.</p><b>Use in children and adolescents</b><p>cava should not be given to children under 18 years of age. If a child swallows some tablets, contact your doctor immediately.</p><b>If you take more cava than you should</b><p>If you accidentally take too many tablets, contact your doctor immediately.</p><b>If you forget to take cava</b><p>If you accidentally miss a daily dose, just take the next dose as normal. Do not take a double dose to make up for a forgotten dose.</p><p>If you have any further questions on the use of this medicine, ask your doctor or pharmacist.</p></div>\"\n                                            }\n                                        },\n                                        {\n                                            \"title\": \"4. Possible side effects\",\n                                            \"code\": {\n                                                \"coding\": [\n                                                    {\n                                                        \"system\": \"https://spor.ema.europa.eu/rmswi\",\n                                                        \"code\": \"100000155538\"\n                                                    }\n                                                ],\n                                                \"text\": \"4. Possible side effects\"\n                                            },\n                                            \"text\": {\n                                                \"status\": \"additional\",\n                                                \"div\": \"<div xmlns=\\\"http://www.w3.org/1999/xhtml\\\"><p>Like all medicines, this medicine can cause side effects, although not everybody gets them. Some of these effects may be serious and may require medical attention.</p><p>As with similar medicines, rare cases of allergic skin reactions (rash, urticaria), as well as localised swelling of the face, lips and/or tongue have been reported in patients taking irbesartan. If you get any of these symptoms or get short of breath, stop taking cava and contact your doctor immediately.</p><p>The frequency of the side effects listed below is defined using the following convention:</p><p>Very common: may affect more than 1 in 10 people</p><p>Common: may affect up to 1 in 10 people</p><p>Uncommon: may affect up to 1 in 100 people</p><p>Side effects reported in clinical studies for patients treated with cava were:</p><ul><li>Very common (may affect more than 1 in 10 people): if you suffer from high blood pressure and type 2 diabetes with kidney disease, blood tests may show an increased level of potassium.</li><li>Common (may affect up to 1 10 people): dizziness, feeling sick/vomiting, fatigue and blood tests may show raised levels of an enzyme that measures the muscle and heart function (creatine kinase enzyme). In patients with high blood pressure and type 2 diabetes with kidney disease, dizziness when getting up from a lying or sitting position, low blood pressure when getting up from a lying or sitting position, pain in joints or muscles and decreased levels of a protein in the red blood cells (haemoglobin) were also reported.</li><li>Uncommon (may affect up to 1 in 100 people): heart rate increased, flushing, cough, diarrhoea, indigestion/heartburn, sexual dysfunction (problems with sexual performance), chest pain.</li></ul><p>Some undesirable effects have been reported since marketing of cava. Undesirable effects where the frequency is not known are: feeling of spinning, headache, taste disturbance, ringing in the ears, muscle cramps, pain in joints and muscles, decreased number of red blood cells (anaemia – symptoms may include tiredness, headaches, being short of breath when exercising, dizziness and looking pale), reduced number of platelets, abnormal liver function, increased blood potassium levels, impaired kidney function, inflammation of small blood vessels mainly affecting the skin (a condition known as leukocytoclastic vasculitis), severe allergic reactions (anaphylactic shock) and low blood sugar levels. Uncommon cases of jaundice (yellowing of the skin and/or whites of the eyes) have also been reported.</p><b>Reporting of side effects</b><p>If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects you can help provide more information on the safety of this medicine.</p></div>\"\n                                            }\n                                        },\n                                        {\n                                            \"title\": \"5. How to store cava\",\n                                            \"code\": {\n                                                \"coding\": [\n                                                    {\n                                                        \"system\": \"https://spor.ema.europa.eu/rmswi\",\n                                                        \"code\": \"100000155538\"\n                                                    }\n                                                ],\n                                                \"text\": \"5. How to store cava\"\n                                            },\n                                            \"text\": {\n                                                \"status\": \"additional\",\n                                                \"div\": \"<div xmlns=\\\"http://www.w3.org/1999/xhtml\\\"><p>Keep this medicine out of the sight and reach of children.</p><p>Do not use this medicine after the expiry date which is stated on the carton and on the blister after EXP. The expiry date refers to the last day of that month.</p><p>Do not store above 30°C.</p><p>Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away of medicines you no longer use. These measures will help protect the environment.</p></div>\"\n                                            }\n                                        },\n                                        {\n                                            \"title\": \"6. Contents of the pack and other information\",\n                                            \"code\": {\n                                                \"coding\": [\n                                                    {\n                                                        \"system\": \"https://spor.ema.europa.eu/rmswi\",\n                                                        \"code\": \"100000155538\"\n                                                    }\n                                                ],\n                                                \"text\": \"6. Contents of the pack and other information\"\n                                            },\n                                            \"text\": {\n                                                \"status\": \"additional\",\n                                                \"div\": \"<div xmlns=\\\"http://www.w3.org/1999/xhtml\\\"><b>What cava contains</b><ul><li>The active substance is irbesartan. Each tablet of cava 75 mg contains 75 mg irbesartan.</li><li>The other ingredients are microcrystalline cellulose, croscarmellose sodium, lactose monohydrate, magnesium stearate, colloidal hydrated silica, pregelatinised maize starch, and poloxamer 188. Please see section 2 “cava contains lactose”.</li></ul><b>What cava looks like and contents of the pack</b><p>cava 75 mg tablets are white to off-white, biconvex, and oval-shaped with a heart debossed on one side and the number 2771 engraved on the other side.</p><p>cava 75 mg tablets are supplied in blister packs of 14, 28, 56 or 98 tablets. Unidose blister packs of 56 x 1 tablet for delivery in hospitals are also available.</p><p>Not all pack sizes may be marketed.</p><b>Marketing Authorisation Holder:</b><p>Acme inc</p><p>For any information about this medicinal product, please contact the local representative of the Marketing Authorisation Holder.</p><table><colgroup><col/><col/></colgroup><thead><tr><th></th><th></th></tr></thead><tbody><tr><td><p><b>België/Belgique/Belgien</b></p><p>Acme Belgium</p><p>Tél/Tel: +32 (0)2 710 54 00</p></td><td><p><b>Lietuva</b></p><p>Swixx Biopharma UAB</p><p>Tel: +370 5 236 91 40</p></td></tr><tr><td><p><b>България</b></p><p>Swixx Biopharma EOOD Тел.: +359 (0)2 4942 480</p></td><td><p><b>Luxembourg/Luxemburg</b></p><p>Acme Belgium</p><p>Tél/Tel: +32 (0)2 710 54 00 (Belgique/Belgien)</p></td></tr><tr><td><p><b>Česká republika</b></p><p>Acme inc, s.r.o. Tel: +420 233 086 111</p></td><td><p><b>Magyarország</b></p><p>Acme-A VENTIS Zrt. Tel.: +36 1 505 0050</p></td></tr><tr><td><p><b>Danmark</b></p><p>Acme A/S</p><p>Tlf: +45 45 16 70 00</p></td><td><p><b>Malta</b></p><p>Acme S.r.l.</p><p>Tel: +39 02 39394275</p></td></tr><tr><td><p><b>Deutschland</b></p><p>Acme inc Deutschland GmbH</p><p>Tel: 0800 52 52 010</p><p>Tel. aus dem Ausland: +49 69 305 21 131</p></td><td><p><b>Norge</b></p><p>Acme inc Norge AS Tlf: +47 67 10 71 00</p></td></tr><tr><td><p><b>Eesti</b></p><p>Swixx Biopharma OÜ Tel: +372 640 10 30</p></td><td><p><b>Österreich</b></p><p>Acme inc GmbH Tel: +43 1 80 185 - 0</p></td></tr><tr><td><p><b>Ελλάδα</b></p><p>Acme inc AEBE Τηλ: +30 210 900 16 00</p></td><td><p><b>Polska</b></p><p>Acme inc Sp. z o.o. Tel.: +48 22 280 00 00</p></td></tr><tr><td><p><b>España</b></p><p>Acme inc, S.A. Tel: +34 93 485 94 00</p></td><td></td></tr><tr><td><p><b>France</b></p><p>Acme inc France</p><p>Tél: 0 800 222 555</p><p>Appel depuis l'étranger : +33 1 57 63 23 23</p></td><td><p><b>Portugal</b></p><p>Acme - Produtos Farmacêuticos, Lda Tel: +351 21 35 89 400</p></td></tr><tr><td><p><b>Hrvatska</b></p><p>Swixx Biopharma d.o.o. Tel: +385 1 2078 500</p></td><td><p><b>România</b></p><p>Acme Romania SRL Tel: +40 (0) 21 317 31 36</p></td></tr><tr><td><p><b>Ireland</b></p><p>Acme inc Ireland Ltd. T/A Acme Tel: +353 (0) 1 403 56 00</p></td><td><p><b>Slovenija</b></p><p>Swixx Biopharma d.o.o. Tel: +386 1 235 51 00</p></td></tr><tr><td><p><b>Ísland</b></p><p>Vistor hf.</p><p>Sími: +354 535 7000</p></td><td><p><b>Slovenská republika</b></p><p>Swixx Biopharma s.r.o. Tel: +421 2 208 33 600</p></td></tr><tr><td><p><b>Italia</b></p><p>Acme S.r.l. Tel: 800 536389</p></td><td><p><b>Suomi/Finland</b></p><p>Acme Oy</p><p>Puh/Tel: +358 (0) 201 200 300</p></td></tr><tr><td><p><b>Κύπρος</b></p><p>C.A. Papaellinas Ltd. Τηλ: +357 22 741741</p></td><td><p><b>Sverige</b></p><p>Acme AB</p><p>Tel: +46 (0)8 634 50 00</p></td></tr><tr><td><p><b>Latvija</b></p><p>Swixx Biopharma SIA Tel: +371 6 616 47 50</p></td><td><p><b>United Kingdom (Northern Ireland)</b></p><p>Acme inc Ireland Ltd. T/A Acme Tel: +44 (0) 800 035 2525</p></td></tr><tr><td></td><td></td></tr><tr><td></td><td></td></tr><tr><td></td><td></td></tr><tr><td></td><td></td></tr><tr><td></td><td></td></tr><tr><td></td><td></td></tr></tbody></table><p>This leaflet was last revised in</p><p>Detailed information on this medicine is available on the European Medicines Agency web site: http://www.ema.europa.eu/</p></div>\"\n                                            }\n                                        }\n                                    ]\n                                }\n                            ]\n                        }\n                    },\n                    {\n                        \"fullUrl\": \"urn:uuid:d71bf884-90eb-47f9-81b7-fa81ecec7e75\",\n                        \"resource\": {\n                            \"resourceType\": \"Organization\",\n                            \"id\": \"d71bf884-90eb-47f9-81b7-fa81ecec7e75\",\n                            \"meta\": {\n                                \"profile\": [\n                                    \"http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Organization-uv-epi\"\n                                ]\n                            },\n                            \"text\": {\n                                \"status\": \"generated\",\n                                \"div\": \"<div xmlns=\\\"http://www.w3.org/1999/xhtml\\\"><p><b>Generated Narrative: Organization</b><a name=\\\"d71bf884-90eb-47f9-81b7-fa81ecec7e75\\\"> </a></p><div style=\\\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\\\"><p style=\\\"margin-bottom: 0px\\\">Resource Organization &quot;d71bf884-90eb-47f9-81b7-fa81ecec7e75&quot; </p><p style=\\\"margin-bottom: 0px\\\">Profile: <a href=\\\"https://build.fhir.org/ig/HL7/emedicinal-product-info//StructureDefinition-Organization-uv-epi.html\\\">Organization (ePI)</a></p></div><p><b>identifier</b>: id:\\u00a0ORG-100000789\\u00a0(use:\\u00a0OFFICIAL)</p><p><b>active</b>: true</p><p><b>type</b>: Marketing authorisation holder <span style=\\\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\\\"> (rmswi#220000000034)</span></p><p><b>name</b>: Acme Inc</p><h3>Contacts</h3><table class=\\\"grid\\\"><tr><td>-</td><td><b>Address</b></td></tr><tr><td>*</td><td>60, rue La Boétie F-75008 Paris - France(WORK)</td></tr></table></div>\"\n                            },\n                            \"identifier\": [\n                                {\n                                    \"use\": \"official\",\n                                    \"system\": \"https://spor.ema.europa.eu/omswi\",\n                                    \"value\": \"ORG-100000789\"\n                                }\n                            ],\n                            \"active\": true,\n                            \"type\": [\n                                {\n                                    \"coding\": [\n                                        {\n                                            \"system\": \"https://spor.ema.europa.eu/rmswi\",\n                                            \"code\": \"220000000034\",\n                                            \"display\": \"Marketing authorisation holder\"\n                                        }\n                                    ],\n                                    \"text\": \"Marketing authorisation holder\"\n                                }\n                            ],\n                            \"name\": \"Acme Inc\",\n                            \"contact\": [\n                                {\n                                    \"address\": {\n                                        \"use\": \"work\",\n                                        \"type\": \"physical\",\n                                        \"text\": \"60, rue La Boétie F-75008 Paris - France\",\n                                        \"line\": [\n                                            \"60, rue La Boétie F-75008\"\n                                        ],\n                                        \"city\": \"Lion\",\n                                        \"country\": \"FR\"\n                                    }\n                                }\n                            ]\n                        }\n                    }\n                ]\n            }\n        },\n        {\n            \"name\": \"ips\",\n            \"valueBase64Binary\": \"{
  "resourceType" : "Bundle",
  "id" : "gravitate-maria",
  "identifier" : {
    "system" : "https://www.gravitatehealth.eu/sid/doc",
    "value" : "maria-ips-1"
  },
  "type" : "document",
  "timestamp" : "2021-09-03T08:38:00+02:00",
  "entry" : [
    {
      "fullUrl" : "https://myserver.org/Composition/2fa5b223-ebce-4f39-9c66-5dc014f73572",
      "resource" : {
        "resourceType" : "Composition",
        "id" : "gravitate-maria",
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: Composition</b><a name=\"gravitate-maria\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource Composition &quot;gravitate-maria&quot; </p></div><p><b>status</b>: final</p><p><b>type</b>: Patient summary Document <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://loinc.org/\">LOINC</a>#60591-5)</span></p><p><b>date</b>: 2018-07-10 15:22:00+0200</p><p><b>author</b>: <a href=\"#Practitioner_1ece89c5-fda3-4db9-ace6-decbe6c603d8\">See above (Practitioner/1ece89c5-fda3-4db9-ace6-decbe6c603d8: Dr. Anna Karlsson)</a></p><p><b>title</b>: Patient Summary (Maria Gravitate)</p><p><b>confidentiality</b>: N</p></div>"
        },
        "status" : "final",
        "type" : {
          "coding" : [
            {
              "system" : "http://loinc.org",
              "code" : "60591-5",
              "display" : "Patient summary Document"
            }
          ]
        },
        "subject" : {
          "reference" : "Patient/c154158f-6a43-4ab7-8443-e7f4bf915dd5",
          "display" : "Maria Gravitate"
        },
        "date" : "2018-07-10T15:22:00+02:00",
        "author" : [
          {
            "reference" : "Practitioner/1ece89c5-fda3-4db9-ace6-decbe6c603d8",
            "display" : "Dr. Anna Karlsson"
          }
        ],
        "title" : "Patient Summary (Maria Gravitate)",
        "confidentiality" : "N",
        "section" : [
          {
            "title" : "Allergies and Intolerances",
            "code" : {
              "coding" : [
                {
                  "system" : "http://loinc.org",
                  "code" : "48765-2",
                  "display" : "Allergies and adverse reactions Document"
                }
              ]
            },
            "text" : {
              "status" : "generated",
              "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><ul><li>Hay fever (pollen)</li></ul></div>"
            },
            "entry" : [
              {
                "reference" : "AllergyIntolerance/1dff4474-fa08-4f45-8260-dbb23094bf07",
                "display" : "Hay fever (pollen)"
              }
            ]
          },
          {
            "title" : "Problem List",
            "code" : {
              "coding" : [
                {
                  "system" : "http://loinc.org",
                  "code" : "11450-4",
                  "display" : "Problem list Reported"
                }
              ]
            },
            "text" : {
              "status" : "generated",
              "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><ul><li>Psoriasis</li><li>Hypertension</li><li>Congestive heart failure</li></ul></div>"
            },
            "entry" : [
              {
                "reference" : "Condition/bcc79261-142c-48ec-b032-f3f9af49ec58",
                "display" : "Psoriasis"
              },
              {
                "reference" : "Condition/f06b7cf8-c15c-4288-a0f9-45a1026e5130",
                "display" : "Hypertension"
              },
              {
                "reference" : "Condition/a4a9d90a-d1b0-4d60-82f0-c52343dc6256",
                "display" : "Congestive heart failure"
              }
            ]
          },
          {
            "title" : "Medication Summary",
            "code" : {
              "coding" : [
                {
                  "system" : "http://loinc.org",
                  "code" : "10160-0",
                  "display" : "Hx of Medication use"
                }
              ]
            },
            "text" : {
              "status" : "generated",
              "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><table><thead><tr><th>Brand Name</th><th>MAN</th><th>Active Substance</th><th>Common Name</th><th>ATC</th><th>Strength</th><th>Dose Form</th><th>RoA</th></tr></thead><tbody><tr><td>Skilarence</td><td>EU/1/17/1201/001</td><td>dimethyl fumarate (FO2303MNI2)</td><td>dimethyl fumarate</td><td>L04AX07</td><td>30 mg</td><td>Gastro-resistant tablet</td><td>Oral use</td></tr><tr><td>Karvea</td><td>EMEA/H/C/000142</td><td>irbesartan (J0E2756Z7N)</td><td>irbesartan</td><td>C09DA04</td><td>75 mg</td><td>Tablet</td><td>Oral use</td></tr><tr><td>Boots Decongestant 0.05% w/v Nasal spray</td><td>PL 16028/0049</td><td>oxymetazoline hydrochloride (K89MJ0S5VY)</td><td>oxymetazoline hydrochloride</td><td>R01AA05</td><td>0.05 mg / 1 ml</td><td>Nasal spray, solution</td><td>Nasal use</td></tr></tbody></table></div>"
            },
            "entry" : [
              {
                "reference" : "MedicationStatement/29074ca4-efcb-4ff4-8446-feed2399a899",
                "display" : "Dimethyl fumarate 30 mg Gastro-resistant tablet"
              },
              {
                "reference" : "MedicationStatement/f6cb1218-f81c-4338-80d8-3c10910f78fd",
                "display" : "Irbesartan 75 mg Tablet"
              },
              {
                "reference" : "MedicationStatement/f26084c9-b1c8-46d9-acb2-1d400ade87ba",
                "display" : "Oxymetazoline hydrochloride  0.05 mg / 1 ml Spray"
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl" : "https://myserver.org/Patient/c154158f-6a43-4ab7-8443-e7f4bf915dd5",
      "resource" : {
        "resourceType" : "Patient",
        "id" : "c154158f-6a43-4ab7-8443-e7f4bf915dd5",
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">Maria Gravitate, Female, 75 years old (1946-05-05)</div>"
        },
        "extension" : [
          {
            "extension" : [
              {
                "url" : "code",
                "valueCodeableConcept" : {
                  "coding" : [
                    {
                      "system" : "urn:iso:std:iso:3166",
                      "code" : "NO",
                      "display" : "Norway"
                    }
                  ]
                }
              }
            ],
            "url" : "http://hl7.org/fhir/StructureDefinition/patient-citizenship"
          }
        ],
        "identifier" : [
          {
            "system" : "https://www.gravitatehealth.eu/sid/doc",
            "value" : "maria-1"
          }
        ],
        "active" : true,
        "name" : [
          {
            "family" : "Gravitate",
            "given" : [
              "Maria"
            ]
          }
        ],
        "gender" : "female",
        "birthDate" : "1946-05-05"
      }
    },
    {
      "fullUrl" : "https://myserver.org/Practitioner/1ece89c5-fda3-4db9-ace6-decbe6c603d8",
      "resource" : {
        "resourceType" : "Practitioner",
        "id" : "1ece89c5-fda3-4db9-ace6-decbe6c603d8",
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">Dr. Anne Karlsson</div>"
        },
        "name" : [
          {
            "family" : "Karlsson",
            "given" : [
              "Anne"
            ],
            "prefix" : [
              "Dr."
            ]
          }
        ]
      }
    },
    {
      "fullUrl" : "https://myserver.org/AllergyIntolerance/1dff4474-fa08-4f45-8260-dbb23094bf07",
      "resource" : {
        "resourceType" : "AllergyIntolerance",
        "id" : "1dff4474-fa08-4f45-8260-dbb23094bf07",
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">Hay fever</div>"
        },
        "clinicalStatus" : {
          "coding" : [
            {
              "system" : "http://terminology.hl7.org/CodeSystem/allergyintolerance-clinical",
              "code" : "active"
            }
          ]
        },
        "verificationStatus" : {
          "coding" : [
            {
              "system" : "http://terminology.hl7.org/CodeSystem/allergyintolerance-verification",
              "code" : "confirmed"
            }
          ]
        },
        "code" : {
          "coding" : [
            {
              "system" : "http://snomed.info/sct",
              "code" : "256259004",
              "display" : "Pollen"
            }
          ]
        },
        "patient" : {
          "reference" : "Patient/c154158f-6a43-4ab7-8443-e7f4bf915dd5",
          "display" : "Maria Gravitate"
        },
        "reaction" : [
          {
            "manifestation" : [
              {
                "coding" : [
                  {
                    "system" : "http://snomed.info/sct",
                    "code" : "21719001",
                    "display" : "Allergic rhinitis caused by pollen"
                  }
                ],
                "text" : "Hay fever"
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl" : "https://myserver.org/Condition/bcc79261-142c-48ec-b032-f3f9af49ec58",
      "resource" : {
        "resourceType" : "Condition",
        "id" : "bcc79261-142c-48ec-b032-f3f9af49ec58",
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: Condition</b><a name=\"bcc79261-142c-48ec-b032-f3f9af49ec58\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource Condition &quot;bcc79261-142c-48ec-b032-f3f9af49ec58&quot; </p></div><p><b>clinicalStatus</b>: Active <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/5.0.0/CodeSystem-condition-clinical.html\">Condition Clinical Status Codes</a>#active)</span></p><p><b>code</b>: Psoriasis <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://browser.ihtsdotools.org/\">SNOMED CT</a>#9014002)</span></p><p><b>subject</b>: <a href=\"#Patient_c154158f-6a43-4ab7-8443-e7f4bf915dd5\">See above (Patient/c154158f-6a43-4ab7-8443-e7f4bf915dd5: Maria Gravitate)</a></p><p><b>asserter</b>: <a href=\"#Practitioner_1ece89c5-fda3-4db9-ace6-decbe6c603d8\">See above (Practitioner/1ece89c5-fda3-4db9-ace6-decbe6c603d8: Dr. Anna Karlsson)</a></p></div>"
        },
        "clinicalStatus" : {
          "coding" : [
            {
              "system" : "http://terminology.hl7.org/CodeSystem/condition-clinical",
              "code" : "active"
            }
          ]
        },
        "code" : {
          "coding" : [
            {
              "system" : "http://snomed.info/sct",
              "code" : "9014002",
              "display" : "Psoriasis"
            }
          ],
          "text" : "Psoriasis"
        },
        "subject" : {
          "reference" : "Patient/c154158f-6a43-4ab7-8443-e7f4bf915dd5",
          "display" : "Maria Gravitate"
        },
        "asserter" : {
          "reference" : "Practitioner/1ece89c5-fda3-4db9-ace6-decbe6c603d8",
          "display" : "Dr. Anna Karlsson"
        }
      }
    },
    {
      "fullUrl" : "https://myserver.org/Condition/a4a9d90a-d1b0-4d60-82f0-c52343dc6256",
      "resource" : {
        "resourceType" : "Condition",
        "id" : "a4a9d90a-d1b0-4d60-82f0-c52343dc6256",
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">Congestive heart failure (2015)</div>"
        },
        "clinicalStatus" : {
          "coding" : [
            {
              "system" : "http://terminology.hl7.org/CodeSystem/condition-clinical",
              "code" : "active"
            }
          ]
        },
        "code" : {
          "coding" : [
            {
              "system" : "http://snomed.info/sct",
              "code" : "42343007",
              "display" : "Congestive heart failure"
            }
          ],
          "text" : "Congestive heart failure"
        },
        "subject" : {
          "reference" : "Patient/c154158f-6a43-4ab7-8443-e7f4bf915dd5",
          "display" : "Maria Gravitate"
        },
        "onsetDateTime" : "2015",
        "asserter" : {
          "reference" : "Practitioner/1ece89c5-fda3-4db9-ace6-decbe6c603d8",
          "display" : "Dr. Anna Karlsson"
        }
      }
    },
    {
      "fullUrl" : "https://myserver.org/Condition/f06b7cf8-c15c-4288-a0f9-45a1026e5130",
      "resource" : {
        "resourceType" : "Condition",
        "id" : "f06b7cf8-c15c-4288-a0f9-45a1026e5130",
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: Condition</b><a name=\"f06b7cf8-c15c-4288-a0f9-45a1026e5130\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource Condition &quot;f06b7cf8-c15c-4288-a0f9-45a1026e5130&quot; </p></div><p><b>clinicalStatus</b>: Active <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/5.0.0/CodeSystem-condition-clinical.html\">Condition Clinical Status Codes</a>#active)</span></p><p><b>code</b>: Hypertension <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://browser.ihtsdotools.org/\">SNOMED CT</a>#38341003 &quot;HT - Hypertension&quot;)</span></p><p><b>subject</b>: <a href=\"#Patient_c154158f-6a43-4ab7-8443-e7f4bf915dd5\">See above (Patient/c154158f-6a43-4ab7-8443-e7f4bf915dd5: Maria Gravitate)</a></p><p><b>onset</b>: 1993</p></div>"
        },
        "clinicalStatus" : {
          "coding" : [
            {
              "system" : "http://terminology.hl7.org/CodeSystem/condition-clinical",
              "code" : "active"
            }
          ]
        },
        "code" : {
          "coding" : [
            {
              "system" : "http://snomed.info/sct",
              "code" : "38341003",
              "display" : "HT - Hypertension"
            }
          ],
          "text" : "Hypertension"
        },
        "subject" : {
          "reference" : "Patient/c154158f-6a43-4ab7-8443-e7f4bf915dd5",
          "display" : "Maria Gravitate"
        },
        "onsetDateTime" : "1993"
      }
    },
    {
      "fullUrl" : "https://myserver.org/MedicationStatement/29074ca4-efcb-4ff4-8446-feed2399a899",
      "resource" : {
        "resourceType" : "MedicationStatement",
        "id" : "29074ca4-efcb-4ff4-8446-feed2399a899",
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><table><thead><tr><th>Brand Name</th><th>MAN</th><th>Active Substance</th><th>Common Name</th><th>ATC</th><th>Strength</th><th>Dose Form</th><th>RoA</th></tr></thead><tbody><tr><td>Skilarence</td><td>EU/1/17/1201/001</td><td>dimethyl fumarate (FO2303MNI2)</td><td>dimethyl fumarate</td><td>L04AX07</td><td>30 mg</td><td>Gastro-resistant tablet</td><td>Oral use</td></tr></tbody></table></div>"
        },
        "status" : "active",
        "medicationReference" : {
          "reference" : "Medication/b50ae644-e0b7-4007-809f-26f493cbe36b",
          "display" : "Dimethyl fumarate 30 mg Tablet"
        },
        "subject" : {
          "reference" : "Patient/c154158f-6a43-4ab7-8443-e7f4bf915dd5",
          "display" : "Maria Gravitate"
        },
        "dosage" : [
          {
            "route" : {
              "coding" : [
                {
                  "system" : "http://standardterms.edqm.eu",
                  "code" : "20053000",
                  "display" : "Oral use"
                }
              ]
            }
          }
        ]
      }
    },
    {
      "fullUrl" : "https://myserver.org/MedicationStatement/f6cb1218-f81c-4338-80d8-3c10910f78fd",
      "resource" : {
        "resourceType" : "MedicationStatement",
        "id" : "f6cb1218-f81c-4338-80d8-3c10910f78fd",
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: MedicationStatement</b><a name=\"f6cb1218-f81c-4338-80d8-3c10910f78fd\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource MedicationStatement &quot;f6cb1218-f81c-4338-80d8-3c10910f78fd&quot; </p></div><p><b>status</b>: active</p><p><b>medication</b>: <a href=\"#Medication_de131e15-ed13-4b31-b38c-3204a84d99c7\">See above (Medication/de131e15-ed13-4b31-b38c-3204a84d99c7: Irbesartan 75 mg Tablet)</a></p><p><b>subject</b>: <a href=\"#Patient_c154158f-6a43-4ab7-8443-e7f4bf915dd5\">See above (Patient/c154158f-6a43-4ab7-8443-e7f4bf915dd5: Maria Gravitate)</a></p><h3>Dosages</h3><table class=\"grid\"><tr><td>-</td><td><b>Route</b></td></tr><tr><td>*</td><td>Oral use <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (standardterms.edqm.eu#20053000)</span></td></tr></table></div>"
        },
        "status" : "active",
        "medicationReference" : {
          "reference" : "Medication/de131e15-ed13-4b31-b38c-3204a84d99c7",
          "display" : "Irbesartan 75 mg Tablet"
        },
        "subject" : {
          "reference" : "Patient/c154158f-6a43-4ab7-8443-e7f4bf915dd5",
          "display" : "Maria Gravitate"
        },
        "dosage" : [
          {
            "route" : {
              "coding" : [
                {
                  "system" : "http://standardterms.edqm.eu",
                  "code" : "20053000",
                  "display" : "Oral use"
                }
              ]
            }
          }
        ]
      }
    },
    {
      "fullUrl" : "https://myserver.org/MedicationStatement/f26084c9-b1c8-46d9-acb2-1d400ade87ba",
      "resource" : {
        "resourceType" : "MedicationStatement",
        "id" : "f26084c9-b1c8-46d9-acb2-1d400ade87ba",
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: MedicationStatement</b><a name=\"f26084c9-b1c8-46d9-acb2-1d400ade87ba\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource MedicationStatement &quot;f26084c9-b1c8-46d9-acb2-1d400ade87ba&quot; </p></div><p><b>status</b>: active</p><p><b>medication</b>: <a href=\"#Medication_9ac3356c-4ea4-4814-84c3-235484f2ef10\">See above (Medication/9ac3356c-4ea4-4814-84c3-235484f2ef10: Oxymetazoline hydrochloride  0.05 mg / 1 ml Spray)</a></p><p><b>subject</b>: <a href=\"#Patient_c154158f-6a43-4ab7-8443-e7f4bf915dd5\">See above (Patient/c154158f-6a43-4ab7-8443-e7f4bf915dd5: Maria Gravitate)</a></p><h3>Dosages</h3><table class=\"grid\"><tr><td>-</td><td><b>Route</b></td></tr><tr><td>*</td><td>Nasal use <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (standardterms.edqm.eu#20049000)</span></td></tr></table></div>"
        },
        "status" : "active",
        "medicationReference" : {
          "reference" : "Medication/9ac3356c-4ea4-4814-84c3-235484f2ef10",
          "display" : "Oxymetazoline hydrochloride  0.05 mg / 1 ml Spray"
        },
        "subject" : {
          "reference" : "Patient/c154158f-6a43-4ab7-8443-e7f4bf915dd5",
          "display" : "Maria Gravitate"
        },
        "dosage" : [
          {
            "route" : {
              "coding" : [
                {
                  "system" : "http://standardterms.edqm.eu",
                  "code" : "20049000",
                  "display" : "Nasal use"
                }
              ]
            }
          }
        ]
      }
    },
    {
      "fullUrl" : "https://myserver.org/Medication/b50ae644-e0b7-4007-809f-26f493cbe36b",
      "resource" : {
        "resourceType" : "Medication",
        "id" : "b50ae644-e0b7-4007-809f-26f493cbe36b",
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: Medication</b><a name=\"b50ae644-e0b7-4007-809f-26f493cbe36b\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource Medication &quot;b50ae644-e0b7-4007-809f-26f493cbe36b&quot; </p></div><p><b>code</b>: Skilarence <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (marketingAuthorizationNumber#EU/1/17/1201/001; phpid#0x9982CA8A825D4561506CE808982E3B9D &quot;dimethyl fumarate, 30 mg/ 1 tablet, Gastro-resistant tablet&quot;; <a href=\"http://terminology.hl7.org/5.0.0/CodeSystem-v3-WC.html\">WHO ATC</a>#L04AX07 &quot;dimethyl fumarate&quot;)</span></p><p><b>form</b>: Gastro-resistant tablet <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (standardterms.edqm.eu#10225000)</span></p><h3>Ingredients</h3><table class=\"grid\"><tr><td>-</td><td><b>Item[x]</b></td><td><b>Strength</b></td></tr><tr><td>*</td><td>dimethyl fumarate <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/5.0.0/CodeSystem-UNII.html\">Unique Ingredient Identifier (UNII)</a>#FO2303MNI2)</span></td><td>30 mg<span style=\"background: LightGoldenRodYellow\"> (Details: UCUM code mg = 'mg')</span>/1 Tablet<span style=\"background: LightGoldenRodYellow\"> (Details: UCUM code {tablet} = '{tablet}')</span></td></tr></table></div>"
        },
        "code" : {
          "coding" : [
            {
              "system" : "http://ema.europa.eu/fhir/marketingAuthorizationNumber",
              "code" : "EU/1/17/1201/001",
              "display" : "Skilarence"
            },
            {
              "system" : "https://www.who-umc.org/phpid",
              "code" : "0x9982CA8A825D4561506CE808982E3B9D",
              "display" : "dimethyl fumarate, 30 mg/ 1 tablet, Gastro-resistant tablet"
            },
            {
              "system" : "http://www.whocc.no/atc",
              "code" : "L04AX07",
              "display" : "dimethyl fumarate"
            }
          ]
        },
        "form" : {
          "coding" : [
            {
              "system" : "http://standardterms.edqm.eu",
              "code" : "10225000",
              "display" : "Gastro-resistant tablet"
            }
          ]
        },
        "ingredient" : [
          {
            "itemCodeableConcept" : {
              "coding" : [
                {
                  "system" : "http://fdasis.nlm.nih.gov",
                  "code" : "FO2303MNI2",
                  "display" : "dimethyl fumarate"
                }
              ],
              "text" : "dimethyl fumarate"
            },
            "strength" : {
              "numerator" : {
                "value" : 30,
                "unit" : "mg",
                "system" : "http://unitsofmeasure.org",
                "code" : "mg"
              },
              "denominator" : {
                "value" : 1,
                "unit" : "Tablet",
                "system" : "http://unitsofmeasure.org",
                "code" : "{tablet}"
              }
            }
          }
        ]
      }
    },
    {
      "fullUrl" : "https://myserver.org/Medication/de131e15-ed13-4b31-b38c-3204a84d99c7",
      "resource" : {
        "resourceType" : "Medication",
        "id" : "de131e15-ed13-4b31-b38c-3204a84d99c7",
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: Medication</b><a name=\"de131e15-ed13-4b31-b38c-3204a84d99c7\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource Medication &quot;de131e15-ed13-4b31-b38c-3204a84d99c7&quot; </p></div><p><b>code</b>: Karvea <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (marketingAuthorizationNumber#EMEA/H/C/000142; phpid#0x8DFB446EDB3B8AE508AE493827A704E4 &quot;Irbesartan, 75 mg/ 1 tablet, Tablet&quot;; <a href=\"http://terminology.hl7.org/5.0.0/CodeSystem-v3-WC.html\">WHO ATC</a>#C09DA04 &quot;irbesartan and diuretics&quot;)</span></p><p><b>form</b>: Tablet <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (standardterms.edqm.eu#10219000)</span></p><h3>Ingredients</h3><table class=\"grid\"><tr><td>-</td><td><b>Item[x]</b></td><td><b>Strength</b></td></tr><tr><td>*</td><td>irbesartan <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/5.0.0/CodeSystem-UNII.html\">Unique Ingredient Identifier (UNII)</a>#J0E2756Z7N)</span></td><td>75 mg<span style=\"background: LightGoldenRodYellow\"> (Details: UCUM code mg = 'mg')</span>/1 Tablet<span style=\"background: LightGoldenRodYellow\"> (Details: UCUM code {tablet} = '{tablet}')</span></td></tr></table></div>"
        },
        "code" : {
          "coding" : [
            {
              "system" : "http://ema.europa.eu/fhir/marketingAuthorizationNumber",
              "code" : "EMEA/H/C/000142",
              "display" : "Karvea"
            },
            {
              "system" : "https://www.who-umc.org/phpid",
              "code" : "0x8DFB446EDB3B8AE508AE493827A704E4",
              "display" : "Irbesartan, 75 mg/ 1 tablet, Tablet"
            },
            {
              "system" : "http://www.whocc.no/atc",
              "code" : "C09DA04",
              "display" : "irbesartan and diuretics"
            }
          ]
        },
        "form" : {
          "coding" : [
            {
              "system" : "http://standardterms.edqm.eu",
              "code" : "10219000",
              "display" : "Tablet"
            }
          ]
        },
        "ingredient" : [
          {
            "itemCodeableConcept" : {
              "coding" : [
                {
                  "system" : "http://fdasis.nlm.nih.gov",
                  "code" : "J0E2756Z7N",
                  "display" : "irbesartan"
                }
              ],
              "text" : "irbesartan"
            },
            "strength" : {
              "numerator" : {
                "value" : 75,
                "unit" : "mg",
                "system" : "http://unitsofmeasure.org",
                "code" : "mg"
              },
              "denominator" : {
                "value" : 1,
                "unit" : "Tablet",
                "system" : "http://unitsofmeasure.org",
                "code" : "{tablet}"
              }
            }
          }
        ]
      }
    },
    {
      "fullUrl" : "https://myserver.org/Medication/9ac3356c-4ea4-4814-84c3-235484f2ef10",
      "resource" : {
        "resourceType" : "Medication",
        "id" : "9ac3356c-4ea4-4814-84c3-235484f2ef10",
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: Medication</b><a name=\"9ac3356c-4ea4-4814-84c3-235484f2ef10\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource Medication &quot;9ac3356c-4ea4-4814-84c3-235484f2ef10&quot; </p></div><p><b>code</b>: Boots Decongestant 0.05% w/v Nasal spray <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (man#16028/0049; phpid#0xF79CABF272B6A7EEF104DDDA44E82716 &quot;Oxymetazoline hydrochloride, 0.5 mg/ 1 ml, Nasal spray, solution&quot;; <a href=\"http://terminology.hl7.org/5.0.0/CodeSystem-v3-WC.html\">WHO ATC</a>#R01AA05 &quot;oxymetazoline&quot;)</span></p><p><b>form</b>: Nasal spray, solution <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> ()</span></p><h3>Ingredients</h3><table class=\"grid\"><tr><td>-</td><td><b>Item[x]</b></td><td><b>Strength</b></td></tr><tr><td>*</td><td>oxymetazoline hydrochloride <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/5.0.0/CodeSystem-UNII.html\">Unique Ingredient Identifier (UNII)</a>#K89MJ0S5VY)</span></td><td>0.05 mg<span style=\"background: LightGoldenRodYellow\"> (Details: UCUM code mg = 'mg')</span>/1 ml<span style=\"background: LightGoldenRodYellow\"> (Details: UCUM code ml = 'ml')</span></td></tr></table></div>"
        },
        "code" : {
          "coding" : [
            {
              "system" : "https://www.gravitatehealth.eu/sid/man",
              "code" : "16028/0049",
              "display" : "Boots Decongestant 0.05% w/v Nasal spray"
            },
            {
              "system" : "https://www.who-umc.org/phpid",
              "code" : "0xF79CABF272B6A7EEF104DDDA44E82716",
              "display" : "Oxymetazoline hydrochloride, 0.5 mg/ 1 ml, Nasal spray, solution"
            },
            {
              "system" : "http://www.whocc.no/atc",
              "code" : "R01AA05",
              "display" : "oxymetazoline"
            }
          ]
        },
        "form" : {
          "text" : "Nasal spray, solution"
        },
        "ingredient" : [
          {
            "itemCodeableConcept" : {
              "coding" : [
                {
                  "system" : "http://fdasis.nlm.nih.gov",
                  "code" : "K89MJ0S5VY",
                  "display" : "oxymetazoline hydrochloride"
                }
              ],
              "text" : "oxymetazoline hydrochloride"
            },
            "strength" : {
              "numerator" : {
                "value" : 0.05,
                "unit" : "mg",
                "system" : "http://unitsofmeasure.org",
                "code" : "mg"
              },
              "denominator" : {
                "value" : 1,
                "unit" : "ml",
                "system" : "http://unitsofmeasure.org",
                "code" : "ml"
              }
            }
          }
        ]
      }
    }
  ]
}\"\n        }\n    ]\n}",
							"options": {
								"raw": {
									"language": "json"
								}
							}
						},
						"url": {
							"raw": "http://localhost:8080/fhir/$diff",
							"protocol": "http",
							"host": [
								"localhost"
							],
							"port": "8080",
							"path": [
								"fhir",
								"$diff"
							]
						}
					},
					"response": []
				}
			]
		},
		{
			"name": "IPS",
			"item": [
				{
					"name": "GET summary",
					"request": {
						"method": "POST",
						"header": [],
						"body": {
							"mode": "raw",
							"raw": "{\n    \"parameter\": [\n        {\n            \"name\": \"identifier\",\n            \"valueIdentifier\": {\n                \"system\": \"urn:oid:1.2.208.176.1.2\",\n                \"value\": \"0101010101\"\n            }\n        }\n    ],\n    \"resourceType\": \"Parameters\"\n}",
							"options": {
								"raw": {
									"language": "json"
								}
							}
						},
						"url": {
							"raw": "https://gravitate-ips.gravitate.tcs.trifork.dev/fhir/Patient/$summary",
							"protocol": "https",
							"host": [
								"gravitate-ips",
								"gravitate",
								"tcs",
								"trifork",
								"dev"
							],
							"path": [
								"fhir",
								"Patient",
								"$summary"
							]
						}
					},
					"response": []
				},
				{
					"name": "GET summary",
					"request": {
						"method": "POST",
						"header": [],
						"body": {
							"mode": "raw",
							"raw": "{\n    \"parameter\": [\n        {\n            \"name\": \"identifier\",\n            \"valueIdentifier\": {\n                \"system\": \"urn:oid:1.2.208.176.1.2\",\n                \"value\": \"0101010101\"\n            }\n        }\n    ],\n    \"resourceType\": \"Parameters\"\n}",
							"options": {
								"raw": {
									"language": "json"
								}
							}
						},
						"url": {
							"raw": "{{server}}/Patient/$summary",
							"host": [
								"{{server}}"
							],
							"path": [
								"Patient",
								"$summary"
							]
						}
					},
					"response": []
				},
				{
					"name": "Get Allergies",
					"protocolProfileBehavior": {
						"disableUrlEncoding": false
					},
					"request": {
						"method": "GET",
						"header": [],
						"url": {
							"raw": "{{server}}/AllergyIntolerance?patient=urn%3Aoid%3A1.2.208.176.1.2%7C0101010101",
							"host": [
								"{{server}}"
							],
							"path": [
								"AllergyIntolerance"
							],
							"query": [
								{
									"key": "patient",
									"value": "urn%3Aoid%3A1.2.208.176.1.2%7C0101010101"
								}
							]
						}
					},
					"response": []
				},
				{
					"name": "Get Medication Request",
					"protocolProfileBehavior": {
						"disableUrlEncoding": false
					},
					"request": {
						"method": "GET",
						"header": [],
						"url": {
							"raw": "{{server}}/MedicationRequest?patient=urn%3Aoid%3A1.2.208.176.1.2%7C0101010101",
							"host": [
								"{{server}}"
							],
							"path": [
								"MedicationRequest"
							],
							"query": [
								{
									"key": "patient",
									"value": "urn%3Aoid%3A1.2.208.176.1.2%7C0101010101"
								}
							]
						}
					},
					"response": []
				}
			]
		},
		{
			"name": "ePI",
			"item": [
				{
					"name": "Find ePI based on identifier",
					"request": {
						"method": "GET",
						"header": [],
						"url": {
							"raw": "{{server}}/Bundle?identifier=https%3A%2F%2Fwww.gravitatehealth.eu%2Fsid%2Fdoc%7CEU%2F1%2F96%2F007%2F035",
							"host": [
								"{{server}}"
							],
							"path": [
								"Bundle"
							],
							"query": [
								{
									"key": "identifier",
									"value": "https%3A%2F%2Fwww.gravitatehealth.eu%2Fsid%2Fdoc%7CEU%2F1%2F96%2F007%2F035"
								}
							]
						},
						"description": "Run docker compose on the following\n\nversion: \"3.9\"services: fhir-server: image: hapiproject/hapi:v6.4.0 ports: - \"8080:8080\" environment: - hapi.fhir.install_transitive_ig_dependencies=false - hapi.fhir.fhir_version=R5 - hapi.fhir.implementationguides.epi.name=hl7.fhir.uv.emedicinal-product-info - hapi.fhir.implementationguides.epi.version=1.0.0-ballot - hapi.fhir.implementationguides.epi.url=http://build.fhir.org/ig/HL7/emedicinal-product-info/package.tgz ember: image: jkiddo/ember:latest environment: - location=http://build.fhir.org/ig/hl7-eu/gravitate-health/package.tgz - serverBase=http://fhir-server:8080/fhir"
					},
					"response": []
				},
				{
					"name": "Find ePI Composition based on identifier",
					"request": {
						"method": "GET",
						"header": [],
						"url": {
							"raw": "{{server}}/Composition?identifier=https%3A%2F%2Fspor.ema.europa.eu%2Frmswi%7C0d69fdcb-33cf-407f-8209-a6529856ab4f",
							"host": [
								"{{server}}"
							],
							"path": [
								"Composition"
							],
							"query": [
								{
									"key": "identifier",
									"value": "https%3A%2F%2Fspor.ema.europa.eu%2Frmswi%7C0d69fdcb-33cf-407f-8209-a6529856ab4f"
								}
							]
						},
						"description": "Run docker compose on the following\n\nversion: \"3.9\"services: fhir-server: image: hapiproject/hapi:v6.4.0 ports: - \"8080:8080\" environment: - hapi.fhir.install_transitive_ig_dependencies=false - hapi.fhir.fhir_version=R5 - hapi.fhir.implementationguides.epi.name=hl7.fhir.uv.emedicinal-product-info - hapi.fhir.implementationguides.epi.version=1.0.0-ballot - hapi.fhir.implementationguides.epi.url=http://build.fhir.org/ig/HL7/emedicinal-product-info/package.tgz ember: image: jkiddo/ember:latest environment: - location=http://build.fhir.org/ig/hl7-eu/gravitate-health/package.tgz - serverBase=http://fhir-server:8080/fhir"
					},
					"response": []
				},
				{
					"name": "Find ContraIndication for a product",
					"request": {
						"method": "GET",
						"header": [],
						"url": {
							"raw": "{{server}}/ClinicalUseDefinition?subject=MedicinalProductDefinition/mpa2bd0171a7654dc24f7eb7e9338e1acc&type=contraindication",
							"host": [
								"{{server}}"
							],
							"path": [
								"ClinicalUseDefinition"
							],
							"query": [
								{
									"key": "subject",
									"value": "MedicinalProductDefinition/mpa2bd0171a7654dc24f7eb7e9338e1acc"
								},
								{
									"key": "type",
									"value": "contraindication"
								}
							]
						}
					},
					"response": []
				},
				{
					"name": "Find ePI based on identifier",
					"request": {
						"method": "GET",
						"header": [],
						"url": {
							"raw": "http://localhost:8080/fhir/Bundle?identifier=https%3A%2F%2Fwww.gravitatehealth.eu%2Fsid%2Fdoc%7CEU%2F1%2F96%2F007%2F035",
							"protocol": "http",
							"host": [
								"localhost"
							],
							"port": "8080",
							"path": [
								"fhir",
								"Bundle"
							],
							"query": [
								{
									"key": "identifier",
									"value": "https%3A%2F%2Fwww.gravitatehealth.eu%2Fsid%2Fdoc%7CEU%2F1%2F96%2F007%2F035"
								}
							]
						},
						"description": "Run docker compose on the following\n\nversion: \"3.9\"services: fhir-server: image: hapiproject/hapi:v6.4.0 ports: - \"8080:8080\" environment: - hapi.fhir.install_transitive_ig_dependencies=false - hapi.fhir.fhir_version=R5 - hapi.fhir.implementationguides.epi.name=hl7.fhir.uv.emedicinal-product-info - hapi.fhir.implementationguides.epi.version=1.0.0-ballot - hapi.fhir.implementationguides.epi.url=http://build.fhir.org/ig/HL7/emedicinal-product-info/package.tgz ember: image: jkiddo/ember:latest environment: - location=http://build.fhir.org/ig/hl7-eu/gravitate-health/package.tgz - serverBase=http://fhir-server:8080/fhir"
					},
					"response": []
				},
				{
					"name": "Find ePI Composition based on identifier",
					"request": {
						"method": "GET",
						"header": [],
						"url": {
							"raw": "http://localhost:8080/fhir/Composition?identifier=https%3A%2F%2Fspor.ema.europa.eu%2Frmswi%7C0d69fdcb-33cf-407f-8209-a6529856ab4f",
							"protocol": "http",
							"host": [
								"localhost"
							],
							"port": "8080",
							"path": [
								"fhir",
								"Composition"
							],
							"query": [
								{
									"key": "identifier",
									"value": "https%3A%2F%2Fspor.ema.europa.eu%2Frmswi%7C0d69fdcb-33cf-407f-8209-a6529856ab4f"
								}
							]
						},
						"description": "Run docker compose on the following\n\nversion: \"3.9\"services: fhir-server: image: hapiproject/hapi:v6.4.0 ports: - \"8080:8080\" environment: - hapi.fhir.install_transitive_ig_dependencies=false - hapi.fhir.fhir_version=R5 - hapi.fhir.implementationguides.epi.name=hl7.fhir.uv.emedicinal-product-info - hapi.fhir.implementationguides.epi.version=1.0.0-ballot - hapi.fhir.implementationguides.epi.url=http://build.fhir.org/ig/HL7/emedicinal-product-info/package.tgz ember: image: jkiddo/ember:latest environment: - location=http://build.fhir.org/ig/hl7-eu/gravitate-health/package.tgz - serverBase=http://fhir-server:8080/fhir"
					},
					"response": []
				}
			]
		},
		{
			"name": "FOSPS",
			"item": [
				{
					"name": "Request authorization token",
					"event": [
						{
							"listen": "prerequest",
							"script": {
								"exec": [
									""
								],
								"type": "text/javascript"
							}
						},
						{
							"listen": "test",
							"script": {
								"exec": [
									"pm.test(\"Status code is 200\", function () {\r",
									"    pm.response.to.have.status(200);\r",
									"});\r",
									"\r",
									"pm.collectionVariables.set(\"auth_key\", pm.response.json().access_token);\r",
									"\r",
									"pm.test('Auth key stored', function () {\r",
									"    pm.expect(pm.collectionVariables.has('auth_key')).to.equal(true);\r",
									"});"
								],
								"type": "text/javascript"
							}
						}
					],
					"request": {
						"auth": {
							"type": "noauth"
						},
						"method": "POST",
						"header": [],
						"body": {
							"mode": "urlencoded",
							"urlencoded": [
								{
									"key": "client_id",
									"value": "{{client}}",
									"type": "text"
								},
								{
									"key": "grant_type",
									"value": "password",
									"type": "text"
								},
								{
									"key": "username",
									"value": "{{username}}",
									"type": "text"
								},
								{
									"key": "password",
									"value": "{{password}}",
									"type": "text"
								}
							]
						},
						"url": {
							"raw": "{{url}}/realms/{{realm}}/protocol/openid-connect/token",
							"host": [
								"{{url}}"
							],
							"path": [
								"realms",
								"{{realm}}",
								"protocol",
								"openid-connect",
								"token"
							]
						}
					},
					"response": []
				},
				{
					"name": "Get information",
					"event": [
						{
							"listen": "test",
							"script": {
								"exec": [
									"pm.test(\"Status code is 200\", function () {\r",
									"    pm.response.to.have.status(200);\r",
									"});\r",
									"\r",
									"pm.test(\"DB is empty\", function () {\r",
									"    pm.response.to.have.body(\"[]\");\r",
									"});"
								],
								"type": "text/javascript"
							}
						}
					],
					"request": {
						"method": "GET",
						"header": [],
						"url": {
							"raw": "{{url}}/med-information/med-informations",
							"host": [
								"{{url}}"
							],
							"path": [
								"med-information",
								"med-informations"
							]
						}
					},
					"response": []
				},
				{
					"name": "Create information",
					"event": [
						{
							"listen": "test",
							"script": {
								"exec": [
									"pm.test(\"Successful POST request\", function () {\r",
									"    pm.expect(pm.response.code).to.be.oneOf([201, 202]);\r",
									"});\r",
									"\r",
									"var jsonData = pm.response.json();\r",
									"pm.collectionVariables.set(\"id\", jsonData.id);"
								],
								"type": "text/javascript"
							}
						}
					],
					"request": {
						"method": "POST",
						"header": [],
						"body": {
							"mode": "raw",
							"raw": "{\r\n  \"id\": \"medtest2\",\r\n  \"status\": \"active\",\r\n  \"eLeaflet\": {\r\n    \"resourceType\": \"Bundle\",\r\n    \"id\": \"cfsb2705555581978\",\r\n    \"identifier\": {\r\n      \"system\": \"https://www.gravitatehealth.eu/sid/doc\",\r\n      \"value\": \"EU/1/96/007/035\"\r\n    },\r\n    \"type\": \"document\",\r\n    \"timestamp\": \"2018-06-23T08:38:00+02:00\",\r\n    \"entry\": [\r\n      {\r\n        \"resource\": {\r\n          \"resourceType\": \"Composition\",\r\n          \"id\": \"cfsb7223870858596\",\r\n          \"language\": \"en\",\r\n          \"text\": {\r\n            \"status\": \"generated\",\r\n            \"div\": \"<div xmlns=\\\"http://www.w3.org/1999/xhtml\\\" xml:lang=\\\"en\\\" lang=\\\"en\\\"><p><b>Generated Narrative</b></p><div style=\\\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\\\"><p style=\\\"margin-bottom: 0px\\\">Resource \\\"cfsb7223870858596\\\"  (Language \\\"en\\\") </p></div><p><b>status</b>: final</p><p><b>type</b>: Package Leaflet <span style=\\\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\\\"> (#100000155538)</span></p><p><b>date</b>: 2015-02-07 01:28:17+0000</p><p><b>author</b>: <a href=\\\"#Organization_cfsb9935015469452\\\">See above (Organization/cfsb9935015469452)</a></p><p><b>title</b>: TEST PURPOSES ONLY - Humalog Vulcan ePI v1</p><p><b>confidentiality</b>: U</p><h3>Attesters</h3><table class=\\\"grid\\\"><tr><td>-</td><td><b>Mode</b></td><td><b>Time</b></td></tr><tr><td>*</td><td>Official <span style=\\\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\\\"> (<a href=\\\"http://build.fhir.org/codesystem-composition-attestation-mode.html\\\">CompositionAttestationMode</a>#official)</span></td><td>2015-02-07 01:28:17+0000</td></tr></table></div>\"\r\n          },\r\n          \"status\": \"final\",\r\n          \"type\": {\r\n            \"coding\": [\r\n              {\r\n                \"system\": \"https://spor.ema.europa.eu/\",\r\n                \"code\": \"100000155538\"\r\n              }\r\n            ],\r\n            \"text\": \"Package Leaflet\"\r\n          },\r\n          \"subject\": {\r\n            \"reference\": \"RegulatedAuthorization/cfsb1529720709344\"\r\n          },\r\n          \"date\": \"2015-02-07T13:28:17Z\",\r\n          \"author\": [\r\n            {\r\n              \"reference\": \"Organization/cfsb9935015469452\"\r\n            }\r\n          ],\r\n          \"title\": \"TEST PURPOSES ONLY - Humalog Vulcan ePI v1\",\r\n          \"confidentiality\": \"U\",\r\n          \"attester\": [\r\n            {\r\n              \"mode\": {\r\n                \"coding\": [\r\n                  {\r\n                    \"system\": \"http://hl7.org/fhir/composition-attestation-mode\",\r\n                    \"code\": \"official\"\r\n                  }\r\n                ]\r\n              },\r\n              \"time\": \"2015-02-07T13:28:17Z\"\r\n            }\r\n          ],\r\n          \"section\": [\r\n            {\r\n              \"title\": \"B. Package Leaflet\",\r\n              \"code\": {\r\n                \"coding\": [\r\n                  {\r\n                    \"system\": \"https://spor.ema.europa.eu/\",\r\n                    \"code\": \"100000155538\"\r\n                  }\r\n                ],\r\n                \"text\": \"B. PACKAGE LEAFLET\"\r\n              },\r\n              \"text\": {\r\n                \"status\": \"additional\",\r\n                \"div\": \"<div xmlns=\\\"http://www.w3.org/1999/xhtml\\\">PACKAGE LEAFLET: INFORMATION FOR THE USER Humalog Mix50 100 units/ml suspension for injection in cartridge insulin lispro Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.<ul><li>Keep this leaflet. You may need to read it again.</li><li>If you have any further questions, ask your doctor or pharmacist.</li><li>This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.</li><li>If you get any side effects talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.</li></ul></div>\"\r\n              }\r\n            },\r\n            {\r\n              \"title\": \"What is in this leaflet\",\r\n              \"code\": {\r\n                \"coding\": [\r\n                  {\r\n                    \"system\": \"https://spor.ema.europa.eu/\",\r\n                    \"code\": \"100000155538-0\"\r\n                  }\r\n                ],\r\n                \"text\": \"B. PACKAGE LEAFLET\"\r\n              },\r\n              \"text\": {\r\n                \"status\": \"additional\",\r\n                \"div\": \"<div xmlns=\\\"http://www.w3.org/1999/xhtml\\\">What in this leaflet<ol><li>What Humalog Mix50 is and what it is used for</li><li>What you need to know before you take Humalog Mix50</li><li>How to take Humalog Mix50</li><li>Possible side effects</li><li>How to store Humalog Mix50</li><li>Contents of the pack and other information</li></ol></div>\"\r\n              }\r\n            },\r\n            {\r\n              \"title\": \"1. What Humalog Mix50 is and what it is used for\",\r\n              \"code\": {\r\n                \"coding\": [\r\n                  {\r\n                    \"system\": \"https://spor.ema.europa.eu/\",\r\n                    \"code\": \"100000155538-1\"\r\n                  }\r\n                ],\r\n                \"text\": \"B. PACKAGE LEAFLET\"\r\n              },\r\n              \"text\": {\r\n                \"status\": \"additional\",\r\n                \"div\": \"<div xmlns=\\\"http://www.w3.org/1999/xhtml\\\"><b>1. What Humalog Mix50 is and what it is used for</b> Humalog Mix50 is used to treat diabetes. Humalog Mix50 is a premixed suspension. Its active substance is insulin lispro.</div>\"\r\n              }\r\n            },\r\n            {\r\n              \"title\": \"2. What you need to know before you use Humalog Mix50\",\r\n              \"code\": {\r\n                \"coding\": [\r\n                  {\r\n                    \"system\": \"https://spor.ema.europa.eu/\",\r\n                    \"code\": \"100000155538-2\"\r\n                  }\r\n                ],\r\n                \"text\": \"B. PACKAGE LEAFLET\"\r\n              },\r\n              \"text\": {\r\n                \"status\": \"additional\",\r\n                \"div\": \"<div xmlns=\\\"http://www.w3.org/1999/xhtml\\\"><b>2. What you need to know before you use Humalog Mix50</b> Do NOT use Humalog Mix50 if you</div>\"\r\n              }\r\n            },\r\n            {\r\n              \"title\": \"3. How to use Humalog Mix50\",\r\n              \"code\": {\r\n                \"coding\": [\r\n                  {\r\n                    \"system\": \"https://spor.ema.europa.eu/\",\r\n                    \"code\": \"100000155538-3\"\r\n                  }\r\n                ],\r\n                \"text\": \"B. PACKAGE LEAFLET\"\r\n              },\r\n              \"text\": {\r\n                \"status\": \"additional\",\r\n                \"div\": \"<div xmlns=\\\"http://www.w3.org/1999/xhtml\\\"><b>3. How to use Humalog Mix50</b> <b>The 3 ml cartridge is only for use in Lilly 3 ml pens. It is not for use in 1.5 ml pens.</b><p>Always use Humalog Mix50 exactly as your doctor has told you. You should check with your doctor if you are not sure. To prevent the possible transmission of disease, each cartridge must be used by you only, even if the needle on the delivery device is changed.</p></div>\"\r\n              }\r\n            },\r\n            {\r\n              \"title\": \"4. Possible side effects\",\r\n              \"code\": {\r\n                \"coding\": [\r\n                  {\r\n                    \"system\": \"https://spor.ema.europa.eu/\",\r\n                    \"code\": \"100000155538-4\"\r\n                  }\r\n                ],\r\n                \"text\": \"B. PACKAGE LEAFLET\"\r\n              },\r\n              \"text\": {\r\n                \"status\": \"additional\",\r\n                \"div\": \"<div xmlns=\\\"http://www.w3.org/1999/xhtml\\\"><p><b>4. Possible side effects</b></p><p>Like all medicines, this medicine can cause side effects, although not everybody gets them.</p></div>\"\r\n              }\r\n            },\r\n            {\r\n              \"title\": \"5. How to store Humalog Mix50\",\r\n              \"code\": {\r\n                \"coding\": [\r\n                  {\r\n                    \"system\": \"https://spor.ema.europa.eu/\",\r\n                    \"code\": \"100000155538-5\"\r\n                  }\r\n                ],\r\n                \"text\": \"B. PACKAGE LEAFLET\"\r\n              },\r\n              \"text\": {\r\n                \"status\": \"additional\",\r\n                \"div\": \"<div xmlns=\\\"http://www.w3.org/1999/xhtml\\\"><b>5. How to store Humalog Mix50</b><p>Before the first use store your Humalog Mix50 in a refrigerator (2°C – 8°C). Do not freeze.</p><p>Keep your cartridge in use at room temperature (below 30°C) and discard after 28 days. Do not put it near heat or in the sun. Do not keep your pen or the cartridges you are using in the fridge. The pen with the inserted cartridge should not be stored with the needle attached.</p><p>Keep out of the sight and reach of children. Do not use this medicine after the expiry date which is stated on the label and the carton. The expiry date refers to the last day of that month.</p><p>Do not use this medicine if you notice clumps of material are present or if solid white particles stick to the bottom or wall of the cartridge, giving it a frosted appearance. Check each time you inject yourself. Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.</p></div>\"\r\n              }\r\n            },\r\n            {\r\n              \"title\": \"6. Contents of the pack and other information\",\r\n              \"code\": {\r\n                \"coding\": [\r\n                  {\r\n                    \"system\": \"https://spor.ema.europa.eu/\",\r\n                    \"code\": \"100000155538-6\"\r\n                  }\r\n                ],\r\n                \"text\": \"B. PACKAGE LEAFLET\"\r\n              },\r\n              \"text\": {\r\n                \"status\": \"additional\",\r\n                \"div\": \"<div xmlns=\\\"http://www.w3.org/1999/xhtml\\\"><b>6. Contents of the pack and other information</b> <b>What Humalog Mix50 100 units/ml suspension for injection in cartridge contains</b><p>The active substance is insulin lispro. Insulin lispro is made in the laboratory by a ‘recombinant DNA technology’ process. It is a changed form of human insulin and so is different from other human and animal insulins. Insulin lispro is closely related to human insulin which is a natural hormone made by the pancreas. The other ingredients are protamine sulphate, m-cresol, phenol, glycerol, dibasic sodium phosphate 7H2O, zinc oxide and water for injection. Sodium hydroxide or hydrochloric acid may have been used to adjust the acidity.</p></div>\"\r\n              }\r\n            }\r\n          ]\r\n        }\r\n      },\r\n      {\r\n        \"resource\": {\r\n          \"resourceType\": \"Organization\",\r\n          \"id\": \"cfsb9935015469452\",\r\n          \"meta\": {\r\n            \"profile\": [\r\n              \"http://hl7.eu/fhir/ig/gravitate-health/StructureDefinition/Organization-uv-epi\"\r\n            ]\r\n          },\r\n          \"text\": {\r\n            \"status\": \"generated\",\r\n            \"div\": \"<div xmlns=\\\"http://www.w3.org/1999/xhtml\\\"><p><b>Generated Narrative</b></p><div style=\\\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\\\"><p style=\\\"margin-bottom: 0px\\\">Resource \\\"cfsb9935015469452\\\" </p><p style=\\\"margin-bottom: 0px\\\">Profile: <a href=\\\"StructureDefinition-Organization-uv-epi.html\\\">Organization (ePI)</a></p></div><p><b>identifier</b>: id: ORG-100000426 (OFFICIAL)</p><p><b>active</b>: true</p><p><b>type</b>: Marketing authorisation holder <span style=\\\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\\\"> (<a href=\\\"CodeSystem-CodeSystemUvEPIRrmswi.html\\\">Referentials Management Services CodeSystem</a>#220000000034)</span></p><p><b>name</b>: Eli Lilly Nederland B.V.</p><p><b>address</b>: Papendorpseweg 83, 3528 BJ Utrecht  The Netherlands(WORK)</p></div>\"\r\n          },\r\n          \"identifier\": [\r\n            {\r\n              \"use\": \"official\",\r\n              \"system\": \"https://spor.ema.europa.eu/omswi\",\r\n              \"value\": \"ORG-100000426\"\r\n            }\r\n          ],\r\n          \"active\": true,\r\n          \"type\": [\r\n            {\r\n              \"coding\": [\r\n                {\r\n                  \"system\": \"https://spor.ema.europa.eu/rmswi\",\r\n                  \"code\": \"220000000034\",\r\n                  \"display\": \"Marketing authorisation holder\"\r\n                }\r\n              ],\r\n              \"text\": \"Marketing authorisation holder\"\r\n            }\r\n          ],\r\n          \"name\": \"Eli Lilly Nederland B.V.\",\r\n          \"address\": [\r\n            {\r\n              \"use\": \"work\",\r\n              \"type\": \"physical\",\r\n              \"text\": \"Papendorpseweg 83, 3528 BJ Utrecht  The Netherlands\",\r\n              \"line\": [\r\n                \"Papendorpseweg 83, 3528 BJ\"\r\n              ],\r\n              \"city\": \"Utrecht\",\r\n              \"country\": \"NL\"\r\n            }\r\n          ]\r\n        }\r\n      },\r\n      {\r\n        \"resource\": {\r\n          \"resourceType\": \"Organization\",\r\n          \"id\": \"cfsb1950833461423\",\r\n          \"meta\": {\r\n            \"profile\": [\r\n              \"http://hl7.eu/fhir/ig/gravitate-health/StructureDefinition/Organization-uv-epi\"\r\n            ]\r\n          },\r\n          \"text\": {\r\n            \"status\": \"generated\",\r\n            \"div\": \"<div xmlns=\\\"http://www.w3.org/1999/xhtml\\\"><p><b>Generated Narrative</b></p><div style=\\\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\\\"><p style=\\\"margin-bottom: 0px\\\">Resource \\\"cfsb1950833461423\\\" </p><p style=\\\"margin-bottom: 0px\\\">Profile: <a href=\\\"StructureDefinition-Organization-uv-epi.html\\\">Organization (ePI)</a></p></div><p><b>identifier</b>: id: ORG-100000156 (OFFICIAL)</p><p><b>active</b>: true</p><p><b>type</b>: Manufacturer API <span style=\\\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\\\"> (<a href=\\\"CodeSystem-CodeSystemUvEPIRrmswi.html\\\">Referentials Management Services CodeSystem</a>#220000000033)</span></p><p><b>name</b>: Eli Lilly and Company</p><p><b>address</b>: Lilly Technology Center Building 333 and 324(WORK)</p></div>\"\r\n          },\r\n          \"identifier\": [\r\n            {\r\n              \"use\": \"official\",\r\n              \"system\": \"https://spor.ema.europa.eu/omswi\",\r\n              \"value\": \"ORG-100000156\"\r\n            }\r\n          ],\r\n          \"active\": true,\r\n          \"type\": [\r\n            {\r\n              \"coding\": [\r\n                {\r\n                  \"system\": \"https://spor.ema.europa.eu/rmswi\",\r\n                  \"code\": \"220000000033\"\r\n                }\r\n              ],\r\n              \"text\": \"Manufacturer API\"\r\n            }\r\n          ],\r\n          \"name\": \"Eli Lilly and Company\",\r\n          \"address\": [\r\n            {\r\n              \"use\": \"work\",\r\n              \"type\": \"physical\",\r\n              \"text\": \"Lilly Technology Center Building 333 and 324\",\r\n              \"line\": [\r\n                \"Lilly Technology Center Building 333 and 324,  Indianapolis, Indiana,  USA\"\r\n              ],\r\n              \"city\": \"Indianapolis\",\r\n              \"country\": \"US\"\r\n            }\r\n          ]\r\n        }\r\n      },\r\n      {\r\n        \"resource\": {\r\n          \"resourceType\": \"Organization\",\r\n          \"id\": \"cfsb8820228934589\",\r\n          \"meta\": {\r\n            \"profile\": [\r\n              \"http://hl7.eu/fhir/ig/gravitate-health/StructureDefinition/Organization-uv-epi\"\r\n            ]\r\n          },\r\n          \"text\": {\r\n            \"status\": \"generated\",\r\n            \"div\": \"<div xmlns=\\\"http://www.w3.org/1999/xhtml\\\"><p><b>Generated Narrative</b></p><div style=\\\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\\\"><p style=\\\"margin-bottom: 0px\\\">Resource \\\"cfsb8820228934589\\\" </p><p style=\\\"margin-bottom: 0px\\\">Profile: <a href=\\\"StructureDefinition-Organization-uv-epi.html\\\">Organization (ePI)</a></p></div><p><b>identifier</b>: id: ORG-100003996 (OFFICIAL)</p><p><b>active</b>: true</p><p><b>type</b>: manufacturer <span style=\\\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\\\"> (<a href=\\\"CodeSystem-CodeSystemUvEPIRrmswi.html\\\">Referentials Management Services CodeSystem</a>#220000000033)</span></p><p><b>name</b>: Lilly S.A.</p><p><b>address</b>: Avenida de la Industria 30(WORK)</p></div>\"\r\n          },\r\n          \"identifier\": [\r\n            {\r\n              \"use\": \"official\",\r\n              \"system\": \"https://spor.ema.europa.eu/omswi\",\r\n              \"value\": \"ORG-100003996\"\r\n            }\r\n          ],\r\n          \"active\": true,\r\n          \"type\": [\r\n            {\r\n              \"coding\": [\r\n                {\r\n                  \"system\": \"https://spor.ema.europa.eu/rmswi\",\r\n                  \"code\": \"220000000033\"\r\n                }\r\n              ],\r\n              \"text\": \"manufacturer\"\r\n            }\r\n          ],\r\n          \"name\": \"Lilly S.A.\",\r\n          \"address\": [\r\n            {\r\n              \"use\": \"work\",\r\n              \"type\": \"physical\",\r\n              \"text\": \"Avenida de la Industria 30\",\r\n              \"line\": [\r\n                \"Avenida de la Industria 30, 28108 Alcobendas, Madrid, Spain\"\r\n              ],\r\n              \"city\": \"Alcobendas\",\r\n              \"country\": \"ES\"\r\n            }\r\n          ]\r\n        }\r\n      },\r\n      {\r\n        \"resource\": {\r\n          \"resourceType\": \"RegulatedAuthorization\",\r\n          \"id\": \"cfsb1529720709344\",\r\n          \"text\": {\r\n            \"status\": \"generated\",\r\n            \"div\": \"<div xmlns=\\\"http://www.w3.org/1999/xhtml\\\"><p><b>Generated Narrative</b></p><div style=\\\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\\\"><p style=\\\"margin-bottom: 0px\\\">Resource \\\"cfsb1529720709344\\\" </p></div><p><b>identifier</b>: id: EU/1/96/007/035 (OFFICIAL)</p><p><b>subject</b>: <a href=\\\"#MedicinalProductDefinition_cfsb7543491765740\\\">See above (MedicinalProductDefinition/cfsb7543491765740)</a></p><p><b>type</b>: Marketing Authorisation <span style=\\\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\\\"> (<a href=\\\"CodeSystem-CodeSystemUvEPIRrmswi.html\\\">Referentials Management Services CodeSystem</a>#100000072062)</span></p><p><b>region</b>: European Union <span style=\\\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\\\"> (unknown#eu)</span></p><p><b>status</b>: Active <span style=\\\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\\\"> (<a href=\\\"http://build.fhir.org/codesystem-publication-status.html\\\">PublicationStatus</a>#active)</span></p><p><b>statusDate</b>: 2015-02-07 01:28:17+0000</p><p><b>holder</b>: <a href=\\\"#Organization_cfsb9935015469452\\\">See above (Organization/cfsb9935015469452)</a></p></div>\"\r\n          },\r\n          \"identifier\": [\r\n            {\r\n              \"use\": \"official\",\r\n              \"system\": \"https://spor.ema.europa.eu/pmswi\",\r\n              \"value\": \"EU/1/96/007/035\"\r\n            }\r\n          ],\r\n          \"subject\": [\r\n            {\r\n              \"reference\": \"MedicinalProductDefinition/cfsb7543491765740\"\r\n            }\r\n          ],\r\n          \"type\": {\r\n            \"coding\": [\r\n              {\r\n                \"system\": \"https://spor.ema.europa.eu/rmswi\",\r\n                \"code\": \"100000072062\"\r\n              }\r\n            ],\r\n            \"text\": \"Marketing Authorisation\"\r\n          },\r\n          \"region\": [\r\n            {\r\n              \"coding\": [\r\n                {\r\n                  \"system\": \"urn:iso:std:iso:3166\",\r\n                  \"code\": \"eu\"\r\n                }\r\n              ],\r\n              \"text\": \"European Union\"\r\n            }\r\n          ],\r\n          \"status\": {\r\n            \"coding\": [\r\n              {\r\n                \"system\": \"http://hl7.org/fhir/publication-status\",\r\n                \"code\": \"active\"\r\n              }\r\n            ],\r\n            \"text\": \"Active\"\r\n          },\r\n          \"statusDate\": \"2015-02-07T13:28:17Z\",\r\n          \"holder\": {\r\n            \"reference\": \"Organization/cfsb9935015469452\"\r\n          }\r\n        }\r\n      },\r\n      {\r\n        \"resource\": {\r\n          \"resourceType\": \"MedicinalProductDefinition\",\r\n          \"id\": \"cfsb7543491765740\",\r\n          \"text\": {\r\n            \"status\": \"generated\",\r\n            \"div\": \"<div xmlns=\\\"http://www.w3.org/1999/xhtml\\\"><p><b>Generated Narrative</b></p><div style=\\\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\\\"><p style=\\\"margin-bottom: 0px\\\">Resource \\\"cfsb7543491765740\\\" </p></div><p><b>identifier</b>: id: 123456</p><p><b>type</b>: Medicinal Product <span style=\\\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\\\"> (<a href=\\\"http://build.fhir.org/codesystem-medicinal-product-type.html\\\">MedicinalProductType</a>#MedicinalProduct)</span></p><p><b>domain</b>: Human use <span style=\\\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\\\"> (<a href=\\\"http://build.fhir.org/codesystem-medicinal-product-domain.html\\\">MedicinalProductDomain</a>#Human)</span></p><p><b>status</b>: Active <span style=\\\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\\\"> (<a href=\\\"http://build.fhir.org/codesystem-publication-status.html\\\">PublicationStatus</a>#active)</span></p><p><b>legalStatusOfSupply</b>: Medicinal product subject to medical prescription <span style=\\\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\\\"> (<a href=\\\"CodeSystem-CodeSystemUvEPIRrmswi.html\\\">Referentials Management Services CodeSystem</a>#100000072084)</span></p><blockquote><p><b>name</b></p><p><b>productName</b>: Humalog Mix50 Insulin KwikPen, 3ml pre-fill</p><p><b>type</b>: Full name <span style=\\\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\\\"> (<a href=\\\"CodeSystem-CodeSystemUvEPIRrmswi.html\\\">Referentials Management Services CodeSystem</a>#220000000001)</span></p><h3>NameParts</h3><table class=\\\"grid\\\"><tr><td>-</td><td><b>Part</b></td><td><b>Type</b></td></tr><tr><td>*</td><td>Suspension for injection</td><td>Pharmaceutical dose form part <span style=\\\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\\\"> (<a href=\\\"CodeSystem-CodeSystemUvEPIRrmswi.html\\\">Referentials Management Services CodeSystem</a>#220000000005)</span></td></tr></table><h3>CountryLanguages</h3><table class=\\\"grid\\\"><tr><td>-</td><td><b>Country</b></td><td><b>Jurisdiction</b></td><td><b>Language</b></td></tr><tr><td>*</td><td>European Union <span style=\\\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\\\"> (unknown#eu)</span></td><td>European Union <span style=\\\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\\\"> (unknown#eu)</span></td><td>English <span style=\\\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\\\"> (<a href=\\\"http://terminology.hl7.org/3.0.0/CodeSystem-v3-ietf3066.html\\\">Tags for the Identification of Languages</a>#en)</span></td></tr></table></blockquote></div>\"\r\n          },\r\n          \"identifier\": [\r\n            {\r\n              \"system\": \"https://spor.ema.europa.eu/pmswi\",\r\n              \"value\": \"123456\"\r\n            }\r\n          ],\r\n          \"type\": {\r\n            \"coding\": [\r\n              {\r\n                \"system\": \"http://hl7.org/fhir/medicinal-product-type\",\r\n                \"code\": \"MedicinalProduct\"\r\n              }\r\n            ],\r\n            \"text\": \"Medicinal Product\"\r\n          },\r\n          \"domain\": {\r\n            \"coding\": [\r\n              {\r\n                \"system\": \"http://hl7.org/fhir/medicinal-product-domain\",\r\n                \"code\": \"Human\"\r\n              }\r\n            ],\r\n            \"text\": \"Human use\"\r\n          },\r\n          \"status\": {\r\n            \"coding\": [\r\n              {\r\n                \"system\": \"http://hl7.org/fhir/publication-status\",\r\n                \"code\": \"active\",\r\n                \"display\": \"Active\"\r\n              }\r\n            ]\r\n          },\r\n          \"legalStatusOfSupply\": {\r\n            \"coding\": [\r\n              {\r\n                \"system\": \"https://spor.ema.europa.eu/rmswi\",\r\n                \"code\": \"100000072084\"\r\n              }\r\n            ],\r\n            \"text\": \"Medicinal product subject to medical prescription\"\r\n          },\r\n          \"name\": [\r\n            {\r\n              \"productName\": \"Humalog Mix50 Insulin KwikPen, 3ml pre-fill\",\r\n              \"type\": {\r\n                \"coding\": [\r\n                  {\r\n                    \"system\": \"https://spor.ema.europa.eu/rmswi\",\r\n                    \"code\": \"220000000001\"\r\n                  }\r\n                ],\r\n                \"text\": \"Full name\"\r\n              },\r\n              \"namePart\": [\r\n                {\r\n                  \"part\": \"Suspension for injection\",\r\n                  \"type\": {\r\n                    \"coding\": [\r\n                      {\r\n                        \"system\": \"https://spor.ema.europa.eu/rmswi\",\r\n                        \"code\": \"220000000005\"\r\n                      }\r\n                    ],\r\n                    \"text\": \"Pharmaceutical dose form part\"\r\n                  }\r\n                }\r\n              ],\r\n              \"countryLanguage\": [\r\n                {\r\n                  \"country\": {\r\n                    \"coding\": [\r\n                      {\r\n                        \"system\": \"urn:iso:std:iso:3166\",\r\n                        \"code\": \"eu\"\r\n                      }\r\n                    ],\r\n                    \"text\": \"European Union\"\r\n                  },\r\n                  \"jurisdiction\": {\r\n                    \"coding\": [\r\n                      {\r\n                        \"system\": \"urn:iso:std:iso:3166\",\r\n                        \"code\": \"eu\"\r\n                      }\r\n                    ],\r\n                    \"text\": \"European Union\"\r\n                  },\r\n                  \"language\": {\r\n                    \"coding\": [\r\n                      {\r\n                        \"system\": \"urn:ietf:bcp:47\",\r\n                        \"code\": \"en\"\r\n                      }\r\n                    ],\r\n                    \"text\": \"English\"\r\n                  }\r\n                }\r\n              ]\r\n            }\r\n          ]\r\n        }\r\n      },\r\n      {\r\n        \"resource\": {\r\n          \"resourceType\": \"PackagedProductDefinition\",\r\n          \"id\": \"cfsb2466848736985\",\r\n          \"text\": {\r\n            \"status\": \"generated\",\r\n            \"div\": \"<div xmlns=\\\"http://www.w3.org/1999/xhtml\\\"><p><b>Generated Narrative</b></p><div style=\\\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\\\"><p style=\\\"margin-bottom: 0px\\\">Resource \\\"cfsb2466848736985\\\" </p></div><p><b>identifier</b>: id: EU/1/96/007/035 (OFFICIAL)</p><p><b>name</b>: Humalog 100 units/ml KwikPen solution for injection in a pre-filled pen</p><p><b>type</b>: Chemical Medicinal Prodcut <span style=\\\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\\\"> (<a href=\\\"CodeSystem-CodeSystemUvEPIRrmswi.html\\\">Referentials Management Services CodeSystem</a>#100000155527)</span></p><p><b>packageFor</b>: <a href=\\\"#MedicinalProductDefinition_cfsb7543491765740\\\">See above (MedicinalProductDefinition/cfsb7543491765740)</a></p><p><b>status</b>: Active <span style=\\\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\\\"> (<a href=\\\"http://build.fhir.org/codesystem-publication-status.html\\\">PublicationStatus</a>#active)</span></p><p><b>statusDate</b>: 2015-02-07 01:28:17+0000</p><p><b>containedItemQuantity</b>: 3 ml</p><p><b>manufacturer</b>: </p><ul><li><a href=\\\"#Organization_cfsb8820228934589\\\">See above (Organization/cfsb8820228934589)</a></li><li><a href=\\\"#Organization_cfsb1950833461423\\\">See above (Organization/cfsb1950833461423)</a></li></ul><h3>Packages</h3><table class=\\\"grid\\\"><tr><td>-</td><td><b>Identifier</b></td><td><b>Type</b></td><td><b>Quantity</b></td><td><b>Material</b></td></tr><tr><td>*</td><td>id: 123456</td><td>Pre-filled pen <span style=\\\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\\\"> (<a href=\\\"CodeSystem-CodeSystemUvEPIRrmswi.html\\\">Referentials Management Services CodeSystem</a>#100000073543)</span></td><td>5</td><td>Glass type 1 <span style=\\\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\\\"> (<a href=\\\"CodeSystem-CodeSystemUvEPIRrmswi.html\\\">Referentials Management Services CodeSystem</a>#200000003204)</span></td></tr></table></div>\"\r\n          },\r\n          \"identifier\": [\r\n            {\r\n              \"use\": \"official\",\r\n              \"system\": \"https://spor.ema.europa.eu/pmswi\",\r\n              \"value\": \"EU/1/96/007/035\"\r\n            }\r\n          ],\r\n          \"name\": \"Humalog 100 units/ml KwikPen solution for injection in a pre-filled pen\",\r\n          \"type\": {\r\n            \"coding\": [\r\n              {\r\n                \"system\": \"https://spor.ema.europa.eu/rmswi\",\r\n                \"code\": \"100000155527\"\r\n              }\r\n            ],\r\n            \"text\": \"Chemical Medicinal Prodcut\"\r\n          },\r\n          \"packageFor\": [\r\n            {\r\n              \"reference\": \"MedicinalProductDefinition/cfsb7543491765740\"\r\n            }\r\n          ],\r\n          \"status\": {\r\n            \"coding\": [\r\n              {\r\n                \"system\": \"http://hl7.org/fhir/publication-status\",\r\n                \"code\": \"active\",\r\n                \"display\": \"Active\"\r\n              }\r\n            ]\r\n          },\r\n          \"statusDate\": \"2015-02-07T13:28:17Z\",\r\n          \"containedItemQuantity\": [\r\n            {\r\n              \"value\": 3,\r\n              \"unit\": \"ml\"\r\n            }\r\n          ],\r\n          \"manufacturer\": [\r\n            {\r\n              \"reference\": \"Organization/cfsb8820228934589\"\r\n            },\r\n            {\r\n              \"reference\": \"Organization/cfsb1950833461423\"\r\n            }\r\n          ],\r\n          \"package\": {\r\n            \"identifier\": [\r\n              {\r\n                \"system\": \"https://spor.ema.europa.eu/pmswi\",\r\n                \"value\": \"123456\"\r\n              }\r\n            ],\r\n            \"type\": {\r\n              \"coding\": [\r\n                {\r\n                  \"system\": \"https://spor.ema.europa.eu/rmswi\",\r\n                  \"code\": \"100000073543\",\r\n                  \"display\": \"Pre-filled pen\"\r\n                }\r\n              ]\r\n            },\r\n            \"quantity\": 5,\r\n            \"material\": [\r\n              {\r\n                \"coding\": [\r\n                  {\r\n                    \"system\": \"https://spor.ema.europa.eu/rmswi\",\r\n                    \"code\": \"200000003204\",\r\n                    \"display\": \"Glass type 1\"\r\n                  }\r\n                ]\r\n              }\r\n            ]\r\n          }\r\n        }\r\n      },\r\n      {\r\n        \"resource\": {\r\n          \"resourceType\": \"AdministrableProductDefinition\",\r\n          \"id\": \"cfsb3624842689213\",\r\n          \"text\": {\r\n            \"status\": \"generated\",\r\n            \"div\": \"<div xmlns=\\\"http://www.w3.org/1999/xhtml\\\"><p><b>Generated Narrative</b></p><div style=\\\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\\\"><p style=\\\"margin-bottom: 0px\\\">Resource \\\"cfsb3624842689213\\\" </p></div><p><b>identifier</b>: id: 0x073AF2E5B92AE19E8B67635AFFB3D6CA</p><p><b>status</b>: active</p><p><b>formOf</b>: <a href=\\\"#MedicinalProductDefinition_cfsb7543491765740\\\">See above (MedicinalProductDefinition/cfsb7543491765740)</a></p><p><b>administrableDoseForm</b>: Suspension for injection <span style=\\\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\\\"> (<a href=\\\"CodeSystem-CodeSystemUvEPIRrmswi.html\\\">Referentials Management Services CodeSystem</a>#100000073864)</span></p><p><b>unitOfPresentation</b>: Pen <span style=\\\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\\\"> (<a href=\\\"CodeSystem-CodeSystemUvEPIRrmswi.html\\\">Referentials Management Services CodeSystem</a>#200000002135)</span></p><p><b>producedFrom</b>: <a href=\\\"#ManufacturedItemDefinition_cfsb1210909903210\\\">See above (ManufacturedItemDefinition/cfsb1210909903210)</a></p><blockquote><p><b>routeOfAdministration</b></p><p><b>code</b>: Subcutaneous use <span style=\\\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\\\"> (<a href=\\\"CodeSystem-CodeSystemUvEPIRrmswi.html\\\">Referentials Management Services CodeSystem</a>#100000073633)</span></p><h3>TargetSpecies</h3><table class=\\\"grid\\\"><tr><td>-</td><td><b>Code</b></td></tr><tr><td>*</td><td>Human <span style=\\\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\\\"> (<a href=\\\"CodeSystem-CodeSystemUvEPIRrmswi.html\\\">Referentials Management Services CodeSystem</a>#100000109093)</span></td></tr></table></blockquote></div>\"\r\n          },\r\n          \"identifier\": [\r\n            {\r\n              \"system\": \"https://www.who-umc.org/phpid\",\r\n              \"value\": \"0x073AF2E5B92AE19E8B67635AFFB3D6CA\"\r\n            }\r\n          ],\r\n          \"status\": \"active\",\r\n          \"formOf\": [\r\n            {\r\n              \"reference\": \"MedicinalProductDefinition/cfsb7543491765740\"\r\n            }\r\n          ],\r\n          \"administrableDoseForm\": {\r\n            \"coding\": [\r\n              {\r\n                \"system\": \"https://spor.ema.europa.eu/rmswi\",\r\n                \"code\": \"100000073864\"\r\n              }\r\n            ],\r\n            \"text\": \"Suspension for injection\"\r\n          },\r\n          \"unitOfPresentation\": {\r\n            \"coding\": [\r\n              {\r\n                \"system\": \"https://spor.ema.europa.eu/rmswi\",\r\n                \"code\": \"200000002135\"\r\n              }\r\n            ],\r\n            \"text\": \"Pen\"\r\n          },\r\n          \"producedFrom\": [\r\n            {\r\n              \"reference\": \"ManufacturedItemDefinition/cfsb1210909903210\"\r\n            }\r\n          ],\r\n          \"routeOfAdministration\": [\r\n            {\r\n              \"code\": {\r\n                \"coding\": [\r\n                  {\r\n                    \"system\": \"https://spor.ema.europa.eu/rmswi\",\r\n                    \"code\": \"100000073633\"\r\n                  }\r\n                ],\r\n                \"text\": \"Subcutaneous use\"\r\n              },\r\n              \"targetSpecies\": [\r\n                {\r\n                  \"code\": {\r\n                    \"coding\": [\r\n                      {\r\n                        \"system\": \"https://spor.ema.europa.eu/rmswi\",\r\n                        \"code\": \"100000109093\"\r\n                      }\r\n                    ],\r\n                    \"text\": \"Human\"\r\n                  }\r\n                }\r\n              ]\r\n            }\r\n          ]\r\n        }\r\n      },\r\n      {\r\n        \"resource\": {\r\n          \"resourceType\": \"ManufacturedItemDefinition\",\r\n          \"id\": \"cfsb1210909903210\",\r\n          \"text\": {\r\n            \"status\": \"generated\",\r\n            \"div\": \"<div xmlns=\\\"http://www.w3.org/1999/xhtml\\\"><p><b>Generated Narrative</b></p><div style=\\\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\\\"><p style=\\\"margin-bottom: 0px\\\">Resource \\\"cfsb1210909903210\\\" </p></div><p><b>identifier</b>: id: EU/1/96/007/035 (OFFICIAL)</p><p><b>status</b>: active</p><p><b>manufacturedDoseForm</b>: Suspension for injection <span style=\\\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\\\"> (#100000073864)</span></p><p><b>unitOfPresentation</b>: Pen <span style=\\\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\\\"> (<a href=\\\"CodeSystem-CodeSystemUvEPIRrmswi.html\\\">Referentials Management Services CodeSystem</a>#200000002135)</span></p><p><b>manufacturer</b>: <a href=\\\"#Organization_cfsb8820228934589\\\">See above (Organization/cfsb8820228934589)</a></p></div>\"\r\n          },\r\n          \"identifier\": [\r\n            {\r\n              \"use\": \"official\",\r\n              \"system\": \"https://spor.ema.europa.eu/pmswi/#/\",\r\n              \"value\": \"EU/1/96/007/035\"\r\n            }\r\n          ],\r\n          \"status\": \"active\",\r\n          \"manufacturedDoseForm\": {\r\n            \"coding\": [\r\n              {\r\n                \"system\": \"https://spor.ema.europa.eu/rmswi/\",\r\n                \"code\": \"100000073864\"\r\n              }\r\n            ],\r\n            \"text\": \"Suspension for injection\"\r\n          },\r\n          \"unitOfPresentation\": {\r\n            \"coding\": [\r\n              {\r\n                \"system\": \"https://spor.ema.europa.eu/rmswi\",\r\n                \"code\": \"200000002135\"\r\n              }\r\n            ],\r\n            \"text\": \"Pen\"\r\n          },\r\n          \"manufacturer\": [\r\n            {\r\n              \"reference\": \"Organization/cfsb8820228934589\"\r\n            }\r\n          ]\r\n        }\r\n      },\r\n      {\r\n        \"resource\": {\r\n          \"resourceType\": \"Ingredient\",\r\n          \"id\": \"cfsb6320144064544\",\r\n          \"text\": {\r\n            \"status\": \"generated\",\r\n            \"div\": \"<div xmlns=\\\"http://www.w3.org/1999/xhtml\\\"><p><b>Generated Narrative</b></p><div style=\\\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\\\"><p style=\\\"margin-bottom: 0px\\\">Resource \\\"cfsb6320144064544\\\" </p></div><p><b>identifier</b>: id: GFX7QIS1II (OFFICIAL)</p><p><b>status</b>: active</p><p><b>role</b>: active <span style=\\\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\\\"> (<a href=\\\"CodeSystem-CodeSystemUvEPIRrmswi.html\\\">Referentials Management Services CodeSystem</a>#00000072072)</span></p><h3>Manufacturers</h3><table class=\\\"grid\\\"><tr><td>-</td><td><b>Manufacturer</b></td></tr><tr><td>*</td><td><a href=\\\"#Organization_cfsb1950833461423\\\">See above (Organization/cfsb1950833461423)</a></td></tr></table><blockquote><p><b>substance</b></p><h3>Strengths</h3><table class=\\\"grid\\\"><tr><td>-</td><td><b>Presentation[x]</b></td><td><b>Basis</b></td></tr><tr><td>*</td><td>100 units/ml</td><td>active ingredient - basis of strength <span style=\\\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\\\"> (v3-RoleClassIngredientEntity#ACTIB)</span></td></tr></table></blockquote></div>\"\r\n          },\r\n          \"identifier\": {\r\n            \"use\": \"official\",\r\n            \"system\": \"https://gsrs.ncats.nih.gov/ginas/app/beta\",\r\n            \"value\": \"GFX7QIS1II\"\r\n          },\r\n          \"status\": \"active\",\r\n          \"role\": {\r\n            \"coding\": [\r\n              {\r\n                \"system\": \"https://spor.ema.europa.eu/rmswi\",\r\n                \"code\": \"00000072072\"\r\n              }\r\n            ],\r\n            \"text\": \"active\"\r\n          },\r\n          \"manufacturer\": [\r\n            {\r\n              \"manufacturer\": {\r\n                \"reference\": \"Organization/cfsb1950833461423\"\r\n              }\r\n            }\r\n          ],\r\n          \"substance\": {\r\n            \"code\": {\r\n              \"concept\": {\r\n                \"coding\": [\r\n                  {\r\n                    \"system\": \"https://gsrs.ncats.nih.gov/ginas/app/beta\",\r\n                    \"code\": \"GFX7QIS1II\",\r\n                    \"display\": \"Insulin lispro\"\r\n                  }\r\n                ]\r\n              }\r\n            },\r\n            \"strength\": [\r\n              {\r\n                \"presentationQuantity\": {\r\n                  \"value\": 100,\r\n                  \"unit\": \"units/ml\"\r\n                },\r\n                \"basis\": {\r\n                  \"coding\": [\r\n                    {\r\n                      \"system\": \"http://terminology.hl7.org/ValueSet/v3-RoleClassIngredientEntity\",\r\n                      \"code\": \"ACTIB\"\r\n                    }\r\n                  ],\r\n                  \"text\": \"active ingredient - basis of strength\"\r\n                }\r\n              }\r\n            ]\r\n          }\r\n        }\r\n      },\r\n      {\r\n        \"resource\": {\r\n          \"resourceType\": \"Ingredient\",\r\n          \"id\": \"cfsb8743912652556\",\r\n          \"text\": {\r\n            \"status\": \"generated\",\r\n            \"div\": \"<div xmlns=\\\"http://www.w3.org/1999/xhtml\\\"><p><b>Generated Narrative</b></p><div style=\\\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\\\"><p style=\\\"margin-bottom: 0px\\\">Resource \\\"cfsb8743912652556\\\" </p></div><p><b>identifier</b>: id: PDC6A3C0OX (OFFICIAL)</p><p><b>status</b>: active</p><p><b>role</b>: Excipient <span style=\\\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\\\"> (<a href=\\\"CodeSystem-CodeSystemUvEPIRrmswi.html\\\">Referentials Management Services CodeSystem</a>#100000072082)</span></p><h3>Manufacturers</h3><table class=\\\"grid\\\"><tr><td>-</td><td><b>Manufacturer</b></td></tr><tr><td>*</td><td><a href=\\\"#Organization_cfsb1950833461423\\\">See above (Organization/cfsb1950833461423)</a></td></tr></table><blockquote><p><b>substance</b></p></blockquote></div>\"\r\n          },\r\n          \"identifier\": {\r\n            \"use\": \"official\",\r\n            \"system\": \"https://gsrs.ncats.nih.gov/ginas/app/beta\",\r\n            \"value\": \"PDC6A3C0OX\"\r\n          },\r\n          \"status\": \"active\",\r\n          \"role\": {\r\n            \"coding\": [\r\n              {\r\n                \"system\": \"https://spor.ema.europa.eu/rmswi\",\r\n                \"code\": \"100000072082\"\r\n              }\r\n            ],\r\n            \"text\": \"Excipient\"\r\n          },\r\n          \"manufacturer\": [\r\n            {\r\n              \"manufacturer\": {\r\n                \"reference\": \"Organization/cfsb1950833461423\"\r\n              }\r\n            }\r\n          ],\r\n          \"substance\": {\r\n            \"code\": {\r\n              \"concept\": {\r\n                \"coding\": [\r\n                  {\r\n                    \"system\": \"https://gsrs.ncats.nih.gov/ginas/app/beta\",\r\n                    \"code\": \"PDC6A3C0OX\",\r\n                    \"display\": \"Glycerin\"\r\n                  }\r\n                ]\r\n              }\r\n            }\r\n          }\r\n        }\r\n      },\r\n      {\r\n        \"resource\": {\r\n          \"resourceType\": \"Ingredient\",\r\n          \"id\": \"cfsb8374942483045\",\r\n          \"text\": {\r\n            \"status\": \"generated\",\r\n            \"div\": \"<div xmlns=\\\"http://www.w3.org/1999/xhtml\\\"><p><b>Generated Narrative</b></p><div style=\\\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\\\"><p style=\\\"margin-bottom: 0px\\\">Resource \\\"cfsb8374942483045\\\" </p></div><p><b>identifier</b>: id: QTT17582CB (OFFICIAL)</p><p><b>status</b>: active</p><p><b>role</b>: Excipient <span style=\\\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\\\"> (<a href=\\\"CodeSystem-CodeSystemUvEPIRrmswi.html\\\">Referentials Management Services CodeSystem</a>#100000072082)</span></p><h3>Manufacturers</h3><table class=\\\"grid\\\"><tr><td>-</td><td><b>Manufacturer</b></td></tr><tr><td>*</td><td><a href=\\\"#Organization_cfsb1950833461423\\\">See above (Organization/cfsb1950833461423)</a></td></tr></table><blockquote><p><b>substance</b></p></blockquote></div>\"\r\n          },\r\n          \"identifier\": {\r\n            \"use\": \"official\",\r\n            \"system\": \"https://gsrs.ncats.nih.gov/ginas/app/beta\",\r\n            \"value\": \"QTT17582CB\"\r\n          },\r\n          \"status\": \"active\",\r\n          \"role\": {\r\n            \"coding\": [\r\n              {\r\n                \"system\": \"https://spor.ema.europa.eu/rmswi\",\r\n                \"code\": \"100000072082\"\r\n              }\r\n            ],\r\n            \"text\": \"Excipient\"\r\n          },\r\n          \"manufacturer\": [\r\n            {\r\n              \"manufacturer\": {\r\n                \"reference\": \"Organization/cfsb1950833461423\"\r\n              }\r\n            }\r\n          ],\r\n          \"substance\": {\r\n            \"code\": {\r\n              \"concept\": {\r\n                \"coding\": [\r\n                  {\r\n                    \"system\": \"https://gsrs.ncats.nih.gov/ginas/app/beta\",\r\n                    \"code\": \"QTT17582CB\",\r\n                    \"display\": \"Hydrochloric acid\"\r\n                  }\r\n                ]\r\n              }\r\n            }\r\n          }\r\n        }\r\n      },\r\n      {\r\n        \"resource\": {\r\n          \"resourceType\": \"Ingredient\",\r\n          \"id\": \"cfsb0965848064378\",\r\n          \"text\": {\r\n            \"status\": \"generated\",\r\n            \"div\": \"<div xmlns=\\\"http://www.w3.org/1999/xhtml\\\"><p><b>Generated Narrative</b></p><div style=\\\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\\\"><p style=\\\"margin-bottom: 0px\\\">Resource \\\"cfsb0965848064378\\\" </p></div><p><b>identifier</b>: id: 55X04QC32I (OFFICIAL)</p><p><b>status</b>: active</p><p><b>role</b>: Excipient <span style=\\\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\\\"> (<a href=\\\"CodeSystem-CodeSystemUvEPIRrmswi.html\\\">Referentials Management Services CodeSystem</a>#100000072082)</span></p><h3>Manufacturers</h3><table class=\\\"grid\\\"><tr><td>-</td><td><b>Manufacturer</b></td></tr><tr><td>*</td><td><a href=\\\"#Organization_cfsb1950833461423\\\">See above (Organization/cfsb1950833461423)</a></td></tr></table><blockquote><p><b>substance</b></p></blockquote></div>\"\r\n          },\r\n          \"identifier\": {\r\n            \"use\": \"official\",\r\n            \"system\": \"https://gsrs.ncats.nih.gov/ginas/app/beta\",\r\n            \"value\": \"55X04QC32I\"\r\n          },\r\n          \"status\": \"active\",\r\n          \"role\": {\r\n            \"coding\": [\r\n              {\r\n                \"system\": \"https://spor.ema.europa.eu/rmswi\",\r\n                \"code\": \"100000072082\"\r\n              }\r\n            ],\r\n            \"text\": \"Excipient\"\r\n          },\r\n          \"manufacturer\": [\r\n            {\r\n              \"manufacturer\": {\r\n                \"reference\": \"Organization/cfsb1950833461423\"\r\n              }\r\n            }\r\n          ],\r\n          \"substance\": {\r\n            \"code\": {\r\n              \"concept\": {\r\n                \"coding\": [\r\n                  {\r\n                    \"system\": \"https://gsrs.ncats.nih.gov/ginas/app/beta\",\r\n                    \"code\": \"55X04QC32I\",\r\n                    \"display\": \"Sodium Hydroxide\"\r\n                  }\r\n                ]\r\n              }\r\n            }\r\n          }\r\n        }\r\n      },\r\n      {\r\n        \"resource\": {\r\n          \"resourceType\": \"Ingredient\",\r\n          \"id\": \"cfsb5825971594998\",\r\n          \"text\": {\r\n            \"status\": \"generated\",\r\n            \"div\": \"<div xmlns=\\\"http://www.w3.org/1999/xhtml\\\"><p><b>Generated Narrative</b></p><div style=\\\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\\\"><p style=\\\"margin-bottom: 0px\\\">Resource \\\"cfsb5825971594998\\\" </p></div><p><b>identifier</b>: id: 059QF0KO0R (OFFICIAL)</p><p><b>status</b>: active</p><p><b>role</b>: Excipient <span style=\\\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\\\"> (<a href=\\\"CodeSystem-CodeSystemUvEPIRrmswi.html\\\">Referentials Management Services CodeSystem</a>#100000072082)</span></p><h3>Manufacturers</h3><table class=\\\"grid\\\"><tr><td>-</td><td><b>Manufacturer</b></td></tr><tr><td>*</td><td><a href=\\\"#Organization_cfsb1950833461423\\\">See above (Organization/cfsb1950833461423)</a></td></tr></table><blockquote><p><b>substance</b></p></blockquote></div>\"\r\n          },\r\n          \"identifier\": {\r\n            \"use\": \"official\",\r\n            \"system\": \"https://gsrs.ncats.nih.gov/ginas/app/beta\",\r\n            \"value\": \"059QF0KO0R\"\r\n          },\r\n          \"status\": \"active\",\r\n          \"role\": {\r\n            \"coding\": [\r\n              {\r\n                \"system\": \"https://spor.ema.europa.eu/rmswi\",\r\n                \"code\": \"100000072082\"\r\n              }\r\n            ],\r\n            \"text\": \"Excipient\"\r\n          },\r\n          \"manufacturer\": [\r\n            {\r\n              \"manufacturer\": {\r\n                \"reference\": \"Organization/cfsb1950833461423\"\r\n              }\r\n            }\r\n          ],\r\n          \"substance\": {\r\n            \"code\": {\r\n              \"concept\": {\r\n                \"coding\": [\r\n                  {\r\n                    \"system\": \"https://gsrs.ncats.nih.gov/ginas/app/beta\",\r\n                    \"code\": \"059QF0KO0R\",\r\n                    \"display\": \"Water for Injection\"\r\n                  }\r\n                ]\r\n              }\r\n            }\r\n          }\r\n        }\r\n      },\r\n      {\r\n        \"resource\": {\r\n          \"resourceType\": \"Ingredient\",\r\n          \"id\": \"cfsb0943822318036\",\r\n          \"text\": {\r\n            \"status\": \"generated\",\r\n            \"div\": \"<div xmlns=\\\"http://www.w3.org/1999/xhtml\\\"><p><b>Generated Narrative</b></p><div style=\\\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\\\"><p style=\\\"margin-bottom: 0px\\\">Resource \\\"cfsb0943822318036\\\" </p></div><p><b>identifier</b>: id: SOI2LOH54Z (OFFICIAL)</p><p><b>status</b>: active</p><p><b>role</b>: Excipient <span style=\\\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\\\"> (<a href=\\\"CodeSystem-CodeSystemUvEPIRrmswi.html\\\">Referentials Management Services CodeSystem</a>#100000072082)</span></p><h3>Manufacturers</h3><table class=\\\"grid\\\"><tr><td>-</td><td><b>Manufacturer</b></td></tr><tr><td>*</td><td><a href=\\\"#Organization_cfsb1950833461423\\\">See above (Organization/cfsb1950833461423)</a></td></tr></table><blockquote><p><b>substance</b></p></blockquote></div>\"\r\n          },\r\n          \"identifier\": {\r\n            \"use\": \"official\",\r\n            \"system\": \"https://gsrs.ncats.nih.gov/ginas/app/beta\",\r\n            \"value\": \"SOI2LOH54Z\"\r\n          },\r\n          \"status\": \"active\",\r\n          \"role\": {\r\n            \"coding\": [\r\n              {\r\n                \"system\": \"https://spor.ema.europa.eu/rmswi\",\r\n                \"code\": \"100000072082\"\r\n              }\r\n            ],\r\n            \"text\": \"Excipient\"\r\n          },\r\n          \"manufacturer\": [\r\n            {\r\n              \"manufacturer\": {\r\n                \"reference\": \"Organization/cfsb1950833461423\"\r\n              }\r\n            }\r\n          ],\r\n          \"substance\": {\r\n            \"code\": {\r\n              \"concept\": {\r\n                \"coding\": [\r\n                  {\r\n                    \"system\": \"https://gsrs.ncats.nih.gov/ginas/app/beta\",\r\n                    \"code\": \"SOI2LOH54Z\",\r\n                    \"display\": \"Zinc Oxide\"\r\n                  }\r\n                ]\r\n              }\r\n            }\r\n          }\r\n        }\r\n      },\r\n      {\r\n        \"resource\": {\r\n          \"resourceType\": \"Ingredient\",\r\n          \"id\": \"cfsb2603878086630\",\r\n          \"text\": {\r\n            \"status\": \"generated\",\r\n            \"div\": \"<div xmlns=\\\"http://www.w3.org/1999/xhtml\\\"><p><b>Generated Narrative</b></p><div style=\\\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\\\"><p style=\\\"margin-bottom: 0px\\\">Resource \\\"cfsb2603878086630\\\" </p></div><p><b>identifier</b>: id: GGO4Y809LO (OFFICIAL)</p><p><b>status</b>: active</p><p><b>role</b>: Excipient <span style=\\\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\\\"> (<a href=\\\"CodeSystem-CodeSystemUvEPIRrmswi.html\\\">Referentials Management Services CodeSystem</a>#100000072082)</span></p><h3>Manufacturers</h3><table class=\\\"grid\\\"><tr><td>-</td><td><b>Manufacturer</b></td></tr><tr><td>*</td><td><a href=\\\"#Organization_cfsb1950833461423\\\">See above (Organization/cfsb1950833461423)</a></td></tr></table><blockquote><p><b>substance</b></p></blockquote></div>\"\r\n          },\r\n          \"identifier\": {\r\n            \"use\": \"official\",\r\n            \"system\": \"https://gsrs.ncats.nih.gov/ginas/app/beta\",\r\n            \"value\": \"GGO4Y809LO\"\r\n          },\r\n          \"status\": \"active\",\r\n          \"role\": {\r\n            \"coding\": [\r\n              {\r\n                \"system\": \"https://spor.ema.europa.eu/rmswi\",\r\n                \"code\": \"100000072082\"\r\n              }\r\n            ],\r\n            \"text\": \"Excipient\"\r\n          },\r\n          \"manufacturer\": [\r\n            {\r\n              \"manufacturer\": {\r\n                \"reference\": \"Organization/cfsb1950833461423\"\r\n              }\r\n            }\r\n          ],\r\n          \"substance\": {\r\n            \"code\": {\r\n              \"concept\": {\r\n                \"coding\": [\r\n                  {\r\n                    \"system\": \"https://gsrs.ncats.nih.gov/ginas/app/beta\",\r\n                    \"code\": \"GGO4Y809LO\",\r\n                    \"display\": \"Metacresol\"\r\n                  }\r\n                ]\r\n              }\r\n            }\r\n          }\r\n        }\r\n      },\r\n      {\r\n        \"resource\": {\r\n          \"resourceType\": \"Ingredient\",\r\n          \"id\": \"cfsb6349319941521\",\r\n          \"text\": {\r\n            \"status\": \"generated\",\r\n            \"div\": \"<div xmlns=\\\"http://www.w3.org/1999/xhtml\\\"><p><b>Generated Narrative</b></p><div style=\\\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\\\"><p style=\\\"margin-bottom: 0px\\\">Resource \\\"cfsb6349319941521\\\" </p></div><p><b>identifier</b>: id: 023C2WHX2V (OFFICIAL)</p><p><b>status</b>: active</p><p><b>role</b>: Excipient <span style=\\\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\\\"> (<a href=\\\"CodeSystem-CodeSystemUvEPIRrmswi.html\\\">Referentials Management Services CodeSystem</a>#100000072082)</span></p><h3>Manufacturers</h3><table class=\\\"grid\\\"><tr><td>-</td><td><b>Manufacturer</b></td></tr><tr><td>*</td><td><a href=\\\"#Organization_cfsb1950833461423\\\">See above (Organization/cfsb1950833461423)</a></td></tr></table><blockquote><p><b>substance</b></p></blockquote></div>\"\r\n          },\r\n          \"identifier\": {\r\n            \"use\": \"official\",\r\n            \"system\": \"https://gsrs.ncats.nih.gov/ginas/app/beta\",\r\n            \"value\": \"023C2WHX2V\"\r\n          },\r\n          \"status\": \"active\",\r\n          \"role\": {\r\n            \"coding\": [\r\n              {\r\n                \"system\": \"https://spor.ema.europa.eu/rmswi\",\r\n                \"code\": \"100000072082\"\r\n              }\r\n            ],\r\n            \"text\": \"Excipient\"\r\n          },\r\n          \"manufacturer\": [\r\n            {\r\n              \"manufacturer\": {\r\n                \"reference\": \"Organization/cfsb1950833461423\"\r\n              }\r\n            }\r\n          ],\r\n          \"substance\": {\r\n            \"code\": {\r\n              \"concept\": {\r\n                \"coding\": [\r\n                  {\r\n                    \"system\": \"https://gsrs.ncats.nih.gov/ginas/app/beta\",\r\n                    \"code\": \"023C2WHX2V\",\r\n                    \"display\": \"Tromethamine\"\r\n                  }\r\n                ]\r\n              }\r\n            }\r\n          }\r\n        }\r\n      }\r\n    ]\r\n  }\r\n}",
							"options": {
								"raw": {
									"language": "json"
								}
							}
						},
						"url": {
							"raw": "{{url}}/med-information/med-informations",
							"host": [
								"{{url}}"
							],
							"path": [
								"med-information",
								"med-informations"
							]
						}
					},
					"response": []
				},
				{
					"name": "Focus information",
					"request": {
						"method": "POST",
						"header": [],
						"body": {
							"mode": "raw",
							"raw": "{\r\n  \"resourceType\": \"Bundle\",\r\n  \"id\": \"IPS-examples-Bundle-01\",\r\n  \"language\": \"en-GB\",\r\n  \"identifier\": {\r\n    \"system\": \"urn:oid:2.16.724.4.8.10.200.10\",\r\n    \"value\": \"175bd032-8b00-4728-b2dc-748bb1501aed\"\r\n  },\r\n  \"type\": \"document\",\r\n  \"timestamp\": \"2017-12-11T14:30:00+01:00\",\r\n  \"entry\": [\r\n    {\r\n      \"fullUrl\": \"urn:uuid:30551ce1-5a28-4356-b684-1e639094ad4d\",\r\n      \"resource\": {\r\n        \"resourceType\": \"Composition\",\r\n        \"id\": \"30551ce1-5a28-4356-b684-1e639094ad4d\",\r\n        \"text\": {\r\n          \"status\": \"generated\",\r\n          \"div\": \"<div xmlns=\\\"http://www.w3.org/1999/xhtml\\\"><p><b>Generated Narrative</b></p><div style=\\\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\\\"><p style=\\\"margin-bottom: 0px\\\">Resource &quot;30551ce1-5a28-4356-b684-1e639094ad4d&quot; </p></div><p><b>identifier</b>: id: 3f69e0a5-2177-4540-baab-7a5d0877428f</p><p><b>status</b>: final</p><p><b>type</b>: Patient summary Document <span style=\\\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\\\"> (<a href=\\\"https://loinc.org/\\\">LOINC</a>#60591-5)</span></p><p><b>date</b>: 2017-12-11 02:30:00+0100</p><p><b>author</b>: Beetje van Hulp, MD</p><p><b>title</b>: Patient Summary as of December 11, 2017 14:30</p><p><b>confidentiality</b>: N</p><blockquote><p><b>attester</b></p><p><b>mode</b>: legal</p><p><b>time</b>: 2017-12-11 02:30:00+0100</p><p><b>party</b>: Beetje van Hulp, MD</p></blockquote><blockquote><p><b>attester</b></p><p><b>mode</b>: legal</p><p><b>time</b>: 2017-12-11 02:30:00+0100</p><p><b>party</b>: Anorg Aniza Tion BV</p></blockquote><p><b>custodian</b>: Anorg Aniza Tion BV</p><h3>RelatesTos</h3><table class=\\\"grid\\\"><tr><td>-</td><td><b>Code</b></td><td><b>Target[x]</b></td></tr><tr><td>*</td><td>appends</td><td>id: c2277753-9f90-4a95-8ddb-a0b3f6e7d292</td></tr></table><h3>Events</h3><table class=\\\"grid\\\"><tr><td>-</td><td><b>Code</b></td><td><b>Period</b></td></tr><tr><td>*</td><td>care provision <span style=\\\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\\\"> (<a href=\\\"http://terminology.hl7.org/3.1.0/CodeSystem-v3-ActClass.html\\\">ActClass</a>#PCPR)</span></td><td>?? --&gt; 2017-12-11 02:30:00+0100</td></tr></table></div>\"\r\n        },\r\n        \"identifier\": {\r\n          \"system\": \"urn:oid:2.16.724.4.8.10.200.10\",\r\n          \"value\": \"3f69e0a5-2177-4540-baab-7a5d0877428f\"\r\n        },\r\n        \"status\": \"final\",\r\n        \"type\": {\r\n          \"coding\": [\r\n            {\r\n              \"system\": \"http://loinc.org\",\r\n              \"code\": \"60591-5\",\r\n              \"display\": \"Patient summary Document\"\r\n            }\r\n          ]\r\n        },\r\n        \"subject\": {\r\n          \"reference\": \"Patient/2b90dd2b-2dab-4c75-9bb9-a355e07401e8\"\r\n        },\r\n        \"date\": \"2017-12-11T14:30:00+01:00\",\r\n        \"author\": [\r\n          {\r\n            \"reference\": \"Practitioner/1c616b24-3895-48c4-9a02-9a64110351ef\"\r\n          }\r\n        ],\r\n        \"title\": \"Patient Summary as of December 11, 2017 14:30\",\r\n        \"confidentiality\": \"N\",\r\n        \"attester\": [\r\n          {\r\n            \"mode\": \"legal\",\r\n            \"time\": \"2017-12-11T14:30:00+01:00\",\r\n            \"party\": {\r\n              \"reference\": \"Practitioner/1c616b24-3895-48c4-9a02-9a64110351ef\"\r\n            }\r\n          },\r\n          {\r\n            \"mode\": \"legal\",\r\n            \"time\": \"2017-12-11T14:30:00+01:00\",\r\n            \"party\": {\r\n              \"reference\": \"Organization/890751f4-2924-4636-bab7-efffc7f3cf15\"\r\n            }\r\n          }\r\n        ],\r\n        \"custodian\": {\r\n          \"reference\": \"Organization/890751f4-2924-4636-bab7-efffc7f3cf15\"\r\n        },\r\n        \"relatesTo\": [\r\n          {\r\n            \"code\": \"appends\",\r\n            \"targetIdentifier\": {\r\n              \"system\": \"urn:oid:2.16.724.4.8.10.200.10\",\r\n              \"value\": \"c2277753-9f90-4a95-8ddb-a0b3f6e7d292\"\r\n            }\r\n          }\r\n        ],\r\n        \"event\": [\r\n          {\r\n            \"code\": [\r\n              {\r\n                \"coding\": [\r\n                  {\r\n                    \"system\": \"http://terminology.hl7.org/CodeSystem/v3-ActClass\",\r\n                    \"code\": \"PCPR\"\r\n                  }\r\n                ]\r\n              }\r\n            ],\r\n            \"period\": {\r\n              \"end\": \"2017-12-11T14:30:00+01:00\"\r\n            }\r\n          }\r\n        ],\r\n        \"section\": [\r\n          {\r\n            \"title\": \"Active Problems\",\r\n            \"code\": {\r\n              \"coding\": [\r\n                {\r\n                  \"system\": \"http://loinc.org\",\r\n                  \"code\": \"11450-4\",\r\n                  \"display\": \"Problem list Reported\"\r\n                }\r\n              ]\r\n            },\r\n            \"text\": {\r\n              \"status\": \"generated\",\r\n              \"div\": \"<div xmlns=\\\"http://www.w3.org/1999/xhtml\\\">Hot flushes</div>\"\r\n            }\r\n          },\r\n          {\r\n            \"title\": \"Medication\",\r\n            \"code\": {\r\n              \"coding\": [\r\n                {\r\n                  \"system\": \"http://loinc.org\",\r\n                  \"code\": \"10160-0\",\r\n                  \"display\": \"History of Medication use Narrative\"\r\n                }\r\n              ]\r\n            },\r\n            \"text\": {\r\n              \"status\": \"generated\",\r\n              \"div\": \"<div xmlns=\\\"http://www.w3.org/1999/xhtml\\\">\\n\\t\\t\\t\\t\\t\\t\\t<table>\\n\\t\\t\\t\\t\\t\\t\\t\\t<thead>\\n\\t\\t\\t\\t\\t\\t\\t\\t\\t<tr>\\n\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t<th>Medication</th>\\n\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t<th>Strength</th>\\n\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t<th>Form</th>\\n\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t<th>Dosage</th>\\n\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t<th>Comment</th>\\n\\t\\t\\t\\t\\t\\t\\t\\t\\t</tr>\\n\\t\\t\\t\\t\\t\\t\\t\\t</thead>\\n\\t\\t\\t\\t\\t\\t\\t\\t<tbody>\\n\\t\\t\\t\\t\\t\\t\\t\\t\\t<tr>\\n\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t<td>Anastrozole</td>\\n\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t<td>1 mg</td>\\n\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t<td>tablet</td>\\n\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t<td>once daily</td>\\n\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t<td>treatment for breast cancer</td>\\n\\t\\t\\t\\t\\t\\t\\t\\t\\t</tr>\\n\\t\\t\\t\\t\\t\\t\\t\\t\\t<tr>\\n\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t<td>Black Cohosh Extract</td>\\n\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t<td> </td>\\n\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t<td>pil</td>\\n\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t<td> </td>\\n\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t<td>herbal supplement</td>\\n\\t\\t\\t\\t\\t\\t\\t\\t\\t</tr>\\n\\t\\t\\t\\t\\t\\t\\t\\t</tbody>\\n\\t\\t\\t\\t\\t\\t\\t</table>\\n\\t\\t\\t\\t\\t\\t</div>\"\r\n            }\r\n          },\r\n          {\r\n            \"title\": \"Allergies and Intolerances\",\r\n            \"code\": {\r\n              \"coding\": [\r\n                {\r\n                  \"system\": \"http://loinc.org\",\r\n                  \"code\": \"48765-2\",\r\n                  \"display\": \"Allergies and adverse reactions Document\"\r\n                }\r\n              ]\r\n            },\r\n            \"text\": {\r\n              \"status\": \"generated\",\r\n              \"div\": \"<div xmlns=\\\"http://www.w3.org/1999/xhtml\\\">Allergy to penicillin, high criticality, active\\n\\t\\t\\t\\t\\t\\t\\tNo known food allergies\\n\\t\\t\\t\\t\\t\\t</div>\"\r\n            }\r\n          },\r\n          {\r\n            \"title\": \"History of Past Illness\",\r\n            \"code\": {\r\n              \"coding\": [\r\n                {\r\n                  \"system\": \"http://loinc.org\",\r\n                  \"code\": \"11348-0\",\r\n                  \"display\": \"Hx of Past illness\"\r\n                }\r\n              ]\r\n            },\r\n            \"text\": {\r\n              \"status\": \"generated\",\r\n              \"div\": \"<div xmlns=\\\"http://www.w3.org/1999/xhtml\\\">Breast cancer Stage II with no evidence of recurrence following treatment</div>\"\r\n            }\r\n          },\r\n          {\r\n            \"title\": \"Plan of Treatment\",\r\n            \"code\": {\r\n              \"coding\": [\r\n                {\r\n                  \"system\": \"http://loinc.org\",\r\n                  \"code\": \"18776-5\",\r\n                  \"display\": \"Plan of care note\"\r\n                }\r\n              ]\r\n            },\r\n            \"text\": {\r\n              \"status\": \"generated\",\r\n              \"div\": \"<div xmlns=\\\"http://www.w3.org/1999/xhtml\\\">Continue hormone medication with Anastrozole for total of 5 years and monitor for potential breast cancer recurrence</div>\"\r\n            }\r\n          },\r\n          {\r\n            \"title\": \"Results\",\r\n            \"code\": {\r\n              \"coding\": [\r\n                {\r\n                  \"system\": \"http://loinc.org\",\r\n                  \"code\": \"30954-2\",\r\n                  \"display\": \"Relevant diagnostic tests/laboratory data Narrative\"\r\n                }\r\n              ]\r\n            },\r\n            \"text\": {\r\n              \"status\": \"generated\",\r\n              \"div\": \"<div xmlns=\\\"http://www.w3.org/1999/xhtml\\\">\\n\\t\\t\\t\\t\\t\\t\\t<table>\\n\\t\\t\\t\\t\\t\\t\\t\\t<thead>\\n\\t\\t\\t\\t\\t\\t\\t\\t\\t<tr>\\n\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t<th colspan=\\\"3\\\">Blood typing</th>\\n\\t\\t\\t\\t\\t\\t\\t\\t\\t</tr>\\n\\t\\t\\t\\t\\t\\t\\t\\t</thead>\\n\\t\\t\\t\\t\\t\\t\\t\\t<tbody>\\n\\t\\t\\t\\t\\t\\t\\t\\t\\t<tr>\\n\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t<td>Blood group</td>\\n\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t<td>A+</td>\\n\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t<td/>\\n\\t\\t\\t\\t\\t\\t\\t\\t\\t</tr>\\n\\t\\t\\t\\t\\t\\t\\t\\t\\t<tr>\\n\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t<td>C Ab [Presence] in Serum or Plasma</td>\\n\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t<td>Positive</td>\\n\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t<td/>\\n\\t\\t\\t\\t\\t\\t\\t\\t\\t</tr>\\n\\t\\t\\t\\t\\t\\t\\t\\t\\t<tr>\\n\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t<td>E Ab [Presence] in Serum or Plasma</td>\\n\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t<td>Positive</td>\\n\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t<td/>\\n\\t\\t\\t\\t\\t\\t\\t\\t\\t</tr>\\n\\t\\t\\t\\t\\t\\t\\t\\t\\t<tr>\\n\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t<td>Little c Ab [Presence] in Serum or Plasma</td>\\n\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t<td>Negative</td>\\n\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t<td/>\\n\\t\\t\\t\\t\\t\\t\\t\\t\\t</tr>\\n\\t\\t\\t\\t\\t\\t\\t\\t</tbody>\\n\\t\\t\\t\\t\\t\\t\\t</table>\\n\\t\\t\\t\\t\\t\\t\\t<table>\\n\\t\\t\\t\\t\\t\\t\\t\\t<thead>\\n\\t\\t\\t\\t\\t\\t\\t\\t\\t<tr>\\n\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t<th colspan=\\\"3\\\">Hemoglobin A1c monitoring</th>\\n\\t\\t\\t\\t\\t\\t\\t\\t\\t</tr>\\n\\t\\t\\t\\t\\t\\t\\t\\t</thead>\\n\\t\\t\\t\\t\\t\\t\\t\\t<tbody>\\n\\t\\t\\t\\t\\t\\t\\t\\t\\t<tr>\\n\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t<td>Hemoglobin A1c/Hemoglobin.total in Blood by HPLC</td>\\n\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t<td>7.5 %</td>\\n\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t<td/>\\n\\t\\t\\t\\t\\t\\t\\t\\t\\t</tr>\\n\\t\\t\\t\\t\\t\\t\\t\\t</tbody>\\n\\t\\t\\t\\t\\t\\t\\t</table>\\n\\t\\t\\t\\t\\t\\t\\t<table>\\n\\t\\t\\t\\t\\t\\t\\t\\t<thead>\\n\\t\\t\\t\\t\\t\\t\\t\\t\\t<tr>\\n\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t<th colspan=\\\"3\\\">Bacteriology</th>\\n\\t\\t\\t\\t\\t\\t\\t\\t\\t</tr>\\n\\t\\t\\t\\t\\t\\t\\t\\t</thead>\\n\\t\\t\\t\\t\\t\\t\\t\\t<tbody>\\n\\t\\t\\t\\t\\t\\t\\t\\t\\t<tr>\\n\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t<td colspan=\\\"3\\\">Methicillin resistant Staphylococcus aureus</td>\\n\\t\\t\\t\\t\\t\\t\\t\\t\\t</tr>\\n\\t\\t\\t\\t\\t\\t\\t\\t\\t<tr>\\n\\t\\t\\t\\t\\t\\t\\t\\t\\t\\t<td colspan=\\\"3\\\">Healthy carrier of MRSA</td>\\n\\t\\t\\t\\t\\t\\t\\t\\t\\t</tr>\\n\\t\\t\\t\\t\\t\\t\\t\\t</tbody>\\n\\t\\t\\t\\t\\t\\t\\t</table>\\n\\t\\t\\t\\t\\t\\t</div>\"\r\n            }\r\n          }\r\n        ]\r\n      }\r\n    },\r\n    {\r\n      \"fullUrl\": \"urn:uuid:2b90dd2b-2dab-4c75-9bb9-a355e07401e8\",\r\n      \"resource\": {\r\n        \"resourceType\": \"Patient\",\r\n        \"id\": \"2b90dd2b-2dab-4c75-9bb9-a355e07401e8\",\r\n        \"text\": {\r\n          \"status\": \"generated\",\r\n          \"div\": \"<div xmlns=\\\"http://www.w3.org/1999/xhtml\\\"><p><b>Generated Narrative</b></p><div style=\\\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\\\"><p style=\\\"margin-bottom: 0px\\\">Resource \\\"2b90dd2b-2dab-4c75-9bb9-a355e07401e8\\\" </p></div><p><b>identifier</b>: id: 574687583</p><p><b>active</b>: true</p><p><b>name</b>: Martha DeLarosa </p><p><b>telecom</b>: <a href=\\\"tel:+31788700800\\\">+31788700800</a></p><p><b>gender</b>: female</p><p><b>birthDate</b>: 1972-05-01</p><p><b>address</b>: Laan Van Europa 1600 Dordrecht 3317 DB NL </p><h3>Contacts</h3><table class=\\\"grid\\\"><tr><td>-</td><td><b>Relationship</b></td><td><b>Name</b></td><td><b>Telecom</b></td><td><b>Address</b></td></tr><tr><td>*</td><td>mother <span style=\\\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\\\"> (<a href=\\\"http://terminology.hl7.org/3.1.0/CodeSystem-v3-RoleCode.html\\\">RoleCode</a>#MTH)</span></td><td>Martha Mum </td><td><a href=\\\"tel:+33-555-20036\\\">+33-555-20036</a></td><td>Promenade des Anglais 111 Lyon 69001 FR </td></tr></table></div>\"\r\n        },\r\n        \"identifier\": [\r\n          {\r\n            \"system\": \"urn:oid:2.16.840.1.113883.2.4.6.3\",\r\n            \"value\": \"574687583\"\r\n          }\r\n        ],\r\n        \"active\": true,\r\n        \"name\": [\r\n          {\r\n            \"family\": \"DeLarosa\",\r\n            \"given\": [\r\n              \"Martha\"\r\n            ]\r\n          }\r\n        ],\r\n        \"telecom\": [\r\n          {\r\n            \"system\": \"phone\",\r\n            \"value\": \"+31788700800\",\r\n            \"use\": \"home\"\r\n          }\r\n        ],\r\n        \"gender\": \"female\",\r\n        \"birthDate\": \"1972-05-01\",\r\n        \"address\": [\r\n          {\r\n            \"line\": [\r\n              \"Laan Van Europa 1600\"\r\n            ],\r\n            \"city\": \"Dordrecht\",\r\n            \"postalCode\": \"3317 DB\",\r\n            \"country\": \"NL\"\r\n          }\r\n        ],\r\n        \"contact\": [\r\n          {\r\n            \"relationship\": [\r\n              {\r\n                \"coding\": [\r\n                  {\r\n                    \"system\": \"http://terminology.hl7.org/CodeSystem/v3-RoleCode\",\r\n                    \"code\": \"MTH\"\r\n                  }\r\n                ]\r\n              }\r\n            ],\r\n            \"name\": {\r\n              \"family\": \"Mum\",\r\n              \"given\": [\r\n                \"Martha\"\r\n              ]\r\n            },\r\n            \"telecom\": [\r\n              {\r\n                \"system\": \"phone\",\r\n                \"value\": \"+33-555-20036\",\r\n                \"use\": \"home\"\r\n              }\r\n            ],\r\n            \"address\": {\r\n              \"line\": [\r\n                \"Promenade des Anglais 111\"\r\n              ],\r\n              \"city\": \"Lyon\",\r\n              \"postalCode\": \"69001\",\r\n              \"country\": \"FR\"\r\n            }\r\n          }\r\n        ]\r\n      }\r\n    },\r\n    {\r\n      \"fullUrl\": \"urn:uuid:1c616b24-3895-48c4-9a02-9a64110351ef\",\r\n      \"resource\": {\r\n        \"resourceType\": \"Practitioner\",\r\n        \"id\": \"1c616b24-3895-48c4-9a02-9a64110351ef\",\r\n        \"text\": {\r\n          \"status\": \"generated\",\r\n          \"div\": \"<div xmlns=\\\"http://www.w3.org/1999/xhtml\\\"><p><b>Generated Narrative</b></p><div style=\\\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\\\"><p style=\\\"margin-bottom: 0px\\\">Resource \\\"1c616b24-3895-48c4-9a02-9a64110351ef\\\" </p></div><p><b>identifier</b>: id: 129854633</p><p><b>active</b>: true</p><p><b>name</b>: Beetje van Hulp </p><h3>Qualifications</h3><table class=\\\"grid\\\"><tr><td>-</td><td><b>Code</b></td></tr><tr><td>*</td><td>Doctor of Medicine <span style=\\\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\\\"> (<a href=\\\"http://hl7.org/fhir/R4/v2/0360/2.7/index.html\\\">v2 table 0360, Version 2.7</a>#MD)</span></td></tr></table></div>\"\r\n        },\r\n        \"identifier\": [\r\n          {\r\n            \"system\": \"urn:oid:2.16.528.1.1007.3.1\",\r\n            \"value\": \"129854633\",\r\n            \"assigner\": {\r\n              \"display\": \"CIBG\"\r\n            }\r\n          }\r\n        ],\r\n        \"active\": true,\r\n        \"name\": [\r\n          {\r\n            \"family\": \"van Hulp\",\r\n            \"given\": [\r\n              \"Beetje\"\r\n            ]\r\n          }\r\n        ],\r\n        \"qualification\": [\r\n          {\r\n            \"code\": {\r\n              \"coding\": [\r\n                {\r\n                  \"system\": \"http://terminology.hl7.org/CodeSystem/v2-0360|2.7\",\r\n                  \"code\": \"MD\",\r\n                  \"display\": \"Doctor of Medicine\"\r\n                }\r\n              ]\r\n            }\r\n          }\r\n        ]\r\n      }\r\n    },\r\n    {\r\n      \"fullUrl\": \"urn:uuid:890751f4-2924-4636-bab7-efffc7f3cf15\",\r\n      \"resource\": {\r\n        \"resourceType\": \"Organization\",\r\n        \"id\": \"890751f4-2924-4636-bab7-efffc7f3cf15\",\r\n        \"text\": {\r\n          \"status\": \"generated\",\r\n          \"div\": \"<div xmlns=\\\"http://www.w3.org/1999/xhtml\\\"><p><b>Generated Narrative</b></p><div style=\\\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\\\"><p style=\\\"margin-bottom: 0px\\\">Resource \\\"890751f4-2924-4636-bab7-efffc7f3cf15\\\" </p></div><p><b>identifier</b>: id: 564738757</p><p><b>active</b>: true</p><p><b>name</b>: Anorg Aniza Tion BV / The best custodian ever</p><p><b>telecom</b>: <a href=\\\"tel:+31-51-34343400\\\">+31-51-34343400</a></p><p><b>address</b>: Houttuinen 27 Dordrecht 3311 CE NL (WORK)</p></div>\"\r\n        },\r\n        \"identifier\": [\r\n          {\r\n            \"system\": \"urn:oid:2.16.528.1.1007.3.3\",\r\n            \"value\": \"564738757\"\r\n          }\r\n        ],\r\n        \"active\": true,\r\n        \"name\": \"Anorg Aniza Tion BV / The best custodian ever\",\r\n        \"telecom\": [\r\n          {\r\n            \"system\": \"phone\",\r\n            \"value\": \"+31-51-34343400\",\r\n            \"use\": \"work\"\r\n          }\r\n        ],\r\n        \"address\": [\r\n          {\r\n            \"use\": \"work\",\r\n            \"line\": [\r\n              \"Houttuinen 27\"\r\n            ],\r\n            \"city\": \"Dordrecht\",\r\n            \"postalCode\": \"3311 CE\",\r\n            \"country\": \"NL\"\r\n          }\r\n        ]\r\n      }\r\n    },\r\n    {\r\n      \"fullUrl\": \"urn:uuid:c64139e7-f02d-409c-bf34-75e8bf23bc80\",\r\n      \"resource\": {\r\n        \"resourceType\": \"Condition\",\r\n        \"id\": \"c64139e7-f02d-409c-bf34-75e8bf23bc80\",\r\n        \"text\": {\r\n          \"status\": \"generated\",\r\n          \"div\": \"<div xmlns=\\\"http://www.w3.org/1999/xhtml\\\"><p><b>Generated Narrative</b></p><div style=\\\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\\\"><p style=\\\"margin-bottom: 0px\\\">Resource \\\"c64139e7-f02d-409c-bf34-75e8bf23bc80\\\" </p></div><p><b>identifier</b>: id: c87bf51c-e53c-4bfe-b8b7-aa62bdd93002</p><p><b>clinicalStatus</b>: Active <span style=\\\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\\\"> (<a href=\\\"http://terminology.hl7.org/3.1.0/CodeSystem-condition-clinical.html\\\">Condition Clinical Status Codes</a>#active)</span></p><p><b>verificationStatus</b>: Confirmed <span style=\\\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\\\"> (<a href=\\\"http://terminology.hl7.org/3.1.0/CodeSystem-condition-ver-status.html\\\">ConditionVerificationStatus</a>#confirmed)</span></p><p><b>category</b>: Problem <span style=\\\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\\\"> (<a href=\\\"https://loinc.org/\\\">LOINC</a>#75326-9)</span></p><p><b>severity</b>: Moderate <span style=\\\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\\\"> (<a href=\\\"https://loinc.org/\\\">LOINC</a>#LA6751-7)</span></p><p><b>code</b>: Menopausal flushing (finding) <span style=\\\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\\\"> (<a href=\\\"https://browser.ihtsdotools.org/\\\">SNOMED CT</a>#198436008; <a href=\\\"http://terminology.hl7.org/3.1.0/CodeSystem-icd10.html\\\">ICD-10</a>#N95.1 \\\"Menopausal and female climacteric states\\\")</span></p><p><b>subject</b>: <a href=\\\"#Patient_2b90dd2b-2dab-4c75-9bb9-a355e07401e8\\\">See above (Patient/2b90dd2b-2dab-4c75-9bb9-a355e07401e8)</a></p><p><b>onset</b>: 2015</p><p><b>recordedDate</b>: 2016-10</p></div>\"\r\n        },\r\n        \"identifier\": [\r\n          {\r\n            \"system\": \"urn:oid:1.2.3.999\",\r\n            \"value\": \"c87bf51c-e53c-4bfe-b8b7-aa62bdd93002\"\r\n          }\r\n        ],\r\n        \"clinicalStatus\": {\r\n          \"coding\": [\r\n            {\r\n              \"system\": \"http://terminology.hl7.org/CodeSystem/condition-clinical\",\r\n              \"code\": \"active\"\r\n            }\r\n          ]\r\n        },\r\n        \"verificationStatus\": {\r\n          \"coding\": [\r\n            {\r\n              \"system\": \"http://terminology.hl7.org/CodeSystem/condition-ver-status\",\r\n              \"code\": \"confirmed\"\r\n            }\r\n          ]\r\n        },\r\n        \"category\": [\r\n          {\r\n            \"coding\": [\r\n              {\r\n                \"system\": \"http://loinc.org\",\r\n                \"code\": \"75326-9\",\r\n                \"display\": \"Problem\"\r\n              }\r\n            ]\r\n          }\r\n        ],\r\n        \"severity\": {\r\n          \"coding\": [\r\n            {\r\n              \"system\": \"http://loinc.org\",\r\n              \"code\": \"LA6751-7\",\r\n              \"display\": \"Moderate\"\r\n            }\r\n          ]\r\n        },\r\n        \"code\": {\r\n          \"coding\": [\r\n            {\r\n              \"system\": \"http://snomed.info/sct\",\r\n              \"code\": \"198436008\",\r\n              \"display\": \"Menopausal flushing (finding)\",\r\n              \"_display\": {\r\n                \"extension\": [\r\n                  {\r\n                    \"url\": \"http://hl7.org/fhir/StructureDefinition/translation\",\r\n                    \"extension\": [\r\n                      {\r\n                        \"url\": \"lang\",\r\n                        \"valueCode\": \"nl-NL\"\r\n                      },\r\n                      {\r\n                        \"url\": \"content\",\r\n                        \"valueString\": \"opvliegers\"\r\n                      }\r\n                    ]\r\n                  }\r\n                ]\r\n              }\r\n            },\r\n            {\r\n              \"system\": \"http://hl7.org/fhir/sid/icd-10\",\r\n              \"code\": \"N95.1\",\r\n              \"display\": \"Menopausal and female climacteric states\"\r\n            }\r\n          ]\r\n        },\r\n        \"subject\": {\r\n          \"reference\": \"Patient/2b90dd2b-2dab-4c75-9bb9-a355e07401e8\"\r\n        },\r\n        \"onsetDateTime\": \"2015\",\r\n        \"recordedDate\": \"2016-10\"\r\n      }\r\n    },\r\n    {\r\n      \"fullUrl\": \"urn:uuid:c220e36c-eb67-4fc4-9ba1-2fabc52acec6\",\r\n      \"resource\": {\r\n        \"resourceType\": \"MedicationStatement\",\r\n        \"id\": \"c220e36c-eb67-4fc4-9ba1-2fabc52acec6\",\r\n        \"text\": {\r\n          \"status\": \"generated\",\r\n          \"div\": \"<div xmlns=\\\"http://www.w3.org/1999/xhtml\\\"><p><b>Generated Narrative</b></p><div style=\\\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\\\"><p style=\\\"margin-bottom: 0px\\\">Resource \\\"c220e36c-eb67-4fc4-9ba1-2fabc52acec6\\\" </p></div><p><b>identifier</b>: id: b75f92cb-61d4-469a-9387-df5ef70d25f0</p><p><b>status</b>: active</p><p><b>medication</b>: <a href=\\\"#Medication_976d0804-cae0-45ae-afe3-a19f3ceba6bc\\\">See above (Medication/976d0804-cae0-45ae-afe3-a19f3ceba6bc)</a></p><p><b>subject</b>: <a href=\\\"#Patient_2b90dd2b-2dab-4c75-9bb9-a355e07401e8\\\">See above (Patient/2b90dd2b-2dab-4c75-9bb9-a355e07401e8)</a></p><p><b>effective</b>: 2015-03 --&gt; (ongoing)</p></div>\"\r\n        },\r\n        \"identifier\": [\r\n          {\r\n            \"system\": \"urn:oid:1.2.3.999\",\r\n            \"value\": \"b75f92cb-61d4-469a-9387-df5ef70d25f0\"\r\n          }\r\n        ],\r\n        \"status\": \"active\",\r\n        \"medicationReference\": {\r\n          \"reference\": \"Medication/976d0804-cae0-45ae-afe3-a19f3ceba6bc\"\r\n        },\r\n        \"subject\": {\r\n          \"reference\": \"Patient/2b90dd2b-2dab-4c75-9bb9-a355e07401e8\"\r\n        },\r\n        \"effectivePeriod\": {\r\n          \"start\": \"2015-03\"\r\n        },\r\n        \"dosage\": [\r\n          {\r\n            \"timing\": {\r\n              \"repeat\": {\r\n                \"count\": 1,\r\n                \"periodUnit\": \"d\"\r\n              }\r\n            },\r\n            \"route\": {\r\n              \"coding\": [\r\n                {\r\n                  \"system\": \"http://standardterms.edqm.eu\",\r\n                  \"code\": \"20053000\",\r\n                  \"display\": \"Oral use\"\r\n                }\r\n              ]\r\n            },\r\n            \"doseAndRate\": [\r\n              {\r\n                \"type\": {\r\n                  \"coding\": [\r\n                    {\r\n                      \"system\": \"http://terminology.hl7.org/CodeSystem/dose-rate-type\",\r\n                      \"code\": \"ordered\",\r\n                      \"display\": \"Ordered\"\r\n                    }\r\n                  ]\r\n                },\r\n                \"doseQuantity\": {\r\n                  \"value\": 1,\r\n                  \"unit\": \"tablet\",\r\n                  \"system\": \"http://unitsofmeasure.org\",\r\n                  \"code\": \"1\"\r\n                }\r\n              }\r\n            ]\r\n          }\r\n        ]\r\n      }\r\n    },\r\n    {\r\n      \"fullUrl\": \"urn:uuid:47524493-846a-4a26-bae2-4ab03e60f02e\",\r\n      \"resource\": {\r\n        \"resourceType\": \"MedicationStatement\",\r\n        \"id\": \"47524493-846a-4a26-bae2-4ab03e60f02e\",\r\n        \"text\": {\r\n          \"status\": \"generated\",\r\n          \"div\": \"<div xmlns=\\\"http://www.w3.org/1999/xhtml\\\"><p><b>Generated Narrative</b></p><div style=\\\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\\\"><p style=\\\"margin-bottom: 0px\\\">Resource \\\"47524493-846a-4a26-bae2-4ab03e60f02e\\\" </p></div><p><b>identifier</b>: id: 9e312d6b-c6b6-439a-a730-6efaa5dcf8bc</p><p><b>status</b>: active</p><p><b>medication</b>: <a href=\\\"#Medication_8adc0999-9468-4ac9-9557-680fa133d626\\\">See above (Medication/8adc0999-9468-4ac9-9557-680fa133d626)</a></p><p><b>subject</b>: <a href=\\\"#Patient_2b90dd2b-2dab-4c75-9bb9-a355e07401e8\\\">See above (Patient/2b90dd2b-2dab-4c75-9bb9-a355e07401e8)</a></p><p><b>effective</b>: 2016-01 --&gt; (ongoing)</p></div>\"\r\n        },\r\n        \"identifier\": [\r\n          {\r\n            \"system\": \"urn:oid:1.2.3.999\",\r\n            \"value\": \"9e312d6b-c6b6-439a-a730-6efaa5dcf8bc\"\r\n          }\r\n        ],\r\n        \"status\": \"active\",\r\n        \"medicationReference\": {\r\n          \"reference\": \"Medication/8adc0999-9468-4ac9-9557-680fa133d626\"\r\n        },\r\n        \"subject\": {\r\n          \"reference\": \"Patient/2b90dd2b-2dab-4c75-9bb9-a355e07401e8\"\r\n        },\r\n        \"effectivePeriod\": {\r\n          \"start\": \"2016-01\"\r\n        },\r\n        \"dosage\": [\r\n          {\r\n            \"route\": {\r\n              \"coding\": [\r\n                {\r\n                  \"system\": \"http://standardterms.edqm.eu\",\r\n                  \"code\": \"20053000\",\r\n                  \"display\": \"Oral use\"\r\n                }\r\n              ]\r\n            }\r\n          }\r\n        ]\r\n      }\r\n    },\r\n    {\r\n      \"fullUrl\": \"urn:uuid:976d0804-cae0-45ae-afe3-a19f3ceba6bc\",\r\n      \"resource\": {\r\n        \"resourceType\": \"Medication\",\r\n        \"id\": \"976d0804-cae0-45ae-afe3-a19f3ceba6bc\",\r\n        \"text\": {\r\n          \"status\": \"generated\",\r\n          \"div\": \"<div xmlns=\\\"http://www.w3.org/1999/xhtml\\\"><p><b>Generated Narrative</b></p><div style=\\\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\\\"><p style=\\\"margin-bottom: 0px\\\">Resource \\\"976d0804-cae0-45ae-afe3-a19f3ceba6bc\\\" </p></div><p><b>code</b>: Product containing anastrozole (medicinal product) <span style=\\\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\\\"> (<a href=\\\"https://browser.ihtsdotools.org/\\\">SNOMED CT</a>#108774000; unknown#99872 \\\"ANASTROZOL 1MG TABLET\\\"; unknown#2076667 \\\"ANASTROZOL CF TABLET FILMOMHULD 1MG\\\"; <a href=\\\"http://terminology.hl7.org/3.1.0/CodeSystem-atc.html\\\">WHO ATC</a>#L02BG03 \\\"anastrozole\\\")</span></p></div>\"\r\n        },\r\n        \"code\": {\r\n          \"coding\": [\r\n            {\r\n              \"system\": \"http://snomed.info/sct\",\r\n              \"code\": \"108774000\",\r\n              \"display\": \"Product containing anastrozole (medicinal product)\"\r\n            },\r\n            {\r\n              \"system\": \"urn:oid:2.16.840.1.113883.2.4.4.1\",\r\n              \"code\": \"99872\",\r\n              \"display\": \"ANASTROZOL 1MG TABLET\"\r\n            },\r\n            {\r\n              \"system\": \"urn:oid:2.16.840.1.113883.2.4.4.7\",\r\n              \"code\": \"2076667\",\r\n              \"display\": \"ANASTROZOL CF TABLET FILMOMHULD 1MG\"\r\n            },\r\n            {\r\n              \"system\": \"http://www.whocc.no/atc\",\r\n              \"code\": \"L02BG03\",\r\n              \"display\": \"anastrozole\"\r\n            }\r\n          ]\r\n        }\r\n      }\r\n    },\r\n    {\r\n      \"fullUrl\": \"urn:uuid:8adc0999-9468-4ac9-9557-680fa133d626\",\r\n      \"resource\": {\r\n        \"resourceType\": \"Medication\",\r\n        \"id\": \"8adc0999-9468-4ac9-9557-680fa133d626\",\r\n        \"text\": {\r\n          \"status\": \"generated\",\r\n          \"div\": \"<div xmlns=\\\"http://www.w3.org/1999/xhtml\\\"><p><b>Generated Narrative</b></p><div style=\\\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\\\"><p style=\\\"margin-bottom: 0px\\\">Resource \\\"8adc0999-9468-4ac9-9557-680fa133d626\\\" </p></div><p><b>code</b>: Black Cohosh Extract herbal supplement <span style=\\\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\\\"> (<a href=\\\"https://browser.ihtsdotools.org/\\\">SNOMED CT</a>#412588001 \\\"Cimicifuga racemosa extract (substance)\\\"; <a href=\\\"http://terminology.hl7.org/3.1.0/CodeSystem-atc.html\\\">WHO ATC</a>#G02CX04 \\\"Cimicifugae rhizoma\\\")</span></p></div>\"\r\n        },\r\n        \"code\": {\r\n          \"coding\": [\r\n            {\r\n              \"system\": \"http://snomed.info/sct\",\r\n              \"code\": \"412588001\",\r\n              \"display\": \"Cimicifuga racemosa extract (substance)\",\r\n              \"_display\": {\r\n                \"extension\": [\r\n                  {\r\n                    \"url\": \"http://hl7.org/fhir/StructureDefinition/translation\",\r\n                    \"extension\": [\r\n                      {\r\n                        \"url\": \"lang\",\r\n                        \"valueCode\": \"nl-NL\"\r\n                      },\r\n                      {\r\n                        \"url\": \"content\",\r\n                        \"valueString\": \"Zwarte Cohosh Extract\"\r\n                      }\r\n                    ]\r\n                  }\r\n                ]\r\n              }\r\n            },\r\n            {\r\n              \"system\": \"http://www.whocc.no/atc\",\r\n              \"code\": \"G02CX04\",\r\n              \"display\": \"Cimicifugae rhizoma\"\r\n            }\r\n          ],\r\n          \"text\": \"Black Cohosh Extract herbal supplement\"\r\n        }\r\n      }\r\n    },\r\n    {\r\n      \"fullUrl\": \"urn:uuid:72884cad-ebe6-4f43-a51a-2f978275f132\",\r\n      \"resource\": {\r\n        \"resourceType\": \"AllergyIntolerance\",\r\n        \"id\": \"72884cad-ebe6-4f43-a51a-2f978275f132\",\r\n        \"text\": {\r\n          \"status\": \"generated\",\r\n          \"div\": \"<div xmlns=\\\"http://www.w3.org/1999/xhtml\\\"><p><b>Generated Narrative</b></p><div style=\\\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\\\"><p style=\\\"margin-bottom: 0px\\\">Resource \\\"72884cad-ebe6-4f43-a51a-2f978275f132\\\" </p></div><p><b>identifier</b>: id: 3a462598-009c-484a-965c-d6b24a821424</p><p><b>clinicalStatus</b>: Active <span style=\\\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\\\"> (<a href=\\\"http://terminology.hl7.org/3.1.0/CodeSystem-allergyintolerance-clinical.html\\\">AllergyIntolerance Clinical Status Codes</a>#active)</span></p><p><b>verificationStatus</b>: Confirmed <span style=\\\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\\\"> (<a href=\\\"http://terminology.hl7.org/3.1.0/CodeSystem-allergyintolerance-verification.html\\\">AllergyIntolerance Verification Status</a>#confirmed)</span></p><p><b>type</b>: allergy</p><p><b>category</b>: medication</p><p><b>criticality</b>: high</p><p><b>code</b>: Substance with penicillin structure and antibacterial mechanism of action (substance) <span style=\\\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\\\"> (<a href=\\\"https://browser.ihtsdotools.org/\\\">SNOMED CT</a>#373270004)</span></p><p><b>patient</b>: <a href=\\\"#Patient_2b90dd2b-2dab-4c75-9bb9-a355e07401e8\\\">See above (Patient/2b90dd2b-2dab-4c75-9bb9-a355e07401e8)</a></p><p><b>onset</b>: 2010</p></div>\"\r\n        },\r\n        \"identifier\": [\r\n          {\r\n            \"system\": \"urn:oid:1.2.3.999\",\r\n            \"value\": \"3a462598-009c-484a-965c-d6b24a821424\"\r\n          }\r\n        ],\r\n        \"clinicalStatus\": {\r\n          \"coding\": [\r\n            {\r\n              \"system\": \"http://terminology.hl7.org/CodeSystem/allergyintolerance-clinical\",\r\n              \"code\": \"active\"\r\n            }\r\n          ]\r\n        },\r\n        \"verificationStatus\": {\r\n          \"coding\": [\r\n            {\r\n              \"system\": \"http://terminology.hl7.org/CodeSystem/allergyintolerance-verification\",\r\n              \"code\": \"confirmed\"\r\n            }\r\n          ]\r\n        },\r\n        \"type\": \"allergy\",\r\n        \"category\": [\r\n          \"medication\"\r\n        ],\r\n        \"criticality\": \"high\",\r\n        \"code\": {\r\n          \"coding\": [\r\n            {\r\n              \"system\": \"http://snomed.info/sct\",\r\n              \"code\": \"373270004\",\r\n              \"display\": \"Substance with penicillin structure and antibacterial mechanism of action (substance)\"\r\n            }\r\n          ]\r\n        },\r\n        \"patient\": {\r\n          \"reference\": \"Patient/2b90dd2b-2dab-4c75-9bb9-a355e07401e8\"\r\n        },\r\n        \"onsetDateTime\": \"2010\"\r\n      }\r\n    },\r\n    {\r\n      \"fullUrl\": \"urn:uuid:c4597aa2-688a-401b-a658-70acc6de28c6\",\r\n      \"resource\": {\r\n        \"resourceType\": \"Condition\",\r\n        \"id\": \"c4597aa2-688a-401b-a658-70acc6de28c6\",\r\n        \"text\": {\r\n          \"status\": \"generated\",\r\n          \"div\": \"<div xmlns=\\\"http://www.w3.org/1999/xhtml\\\"><p><b>Generated Narrative</b></p><div style=\\\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\\\"><p style=\\\"margin-bottom: 0px\\\">Resource \\\"c4597aa2-688a-401b-a658-70acc6de28c6\\\" </p></div><p><b>identifier</b>: id: 66d4a8c7-9081-43e0-a63f-489c2ae6edd6</p><p><b>clinicalStatus</b>: Remission <span style=\\\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\\\"> (<a href=\\\"http://terminology.hl7.org/3.1.0/CodeSystem-condition-clinical.html\\\">Condition Clinical Status Codes</a>#remission)</span></p><p><b>verificationStatus</b>: Confirmed <span style=\\\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\\\"> (<a href=\\\"http://terminology.hl7.org/3.1.0/CodeSystem-condition-ver-status.html\\\">ConditionVerificationStatus</a>#confirmed)</span></p><p><b>category</b>: Problem <span style=\\\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\\\"> (<a href=\\\"https://loinc.org/\\\">LOINC</a>#75326-9)</span></p><p><b>severity</b>: Severe <span style=\\\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\\\"> (<a href=\\\"https://loinc.org/\\\">LOINC</a>#LA6750-9)</span></p><p><b>code</b>: Malignant tumor of breast <span style=\\\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\\\"> (<a href=\\\"https://browser.ihtsdotools.org/\\\">SNOMED CT</a>#254837009; unknown#8500/3 \\\"Infiltrating duct carcinoma, NOS\\\")</span></p><p><b>subject</b>: <a href=\\\"#Patient_2b90dd2b-2dab-4c75-9bb9-a355e07401e8\\\">See above (Patient/2b90dd2b-2dab-4c75-9bb9-a355e07401e8)</a></p><p><b>onset</b>: 2015-01</p><p><b>abatement</b>: 2015-03</p></div>\"\r\n        },\r\n        \"identifier\": [\r\n          {\r\n            \"system\": \"urn:oid:1.2.3.999\",\r\n            \"value\": \"66d4a8c7-9081-43e0-a63f-489c2ae6edd6\"\r\n          }\r\n        ],\r\n        \"clinicalStatus\": {\r\n          \"coding\": [\r\n            {\r\n              \"system\": \"http://terminology.hl7.org/CodeSystem/condition-clinical\",\r\n              \"code\": \"remission\"\r\n            }\r\n          ]\r\n        },\r\n        \"verificationStatus\": {\r\n          \"coding\": [\r\n            {\r\n              \"system\": \"http://terminology.hl7.org/CodeSystem/condition-ver-status\",\r\n              \"code\": \"confirmed\"\r\n            }\r\n          ]\r\n        },\r\n        \"category\": [\r\n          {\r\n            \"coding\": [\r\n              {\r\n                \"system\": \"http://loinc.org\",\r\n                \"code\": \"75326-9\",\r\n                \"display\": \"Problem\"\r\n              }\r\n            ]\r\n          }\r\n        ],\r\n        \"severity\": {\r\n          \"coding\": [\r\n            {\r\n              \"system\": \"http://loinc.org\",\r\n              \"code\": \"LA6750-9\",\r\n              \"display\": \"Severe\"\r\n            }\r\n          ]\r\n        },\r\n        \"code\": {\r\n          \"coding\": [\r\n            {\r\n              \"system\": \"http://snomed.info/sct\",\r\n              \"code\": \"254837009\",\r\n              \"display\": \"Malignant tumor of breast\",\r\n              \"_display\": {\r\n                \"extension\": [\r\n                  {\r\n                    \"url\": \"http://hl7.org/fhir/StructureDefinition/translation\",\r\n                    \"extension\": [\r\n                      {\r\n                        \"url\": \"lang\",\r\n                        \"valueCode\": \"nl-NL\"\r\n                      },\r\n                      {\r\n                        \"url\": \"content\",\r\n                        \"valueString\": \"Borstkanker stadium II zonder aanwijzingen van recidieven na behandeling\"\r\n                      }\r\n                    ]\r\n                  }\r\n                ]\r\n              }\r\n            },\r\n            {\r\n              \"system\": \"urn:oid:2.16.840.1.113883.6.43.1\",\r\n              \"code\": \"8500/3\",\r\n              \"display\": \"Infiltrating duct carcinoma, NOS\"\r\n            }\r\n          ]\r\n        },\r\n        \"subject\": {\r\n          \"reference\": \"Patient/2b90dd2b-2dab-4c75-9bb9-a355e07401e8\"\r\n        },\r\n        \"onsetDateTime\": \"2015-01\",\r\n        \"abatementDateTime\": \"2015-03\"\r\n      }\r\n    },\r\n    {\r\n      \"fullUrl\": \"urn:uuid:45a5c5b1-4ec1-4d60-b4b2-ff5a84a41fd7\",\r\n      \"resource\": {\r\n        \"resourceType\": \"Organization\",\r\n        \"id\": \"45a5c5b1-4ec1-4d60-b4b2-ff5a84a41fd7\",\r\n        \"text\": {\r\n          \"status\": \"generated\",\r\n          \"div\": \"<div xmlns=\\\"http://www.w3.org/1999/xhtml\\\"><p><b>Generated Narrative</b></p><div style=\\\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\\\"><p style=\\\"margin-bottom: 0px\\\">Resource \\\"45a5c5b1-4ec1-4d60-b4b2-ff5a84a41fd7\\\" </p></div><p><b>active</b>: true</p><p><b>type</b>: Other <span style=\\\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\\\"> (<a href=\\\"http://terminology.hl7.org/3.1.0/CodeSystem-organization-type.html\\\">Organization type</a>#other)</span></p><p><b>name</b>: Laboratoire de charme</p></div>\"\r\n        },\r\n        \"active\": true,\r\n        \"type\": [\r\n          {\r\n            \"coding\": [\r\n              {\r\n                \"system\": \"http://terminology.hl7.org/CodeSystem/organization-type\",\r\n                \"code\": \"other\"\r\n              }\r\n            ]\r\n          }\r\n        ],\r\n        \"name\": \"Laboratoire de charme\"\r\n      }\r\n    },\r\n    {\r\n      \"fullUrl\": \"urn:uuid:aa11a2be-3e36-4be7-b58a-6fc3dace2741\",\r\n      \"resource\": {\r\n        \"resourceType\": \"Observation\",\r\n        \"id\": \"aa11a2be-3e36-4be7-b58a-6fc3dace2741\",\r\n        \"text\": {\r\n          \"status\": \"generated\",\r\n          \"div\": \"<div xmlns=\\\"http://www.w3.org/1999/xhtml\\\"><p><b>Generated Narrative</b></p><div style=\\\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\\\"><p style=\\\"margin-bottom: 0px\\\">Resource \\\"aa11a2be-3e36-4be7-b58a-6fc3dace2741\\\" </p></div><p><b>status</b>: final</p><p><b>category</b>: Laboratory <span style=\\\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\\\"> (<a href=\\\"http://terminology.hl7.org/3.1.0/CodeSystem-observation-category.html\\\">Observation Category Codes</a>#laboratory)</span></p><p><b>code</b>: ABO and Rh group [Type] in Blood <span style=\\\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\\\"> (<a href=\\\"https://loinc.org/\\\">LOINC</a>#882-1)</span></p><p><b>subject</b>: <a href=\\\"#Patient_2b90dd2b-2dab-4c75-9bb9-a355e07401e8\\\">See above (Patient/2b90dd2b-2dab-4c75-9bb9-a355e07401e8)</a></p><p><b>effective</b>: 2015-10-10 09:15:00+0100</p><p><b>performer</b>: <a href=\\\"#Organization_45a5c5b1-4ec1-4d60-b4b2-ff5a84a41fd7\\\">See above (Organization/45a5c5b1-4ec1-4d60-b4b2-ff5a84a41fd7)</a></p><p><b>value</b>: Blood group A Rh(D) positive <span style=\\\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\\\"> (<a href=\\\"https://browser.ihtsdotools.org/\\\">SNOMED CT</a>#278149003)</span></p></div>\"\r\n        },\r\n        \"status\": \"final\",\r\n        \"category\": [\r\n          {\r\n            \"coding\": [\r\n              {\r\n                \"system\": \"http://terminology.hl7.org/CodeSystem/observation-category\",\r\n                \"code\": \"laboratory\"\r\n              }\r\n            ]\r\n          }\r\n        ],\r\n        \"code\": {\r\n          \"coding\": [\r\n            {\r\n              \"system\": \"http://loinc.org\",\r\n              \"code\": \"882-1\",\r\n              \"display\": \"ABO and Rh group [Type] in Blood\"\r\n            }\r\n          ]\r\n        },\r\n        \"subject\": {\r\n          \"reference\": \"Patient/2b90dd2b-2dab-4c75-9bb9-a355e07401e8\"\r\n        },\r\n        \"effectiveDateTime\": \"2015-10-10T09:15:00+01:00\",\r\n        \"performer\": [\r\n          {\r\n            \"reference\": \"Organization/45a5c5b1-4ec1-4d60-b4b2-ff5a84a41fd7\"\r\n          }\r\n        ],\r\n        \"valueCodeableConcept\": {\r\n          \"coding\": [\r\n            {\r\n              \"system\": \"http://snomed.info/sct\",\r\n              \"code\": \"278149003\",\r\n              \"display\": \"Blood group A Rh(D) positive\"\r\n            }\r\n          ]\r\n        }\r\n      }\r\n    },\r\n    {\r\n      \"fullUrl\": \"urn:uuid:6e39ccf3-f997-4a2b-8f28-b4b71c778c70\",\r\n      \"resource\": {\r\n        \"resourceType\": \"Observation\",\r\n        \"id\": \"6e39ccf3-f997-4a2b-8f28-b4b71c778c70\",\r\n        \"text\": {\r\n          \"status\": \"generated\",\r\n          \"div\": \"<div xmlns=\\\"http://www.w3.org/1999/xhtml\\\"><p><b>Generated Narrative</b></p><div style=\\\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\\\"><p style=\\\"margin-bottom: 0px\\\">Resource \\\"6e39ccf3-f997-4a2b-8f28-b4b71c778c70\\\" </p></div><p><b>status</b>: final</p><p><b>category</b>: Laboratory <span style=\\\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\\\"> (<a href=\\\"http://terminology.hl7.org/3.1.0/CodeSystem-observation-category.html\\\">Observation Category Codes</a>#laboratory)</span></p><p><b>code</b>: C Ab [Presence] in Serum or Plasma <span style=\\\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\\\"> (<a href=\\\"https://loinc.org/\\\">LOINC</a>#945-6)</span></p><p><b>subject</b>: <a href=\\\"#Patient_2b90dd2b-2dab-4c75-9bb9-a355e07401e8\\\">See above (Patient/2b90dd2b-2dab-4c75-9bb9-a355e07401e8)</a></p><p><b>effective</b>: 2015-10-10 09:35:00+0100</p><p><b>performer</b>: <a href=\\\"#Organization_45a5c5b1-4ec1-4d60-b4b2-ff5a84a41fd7\\\">See above (Organization/45a5c5b1-4ec1-4d60-b4b2-ff5a84a41fd7)</a></p><p><b>value</b>: Positive <span style=\\\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\\\"> (<a href=\\\"https://browser.ihtsdotools.org/\\\">SNOMED CT</a>#10828004)</span></p></div>\"\r\n        },\r\n        \"status\": \"final\",\r\n        \"category\": [\r\n          {\r\n            \"coding\": [\r\n              {\r\n                \"system\": \"http://terminology.hl7.org/CodeSystem/observation-category\",\r\n                \"code\": \"laboratory\"\r\n              }\r\n            ]\r\n          }\r\n        ],\r\n        \"code\": {\r\n          \"coding\": [\r\n            {\r\n              \"system\": \"http://loinc.org\",\r\n              \"code\": \"945-6\",\r\n              \"display\": \"C Ab [Presence] in Serum or Plasma\"\r\n            }\r\n          ]\r\n        },\r\n        \"subject\": {\r\n          \"reference\": \"Patient/2b90dd2b-2dab-4c75-9bb9-a355e07401e8\"\r\n        },\r\n        \"effectiveDateTime\": \"2015-10-10T09:35:00+01:00\",\r\n        \"performer\": [\r\n          {\r\n            \"reference\": \"Organization/45a5c5b1-4ec1-4d60-b4b2-ff5a84a41fd7\"\r\n          }\r\n        ],\r\n        \"valueCodeableConcept\": {\r\n          \"coding\": [\r\n            {\r\n              \"system\": \"http://snomed.info/sct\",\r\n              \"code\": \"10828004\",\r\n              \"display\": \"Positive\"\r\n            }\r\n          ]\r\n        }\r\n      }\r\n    },\r\n    {\r\n      \"fullUrl\": \"urn:uuid:b4916505-a06b-460c-9be8-011609282457\",\r\n      \"resource\": {\r\n        \"resourceType\": \"Observation\",\r\n        \"id\": \"b4916505-a06b-460c-9be8-011609282457\",\r\n        \"text\": {\r\n          \"status\": \"generated\",\r\n          \"div\": \"<div xmlns=\\\"http://www.w3.org/1999/xhtml\\\"><p><b>Generated Narrative</b></p><div style=\\\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\\\"><p style=\\\"margin-bottom: 0px\\\">Resource \\\"b4916505-a06b-460c-9be8-011609282457\\\" </p></div><p><b>status</b>: final</p><p><b>category</b>: Laboratory <span style=\\\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\\\"> (<a href=\\\"http://terminology.hl7.org/3.1.0/CodeSystem-observation-category.html\\\">Observation Category Codes</a>#laboratory)</span></p><p><b>code</b>: E Ab [Presence] in Serum or Plasma <span style=\\\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\\\"> (<a href=\\\"https://loinc.org/\\\">LOINC</a>#1018-1)</span></p><p><b>subject</b>: <a href=\\\"#Patient_2b90dd2b-2dab-4c75-9bb9-a355e07401e8\\\">See above (Patient/2b90dd2b-2dab-4c75-9bb9-a355e07401e8)</a></p><p><b>effective</b>: 2015-10-10 09:35:00+0100</p><p><b>performer</b>: <a href=\\\"#Organization_45a5c5b1-4ec1-4d60-b4b2-ff5a84a41fd7\\\">See above (Organization/45a5c5b1-4ec1-4d60-b4b2-ff5a84a41fd7)</a></p><p><b>value</b>: Positive <span style=\\\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\\\"> (<a href=\\\"https://browser.ihtsdotools.org/\\\">SNOMED CT</a>#10828004)</span></p></div>\"\r\n        },\r\n        \"status\": \"final\",\r\n        \"category\": [\r\n          {\r\n            \"coding\": [\r\n              {\r\n                \"system\": \"http://terminology.hl7.org/CodeSystem/observation-category\",\r\n                \"code\": \"laboratory\"\r\n              }\r\n            ]\r\n          }\r\n        ],\r\n        \"code\": {\r\n          \"coding\": [\r\n            {\r\n              \"system\": \"http://loinc.org\",\r\n              \"code\": \"1018-1\",\r\n              \"display\": \"E Ab [Presence] in Serum or Plasma\"\r\n            }\r\n          ]\r\n        },\r\n        \"subject\": {\r\n          \"reference\": \"Patient/2b90dd2b-2dab-4c75-9bb9-a355e07401e8\"\r\n        },\r\n        \"effectiveDateTime\": \"2015-10-10T09:35:00+01:00\",\r\n        \"performer\": [\r\n          {\r\n            \"reference\": \"Organization/45a5c5b1-4ec1-4d60-b4b2-ff5a84a41fd7\"\r\n          }\r\n        ],\r\n        \"valueCodeableConcept\": {\r\n          \"coding\": [\r\n            {\r\n              \"system\": \"http://snomed.info/sct\",\r\n              \"code\": \"10828004\",\r\n              \"display\": \"Positive\"\r\n            }\r\n          ]\r\n        }\r\n      }\r\n    },\r\n    {\r\n      \"fullUrl\": \"urn:uuid:a6a5a1d5-c896-4c7e-b922-888fcc7e6ae4\",\r\n      \"resource\": {\r\n        \"resourceType\": \"Observation\",\r\n        \"id\": \"a6a5a1d5-c896-4c7e-b922-888fcc7e6ae4\",\r\n        \"text\": {\r\n          \"status\": \"generated\",\r\n          \"div\": \"<div xmlns=\\\"http://www.w3.org/1999/xhtml\\\"><p><b>Generated Narrative</b></p><div style=\\\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\\\"><p style=\\\"margin-bottom: 0px\\\">Resource \\\"a6a5a1d5-c896-4c7e-b922-888fcc7e6ae4\\\" </p></div><p><b>status</b>: final</p><p><b>category</b>: Laboratory <span style=\\\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\\\"> (<a href=\\\"http://terminology.hl7.org/3.1.0/CodeSystem-observation-category.html\\\">Observation Category Codes</a>#laboratory)</span></p><p><b>code</b>: little c Ab [Presence] in Serum or Plasma <span style=\\\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\\\"> (<a href=\\\"https://loinc.org/\\\">LOINC</a>#1156-9)</span></p><p><b>subject</b>: <a href=\\\"#Patient_2b90dd2b-2dab-4c75-9bb9-a355e07401e8\\\">See above (Patient/2b90dd2b-2dab-4c75-9bb9-a355e07401e8)</a></p><p><b>effective</b>: 2015-10-10 09:35:00+0100</p><p><b>performer</b>: <a href=\\\"#Organization_45a5c5b1-4ec1-4d60-b4b2-ff5a84a41fd7\\\">See above (Organization/45a5c5b1-4ec1-4d60-b4b2-ff5a84a41fd7)</a></p><p><b>value</b>: Negative <span style=\\\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\\\"> (<a href=\\\"https://browser.ihtsdotools.org/\\\">SNOMED CT</a>#260385009)</span></p></div>\"\r\n        },\r\n        \"status\": \"final\",\r\n        \"category\": [\r\n          {\r\n            \"coding\": [\r\n              {\r\n                \"system\": \"http://terminology.hl7.org/CodeSystem/observation-category\",\r\n                \"code\": \"laboratory\"\r\n              }\r\n            ]\r\n          }\r\n        ],\r\n        \"code\": {\r\n          \"coding\": [\r\n            {\r\n              \"system\": \"http://loinc.org\",\r\n              \"code\": \"1156-9\",\r\n              \"display\": \"little c Ab [Presence] in Serum or Plasma\"\r\n            }\r\n          ]\r\n        },\r\n        \"subject\": {\r\n          \"reference\": \"Patient/2b90dd2b-2dab-4c75-9bb9-a355e07401e8\"\r\n        },\r\n        \"effectiveDateTime\": \"2015-10-10T09:35:00+01:00\",\r\n        \"performer\": [\r\n          {\r\n            \"reference\": \"Organization/45a5c5b1-4ec1-4d60-b4b2-ff5a84a41fd7\"\r\n          }\r\n        ],\r\n        \"valueCodeableConcept\": {\r\n          \"coding\": [\r\n            {\r\n              \"system\": \"http://snomed.info/sct\",\r\n              \"code\": \"260385009\",\r\n              \"display\": \"Negative\"\r\n            }\r\n          ]\r\n        }\r\n      }\r\n    },\r\n    {\r\n      \"fullUrl\": \"urn:uuid:2639657a-c19a-48e2-82cc-471e13b8ad94\",\r\n      \"resource\": {\r\n        \"resourceType\": \"Observation\",\r\n        \"id\": \"2639657a-c19a-48e2-82cc-471e13b8ad94\",\r\n        \"text\": {\r\n          \"status\": \"generated\",\r\n          \"div\": \"<div xmlns=\\\"http://www.w3.org/1999/xhtml\\\"><p><b>Generated Narrative</b></p><div style=\\\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\\\"><p style=\\\"margin-bottom: 0px\\\">Resource \\\"2639657a-c19a-48e2-82cc-471e13b8ad94\\\" </p></div><p><b>status</b>: final</p><p><b>category</b>: Laboratory <span style=\\\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\\\"> (<a href=\\\"http://terminology.hl7.org/3.1.0/CodeSystem-observation-category.html\\\">Observation Category Codes</a>#laboratory)</span></p><p><b>code</b>: Blood typing <span style=\\\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\\\"> ()</span></p><p><b>subject</b>: <a href=\\\"#Patient_2b90dd2b-2dab-4c75-9bb9-a355e07401e8\\\">See above (Patient/2b90dd2b-2dab-4c75-9bb9-a355e07401e8)</a></p><p><b>effective</b>: 2015-10-10</p><p><b>performer</b>: <a href=\\\"#Organization_45a5c5b1-4ec1-4d60-b4b2-ff5a84a41fd7\\\">See above (Organization/45a5c5b1-4ec1-4d60-b4b2-ff5a84a41fd7)</a></p><p><b>hasMember</b>: </p><ul><li><a href=\\\"#Observation_aa11a2be-3e36-4be7-b58a-6fc3dace2741\\\">See above (Observation/aa11a2be-3e36-4be7-b58a-6fc3dace2741)</a></li><li><a href=\\\"#Observation_6e39ccf3-f997-4a2b-8f28-b4b71c778c70\\\">See above (Observation/6e39ccf3-f997-4a2b-8f28-b4b71c778c70)</a></li><li><a href=\\\"#Observation_b4916505-a06b-460c-9be8-011609282457\\\">See above (Observation/b4916505-a06b-460c-9be8-011609282457)</a></li><li><a href=\\\"#Observation_a6a5a1d5-c896-4c7e-b922-888fcc7e6ae4\\\">See above (Observation/a6a5a1d5-c896-4c7e-b922-888fcc7e6ae4)</a></li></ul></div>\"\r\n        },\r\n        \"status\": \"final\",\r\n        \"category\": [\r\n          {\r\n            \"coding\": [\r\n              {\r\n                \"system\": \"http://terminology.hl7.org/CodeSystem/observation-category\",\r\n                \"code\": \"laboratory\"\r\n              }\r\n            ]\r\n          }\r\n        ],\r\n        \"code\": {\r\n          \"text\": \"Blood typing\"\r\n        },\r\n        \"subject\": {\r\n          \"reference\": \"Patient/2b90dd2b-2dab-4c75-9bb9-a355e07401e8\"\r\n        },\r\n        \"effectiveDateTime\": \"2015-10-10\",\r\n        \"performer\": [\r\n          {\r\n            \"reference\": \"Organization/45a5c5b1-4ec1-4d60-b4b2-ff5a84a41fd7\"\r\n          }\r\n        ],\r\n        \"hasMember\": [\r\n          {\r\n            \"reference\": \"Observation/aa11a2be-3e36-4be7-b58a-6fc3dace2741\"\r\n          },\r\n          {\r\n            \"reference\": \"Observation/6e39ccf3-f997-4a2b-8f28-b4b71c778c70\"\r\n          },\r\n          {\r\n            \"reference\": \"Observation/b4916505-a06b-460c-9be8-011609282457\"\r\n          },\r\n          {\r\n            \"reference\": \"Observation/a6a5a1d5-c896-4c7e-b922-888fcc7e6ae4\"\r\n          }\r\n        ]\r\n      }\r\n    },\r\n    {\r\n      \"fullUrl\": \"urn:uuid:cc354e00-a419-47ea-8b6c-1768b2a01646\",\r\n      \"resource\": {\r\n        \"resourceType\": \"Observation\",\r\n        \"id\": \"cc354e00-a419-47ea-8b6c-1768b2a01646\",\r\n        \"text\": {\r\n          \"status\": \"generated\",\r\n          \"div\": \"<div xmlns=\\\"http://www.w3.org/1999/xhtml\\\"><p><b>Generated Narrative</b></p><div style=\\\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\\\"><p style=\\\"margin-bottom: 0px\\\">Resource \\\"cc354e00-a419-47ea-8b6c-1768b2a01646\\\" </p></div><p><b>status</b>: final</p><p><b>category</b>: Laboratory <span style=\\\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\\\"> (<a href=\\\"http://terminology.hl7.org/3.1.0/CodeSystem-observation-category.html\\\">Observation Category Codes</a>#laboratory)</span></p><p><b>code</b>: Hemoglobin A1c/Hemoglobin.total in Blood by HPLC <span style=\\\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\\\"> (<a href=\\\"https://loinc.org/\\\">LOINC</a>#17856-6)</span></p><p><b>subject</b>: <a href=\\\"#Patient_2b90dd2b-2dab-4c75-9bb9-a355e07401e8\\\">See above (Patient/2b90dd2b-2dab-4c75-9bb9-a355e07401e8)</a></p><p><b>effective</b>: 2017-11-10 08:20:00+0100</p><p><b>performer</b>: <a href=\\\"#Organization_45a5c5b1-4ec1-4d60-b4b2-ff5a84a41fd7\\\">See above (Organization/45a5c5b1-4ec1-4d60-b4b2-ff5a84a41fd7)</a></p><p><b>value</b>: 7.5 %<span style=\\\"background: LightGoldenRodYellow\\\"> (Details: UCUM code % = '%')</span></p><p><b>note</b>: Above stated goal of 7.0 %</p></div>\"\r\n        },\r\n        \"status\": \"final\",\r\n        \"category\": [\r\n          {\r\n            \"coding\": [\r\n              {\r\n                \"system\": \"http://terminology.hl7.org/CodeSystem/observation-category\",\r\n                \"code\": \"laboratory\"\r\n              }\r\n            ]\r\n          }\r\n        ],\r\n        \"code\": {\r\n          \"coding\": [\r\n            {\r\n              \"system\": \"http://loinc.org\",\r\n              \"code\": \"17856-6\",\r\n              \"display\": \"Hemoglobin A1c/Hemoglobin.total in Blood by HPLC\"\r\n            }\r\n          ]\r\n        },\r\n        \"subject\": {\r\n          \"reference\": \"Patient/2b90dd2b-2dab-4c75-9bb9-a355e07401e8\"\r\n        },\r\n        \"effectiveDateTime\": \"2017-11-10T08:20:00+01:00\",\r\n        \"performer\": [\r\n          {\r\n            \"reference\": \"Organization/45a5c5b1-4ec1-4d60-b4b2-ff5a84a41fd7\"\r\n          }\r\n        ],\r\n        \"valueQuantity\": {\r\n          \"value\": 7.5,\r\n          \"unit\": \"%\",\r\n          \"system\": \"http://unitsofmeasure.org\",\r\n          \"code\": \"%\"\r\n        },\r\n        \"note\": [\r\n          {\r\n            \"text\": \"Above stated goal of 7.0 %\"\r\n          }\r\n        ]\r\n      }\r\n    },\r\n    {\r\n      \"fullUrl\": \"urn:uuid:26bee0a9-5997-4557-ab9d-c6adbb05b572\",\r\n      \"resource\": {\r\n        \"resourceType\": \"Observation\",\r\n        \"id\": \"26bee0a9-5997-4557-ab9d-c6adbb05b572\",\r\n        \"text\": {\r\n          \"status\": \"generated\",\r\n          \"div\": \"<div xmlns=\\\"http://www.w3.org/1999/xhtml\\\"><p><b>Generated Narrative</b></p><div style=\\\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\\\"><p style=\\\"margin-bottom: 0px\\\">Resource \\\"26bee0a9-5997-4557-ab9d-c6adbb05b572\\\" </p></div><p><b>status</b>: final</p><p><b>category</b>: Laboratory <span style=\\\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\\\"> (<a href=\\\"http://terminology.hl7.org/3.1.0/CodeSystem-observation-category.html\\\">Observation Category Codes</a>#laboratory)</span></p><p><b>code</b>: Bacteria identified in Isolate <span style=\\\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\\\"> (<a href=\\\"https://loinc.org/\\\">LOINC</a>#42803-7)</span></p><p><b>subject</b>: <a href=\\\"#Patient_2b90dd2b-2dab-4c75-9bb9-a355e07401e8\\\">See above (Patient/2b90dd2b-2dab-4c75-9bb9-a355e07401e8)</a></p><p><b>effective</b>: 2017-12-10 08:20:00+0100</p><p><b>performer</b>: <a href=\\\"#Organization_45a5c5b1-4ec1-4d60-b4b2-ff5a84a41fd7\\\">See above (Organization/45a5c5b1-4ec1-4d60-b4b2-ff5a84a41fd7)</a></p><p><b>value</b>: Methicillin resistant Staphylococcus aureus <span style=\\\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\\\"> (<a href=\\\"https://browser.ihtsdotools.org/\\\">SNOMED CT</a>#115329001)</span></p><p><b>note</b>: Healthy carrier of MRSA</p></div>\"\r\n        },\r\n        \"status\": \"final\",\r\n        \"category\": [\r\n          {\r\n            \"coding\": [\r\n              {\r\n                \"system\": \"http://terminology.hl7.org/CodeSystem/observation-category\",\r\n                \"code\": \"laboratory\"\r\n              }\r\n            ]\r\n          }\r\n        ],\r\n        \"code\": {\r\n          \"coding\": [\r\n            {\r\n              \"system\": \"http://loinc.org\",\r\n              \"code\": \"42803-7\",\r\n              \"display\": \"Bacteria identified in Isolate\"\r\n            }\r\n          ]\r\n        },\r\n        \"subject\": {\r\n          \"reference\": \"Patient/2b90dd2b-2dab-4c75-9bb9-a355e07401e8\"\r\n        },\r\n        \"effectiveDateTime\": \"2017-12-10T08:20:00+01:00\",\r\n        \"performer\": [\r\n          {\r\n            \"reference\": \"Organization/45a5c5b1-4ec1-4d60-b4b2-ff5a84a41fd7\"\r\n          }\r\n        ],\r\n        \"valueCodeableConcept\": {\r\n          \"coding\": [\r\n            {\r\n              \"system\": \"http://snomed.info/sct\",\r\n              \"code\": \"115329001\",\r\n              \"display\": \"Methicillin resistant Staphylococcus aureus\"\r\n            }\r\n          ]\r\n        },\r\n        \"note\": [\r\n          {\r\n            \"text\": \"Healthy carrier of MRSA\"\r\n          }\r\n        ]\r\n      }\r\n    },\r\n    {\r\n      \"fullUrl\": \"urn:uuid:c7781f44-6df8-4a8b-9e06-0b34263a47c5\",\r\n      \"resource\": {\r\n        \"resourceType\": \"AllergyIntolerance\",\r\n        \"id\": \"c7781f44-6df8-4a8b-9e06-0b34263a47c5\",\r\n        \"text\": {\r\n          \"status\": \"generated\",\r\n          \"div\": \"<div xmlns=\\\"http://www.w3.org/1999/xhtml\\\"><p><b>Generated Narrative</b></p><div style=\\\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\\\"><p style=\\\"margin-bottom: 0px\\\">Resource \\\"c7781f44-6df8-4a8b-9e06-0b34263a47c5\\\" </p></div><p><b>clinicalStatus</b>: Active <span style=\\\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\\\"> (<a href=\\\"http://terminology.hl7.org/3.1.0/CodeSystem-allergyintolerance-clinical.html\\\">AllergyIntolerance Clinical Status Codes</a>#active)</span></p><p><b>code</b>: No known food allergies <span style=\\\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\\\"> (<a href=\\\"CodeSystem-absent-unknown-uv-ips.html\\\">Absent and Unknown Data - IPS</a>#no-known-food-allergies)</span></p><p><b>patient</b>: <a href=\\\"#Patient_2b90dd2b-2dab-4c75-9bb9-a355e07401e8\\\">See above (Patient/2b90dd2b-2dab-4c75-9bb9-a355e07401e8)</a></p></div>\"\r\n        },\r\n        \"clinicalStatus\": {\r\n          \"coding\": [\r\n            {\r\n              \"system\": \"http://terminology.hl7.org/CodeSystem/allergyintolerance-clinical\",\r\n              \"code\": \"active\"\r\n            }\r\n          ]\r\n        },\r\n        \"code\": {\r\n          \"coding\": [\r\n            {\r\n              \"system\": \"http://hl7.org/fhir/uv/ips/CodeSystem/absent-unknown-uv-ips\",\r\n              \"code\": \"no-known-food-allergies\"\r\n            }\r\n          ]\r\n        },\r\n        \"patient\": {\r\n          \"reference\": \"Patient/2b90dd2b-2dab-4c75-9bb9-a355e07401e8\"\r\n        }\r\n      }\r\n    }\r\n  ]\r\n}",
							"options": {
								"raw": {
									"language": "json"
								}
							}
						},
						"url": {
							"raw": "{{url}}/med-information/med-informations/6315d832714cef6c95a8ae51",
							"host": [
								"{{url}}"
							],
							"path": [
								"med-information",
								"med-informations",
								"6315d832714cef6c95a8ae51"
							]
						}
					},
					"response": []
				},
				{
					"name": "Delete information",
					"event": [
						{
							"listen": "test",
							"script": {
								"exec": [
									"pm.test(\"Status code is 200\", function () {\r",
									"    pm.response.to.have.status(200);\r",
									"});"
								],
								"type": "text/javascript"
							}
						}
					],
					"request": {
						"method": "DELETE",
						"header": [],
						"url": {
							"raw": "{{url}}/med-information/med-informations/{{id}}",
							"host": [
								"{{url}}"
							],
							"path": [
								"med-information",
								"med-informations",
								"{{id}}"
							]
						}
					},
					"response": []
				}
			]
		}
	],
	"variable": [
		{
			"key": "url",
			"value": "https://gravitate-health.lst.tfo.upm.es"
		},
		{
			"key": "realm",
			"value": "GravitateHealth"
		},
		{
			"key": "client",
			"value": "GravitateHealth"
		},
		{
			"key": "username",
			"value": "user-test@gh.com"
		},
		{
			"key": "password",
			"value": "Alumni-diabetic-attentive1"
		},
		{
			"key": "auth_key",
			"value": ""
		},
		{
			"key": "id",
			"value": "0"
		}
	]
}